0001437749-23-008107.txt : 20230328 0001437749-23-008107.hdr.sgml : 20230328 20230328110535 ACCESSION NUMBER: 0001437749-23-008107 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230328 DATE AS OF CHANGE: 20230328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OCULUS VISIONTECH INC. CENTRAL INDEX KEY: 0001107280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 061576391 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29651 FILM NUMBER: 23767097 BUSINESS ADDRESS: STREET 1: 837 WEST HASTINGS STREET STREET 2: SUITE 507 CITY: VANCOUVER STATE: A1 ZIP: V6C 3N6 BUSINESS PHONE: 6046851017 MAIL ADDRESS: STREET 1: 837 WEST HASTINGS STREET STREET 2: SUITE 507 CITY: VANCOUVER STATE: A1 ZIP: V6C 3N6 FORMER COMPANY: FORMER CONFORMED NAME: OCULUS VISION TECH INC. DATE OF NAME CHANGE: 20120201 FORMER COMPANY: FORMER CONFORMED NAME: USA VIDEO INTERACTIVE CORP DATE OF NAME CHANGE: 20000217 10-K 1 ovtz20221231_10k.htm FORM 10-K ovtz20221231_10k.htm
0001107280 OCULUS VISIONTECH INC. false --12-31 FY 2022 0 0 250,000,000 250,000,000 0 0 0 0 500,000,000 500,000,000 91,422,569 91,422,569 91,422,569 91,422,569 0.02 0 500,000,000 0.80 3,920,000 1 1 1 1.00 2.50 10 45,500 10 0.80 54,600 119.10 1.24 0 0.78 36,511 1.20 424,300 125.00 0.14 0 1.18 285,557 115,811 0.80 211,700 120.80 0.25 0 0.80 101,058 83,351 0.60 219,100 119.89 0.63 0 0.54 42,819 128,164 0.35 909,900 125 0.27 0 0.35 406,133 129,990 0.45 75,800 125 0.02 0 0.425 52,835 18,207 July 21, 2023 December 21, 2023 January 29, 2024 June 10, 2024 October 14, 2024 January 31, 2025 1.00 0 00011072802022-01-012022-12-31 iso4217:USD 00011072802022-06-30 xbrli:shares 00011072802023-03-28 thunderdome:item 00011072802022-12-31 00011072802021-12-31 iso4217:USDxbrli:shares 00011072802021-01-012021-12-31 0001107280us-gaap:CommonStockMember2020-12-31 0001107280us-gaap:AdditionalPaidInCapitalMember2020-12-31 0001107280ovtz:CommitmentToIssueSharesMember2020-12-31 0001107280us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-31 0001107280us-gaap:RetainedEarningsMember2020-12-31 00011072802020-12-31 0001107280us-gaap:CommonStockMember2021-01-012021-12-31 0001107280us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-31 0001107280ovtz:CommitmentToIssueSharesMember2021-01-012021-12-31 0001107280us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-31 0001107280us-gaap:RetainedEarningsMember2021-01-012021-12-31 0001107280us-gaap:CommonStockMember2021-12-31 0001107280us-gaap:AdditionalPaidInCapitalMember2021-12-31 0001107280ovtz:CommitmentToIssueSharesMember2021-12-31 0001107280us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-31 0001107280us-gaap:RetainedEarningsMember2021-12-31 0001107280us-gaap:CommonStockMember2022-01-012022-12-31 0001107280us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-31 0001107280ovtz:CommitmentToIssueSharesMember2022-01-012022-12-31 0001107280us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-31 0001107280us-gaap:RetainedEarningsMember2022-01-012022-12-31 0001107280us-gaap:CommonStockMember2022-12-31 0001107280us-gaap:AdditionalPaidInCapitalMember2022-12-31 0001107280ovtz:CommitmentToIssueSharesMember2022-12-31 0001107280us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-31 0001107280us-gaap:RetainedEarningsMember2022-12-31 xbrli:pure 0001107280ovtz:ComplytrustIncMember2022-12-31 0001107280ovtz:ComplytrustIncMember2021-12-31 0001107280us-gaap:EmployeeStockOptionMember2022-01-012022-12-31 0001107280us-gaap:EmployeeStockOptionMember2021-01-012021-12-31 0001107280us-gaap:WarrantMember2022-01-012022-12-31 0001107280us-gaap:WarrantMember2021-01-012021-12-31 0001107280us-gaap:PrivatePlacementMember2021-06-142021-06-14 iso4217:CADxbrli:shares iso4217:CAD 0001107280us-gaap:PrivatePlacementMember2021-06-14 0001107280ovtz:WarrantsIssuedInConnectionWithPrivatePlacementMember2021-06-14 utr:M 0001107280ovtz:WarrantsIssuedInConnectionWithPrivatePlacementMember2021-06-142021-06-14 0001107280ovtz:RollingStockOptionPlanMember2022-12-30 0001107280ovtz:RollingStockOptionPlanMember2021-12-31 0001107280ovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2022-01-012022-12-30 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary312025Memberovtz:RollingStockOptionPlanMember2022-01-012022-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary312025Memberovtz:RollingStockOptionPlanMember2022-12-31 utr:Y 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary312025Memberovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2022-01-012022-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Memberovtz:RollingStockOptionPlanMember2021-12-012021-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Memberovtz:RollingStockOptionPlanMember2021-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Memberovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2021-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Memberovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2021-12-012021-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Memberovtz:RollingStockOptionPlanMember2022-12-012022-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJune102024Memberovtz:RollingStockOptionPlanMember2021-01-012021-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJune102024Memberovtz:RollingStockOptionPlanMember2021-12-31 0001107280us-gaap:EmployeeStockOptionMemberovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2021-01-012021-12-31 0001107280us-gaap:EmployeeStockOptionMemberovtz:RollingStockOptionPlanMember2021-01-012021-09-30 0001107280us-gaap:EmployeeStockOptionMemberovtz:RollingStockOptionPlanMember2022-01-012022-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfOctober142024Memberovtz:RollingStockOptionPlanMember2021-01-012021-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfOctober142024Memberovtz:RollingStockOptionPlanMember2021-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfOctober142024Memberovtz:RollingStockOptionPlanMemberovtz:VestingEverySixMonthsMember2021-01-012021-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfOctober142024Memberovtz:RollingStockOptionPlanMember2022-01-012022-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMember2020-01-012020-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMember2020-12-31 0001107280us-gaap:EmployeeStockOptionMemberovtz:RollingStockOptionPlanMember2020-01-012020-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2020-01-012020-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMember2021-01-012021-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfJuly212023Memberovtz:RollingStockOptionPlanMember2022-01-012022-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMember2020-12-212020-12-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMember2020-12-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMember2020-01-012020-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2020-12-212020-12-21 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMember2021-01-012021-12-31 0001107280ovtz:EmployeeStockOptionExpirationDateOfDecember212023Memberovtz:RollingStockOptionPlanMember2022-01-012022-12-31 0001107280ovtz:RangeOneMember2022-12-31 0001107280ovtz:RangeOneMember2022-01-012022-12-31 0001107280ovtz:RangeTwoMember2022-12-31 0001107280ovtz:RangeTwoMember2022-01-012022-12-31 0001107280ovtz:RangeThreeMember2022-12-31 0001107280ovtz:RangeThreeMember2022-01-012022-12-31 0001107280ovtz:RangeFourMember2022-12-31 0001107280ovtz:RangeFourMember2022-01-012022-12-31 0001107280ovtz:RangeFiveMember2022-12-31 0001107280ovtz:RangeFiveMember2022-01-012022-12-31 0001107280ovtz:RangeSixMember2022-12-31 0001107280ovtz:RangeSixMember2022-01-012022-12-31 0001107280us-gaap:EmployeeStockOptionMember2022-01-012022-12-31 0001107280us-gaap:EmployeeStockOptionMember2021-01-012021-12-31 0001107280us-gaap:EmployeeStockOptionMember2022-12-31 0001107280us-gaap:EmployeeStockOptionMember2021-12-31 0001107280ovtz:WarrantsExpiringOnApril192023Member2022-12-31 0001107280ovtz:WarrantsExpiringOnApril192023Member2022-01-012022-12-31 0001107280ovtz:WarrantsExpiringOnJune42025Member2022-12-31 0001107280ovtz:WarrantsExpiringOnJune42025Member2022-01-012022-12-31 0001107280us-gaap:ForeignCountryMemberus-gaap:CanadaRevenueAgencyMember2022-12-31 0001107280us-gaap:ForeignCountryMemberus-gaap:CanadaRevenueAgencyMember2021-12-31 0001107280us-gaap:DomesticCountryMemberus-gaap:InternalRevenueServiceIRSMember2022-12-31 0001107280us-gaap:DomesticCountryMemberus-gaap:InternalRevenueServiceIRSMember2021-12-31 0001107280us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-12-31 0001107280us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-31 0001107280ovtz:SharebasedCompensationMember2022-01-012022-12-31 0001107280ovtz:SharebasedCompensationMember2021-01-012021-12-31 0001107280ovtz:ReimbursementMember2022-01-012022-12-31 0001107280ovtz:ReimbursementMember2021-01-012021-12-31 0001107280us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-12-31 0001107280us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-12-31 0001107280ovtz:VancouverCAOperatingLeaseMember2022-01-012022-12-31 0001107280ovtz:VancouverCAOperatingLeaseMember2021-01-012021-12-31
 
 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-K

 

ANNUAL REPORT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the fiscal year ended December 31, 2022

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission file number 000-29651

 

ovtz20221231_10kimg001.jpg

 

 

OCULUS VISIONTECH INC.

 

 


 

(Exact name of registrant as specified in its charter)

 

Wyoming 

 

06-1576391

(State or Other Jurisdiction of 

 

(I.R.S. Employer Identification No.)

Incorporation of Organization)

  

 

#507, 837 West Hastings Street, Vancouver, BC

V6C 3N6

(Address of principal executive offices)

(ZIP Code)

 

Registrant’s telephone number, including area code:

(604) 685-1017

 

Securities registered pursuant to Section 12(b) of the Act:         None         

 

Title of Each Class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

 

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, no par value

(Title of Class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant as required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐.

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or fur such shorter period that the registrant was required to submit such files). Yes ☒ No ☐.

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

  

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes No ☒.

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold as of the last business day of the registrant’s most recently completed second fiscal quarter ($0.61 on June 30, 2021) was approximately $37.8 million.

 

The registrant had 91,422,469 shares of common stock outstanding as of March 28, 2023.

 

 

 

 

TABLE OF CONTENTS

 

Part 1

 

Item 1 

Description of Business

5

Item 1A

Risk Factors

14

Item 1B

Unresolved Staff Comments

21

Item 2

Description of Properties

21

Item 3

Legal Proceedings

21

Item 4

Mine Safety Disclosure

21
     

Part II

 

Item 5

Market for Registrations Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

22

Item 6

Selected Financial Data

27

Item 7

Managements Discussion and Analysis of Financial Condition and Results of Operation

28

Item 7A

Quantitative and Qualitative Disclosures About Market Risk

30

Item 8

Financial Statements and Supplementary Data

30

Item 9A

Controls and Procedures

51

Item 9B

Other Information

52

Item 9C

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

52
     

PART III

 

Item 10

Directors, Executive Officers and Corporate Governance

53

Item 11

Executive Compensation

57

Item 12

Security Ownership of Certain Beneficial Owners and Management

60

Item 13

Certain Relationships and Related Transactions

61

Item 14

Principal Accountant Fees and Services

61

Item 15

Exhibits, Financial Statement Schedules, and Reports on Form 8-K

62

Item 16

Form 10-K Summary

63

 

 

 

 

GENERAL

 

References herein to "we," "us," and "the Company" are to Oculus VisionTech Inc. and our subsidiary.

 

Cautionary Statement regarding Forward-Looking Statements

 

This annual report on Form 10-K contains "forward-looking statements" within the meaning of the Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements made in this annual report, other than statements of historical fact, including statements addressing operating and financial performance, our products and services, including our digital watermarking technology and Cloud-based document protection system, our data privacy and data protection services and solutions, our technology, our cash needs, including our ability to fund our future capital expenditures and working capital requirements, and our expectations regarding competition and growth in our sector, are forward looking statements. Because they refer to future events or conditions, forward-looking statements may include words such as "anticipate," "believe," "estimate," "intend," "could," "should," "would," "may," "seek," "plan," "might," "will," "expect," "predict," "project," "forecast," "potential," "continue," "up to," and similar terms and phrases. Though we believe that the expectations reflected in these statements are reasonable, they involve certain assumptions, risks and uncertainties. For a discussion of the risks, uncertainties and assumptions that could affect our future events, developments or results, you should carefully review the risk factors described in "Item 1A. Risk Factors" below in this annual report, as well as "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" below in this annual report. Many of those factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. All subsequent written and oral forward-looking statements concerning other matters addressed in this Report and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this annual report. Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

 

Exchange Rate for Canadian Dollar

 

The accounts for Oculus are maintained in Canadian dollars which is the Company's functional currency. All dollar amounts contained herein are expressed in U.S. dollars, except as otherwise indicated. As at March 28, 2023, the exchange rate for Canadian dollars/United States dollars based on the Bank of Canada closing rate was $1.00 (CAD) = $0.7297 (U.S.).

 

Set forth below are the exchange rates based on the Bank of Canada noon rates for the Canadian dollar equivalent expressed in United States currency during 2022 and 2021.

 

   

Years ended December 31,

 
   

2022

   

2021

 

At End of Year

    0.7383       0.7824  

Average

    0.7692       0.8043  

High

    0.8031       0.8306  

Low

    0.7217       0.7727  

 

 

PART I

 

 

Item 1.

Description of Business

 

Overview

 

Oculus VisionTech Inc. (OVTZ) is a Canadian-based development-stage technology company focused on cyber security, data privacy and data protection solutions for Enterprise business customers. Headquartered in Vancouver, British Columbia, Canada, the company was originally founded by image processing experts and is operated by experienced leadership. Currently, OVTZ is expanding and investing in a suite of new data protection and data privacy security products that will revolutionize CCPA, GDPR, LGPD and other data privacy legislation compliance for both data subjects and data controllers worldwide. Our mission is to provide intelligent software tools for continual enablement of data privacy and data protection for individuals, organizations and their customers worldwide, through a vision of mutually trusted data governance compliance.

 

Our Forget-Me-Yes® data privacy product is a Software-as-a-Service (SaaS) platform developed to specifically address the global ‘Right-to-be-Forgotten’ (RtbF) and Right-of-Erase (RoE) data subject deletion request legal compliance components of Brazil’s LGPD, Europe’s GDPR, California’s Consumer Privacy Act (CCPA), China’s Personal Information Protection Law (PIPL), Colorado’s Consumer Protection Act (CPA), Virginia’s Consumer Data Protection Act (CDPA) and Washington’s Privacy Act (WPA) regulations. Additional new data protection software tools are being developed to address public cloud data governance compliance globally. Our Cloud Document Protection System (Cloud-DPS) technology leverages our digital watermarking technology enabling OVTZ to offer a SaaS-based document management platform for tamper-proof document authentication and protection. Historically, we have used our digital watermarking technology for streaming video content distribution based on embedded digital watermarking, as well as video-on-demand (VOD) systems, services and source-to-destination digital media delivery solutions that allow live or recorded digitized and compressed video to be transmitted through Internet, intranet, satellite or wireless connectivity.

 

We were incorporated on April 18, 1986, as "First Commercial Financial Group Inc." in the Province of Alberta, Canada. In 1989, our name was changed to "Micron Metals Canada Corp.", which purchased 100% of the outstanding shares of USA Video Inc., a Texas corporation, in order to focus on the digital media business. In 1995, we changed our name to "USA Video Interactive Corp." and continued out of the Province of Alberta into the State of Wyoming. At a shareholders meeting held on December 30, 2011, a resolution was passed to change our name to "Oculus VisionTech Inc." and to alter our share capital by way of a reverse stock split (share consolidation) on the basis of fifteen old common shares for one new common share. On January 25, 2012, we changed our name to "Oculus VisionTech Inc." In June 2020, OVTZ acquired OCL Technologies Corp. (“OCL”), a Delaware corporation data privacy software development startup based in San Diego, California. As a 100% wholly-owned subsidiary of OVTZ and to better align with customer and market focus, OCL has completed a corporate name change to ComplyTrust® Inc. (“CTI”) on January 21, 2021. Any and all OCL references throughout this document are synonymous with the new name change, CTI.

 

Our executive and corporate headquarter offices are located at Suite 507, 837 West Hastings Street, Vancouver, British Columbia, Canada, V6C 3N6. Our telephone number is 1-800-684-0183 and our facsimile number is 604-685-5777. Our email address is contact@ovtz.com and our website is www.ovtz.com. Our common shares are listed for trading on the TSX Venture Exchange (TSX.V – OVT, OTCQB – OVTZ, FSE – USF1).

 

Business Environment and Market Opportunity

 

In this age of digital transformation, data monetization, IoT, and massive data migration to converged hyperscale, geo-disbursed Cloud infrastructure and workloads, data protection and data privacy have taken center stage. GDPR, LGPD, CCPA, and many other new international (China, India) and upcoming US data privacy regulations enable individuals and organizations the right to access and request deletion of all personal information for a given data subject. In our ever increasing Everything-as-a-Service world, OVTZ recognizes the need for global cloud-native data privacy and data protection solutions that are multi-cloud platform-ready and can augment both existing legacy and newer agile-driven architectures. OVTZ is building modular microservices-based software solutions and services for both hybrid on-premise and multi-cloud data management that incorporate automated malware, privacy and ransomware scanning, reporting and visualization.

 

 

Our new Forget-Me-Yes® (FMY) Software-as-a-Service (SaaS) data privacy solution is a highly-secure, Zero-Knowledge platform providing a single-source capability of continuous ‘right-to-be-forgotten’ (RtbF) and ‘right-of-erase’ (RoE) privacy compliance by incorporating automated policy-driven re-query services that guarantees a Data Subject’s requested RtbF/RoE data remains ‘forgotten’ over the life of their FMY subscription. FMY incorporates hybrid polymorphic encryption technology that ensures all User Interface, data-in-transit and data-at-rest remain secure and can only be accessed by the subscriber. With a cloud-native architecture, the FMY functionality can be utilized as either a complete turnkey SaaS subscription platform, or individually licensed for seamless integration with existing 3rd. party applications and data privacy platforms.

 

Our new ComplyTrust® Software-as-a-Service Suite (CTSS) is a set of software tools specifically designed to address cloud-native data management and regulatory compliant data governance. CTSS will help to remove enterprise organizational barriers and blockers to further enable successful cloud migration and deployment that benefit the cloud infrastructure providers, enterprise organizations, and users collectively. CTSS helps to automate and visualize cloud compliance reporting across accounts, regions and services based on a variety of user-definable and data driven metrics.

 

OVTZ had recognized that cloud-based, digital document security/protection products were a potentially viable business opportunity for the Company that allowed us to apply our proprietary real-time digital video watermarking technology, originally developed for studios and networks in the entertainment industry, to the digital document security/protection market. Cloud-DPS secures and protects digital documents (including text documents, photos, blueprints, etc.) from any modification, and/or attempted forgery by imperceptibly watermarking documents, using real-time image processing and watermarking algorithms, embedded into a secured/protected copy of a document. This authentication and verification process ensures the integrity of the original digital document.

 

Strategic Plan

 

Our strategic plan is to first introduce the cloud-native Forget-Me-Yes® (FMY) data privacy SaaS platform under the AWS Web Services Cloud infrastructure on a monthly subscription basis for structured data. Initial release will include subscriber connections specific to Salesforce organizations with other connectors to be added over time, including but not limited to AWS RDS, Hubspot, Marketo, Shopify, and more. Additional connectors for Database-as-a-Service (DBaaS) providers for MySQL, NoSQL and SQL databases, for both structured and unstructured data, are also planned. Going forward, we plan to license FMY API microservices for integration with 3rd. party application partners, software providers and potential OEM’s. FMY’s cloud native enables it to be integrated and run under any on-premises, hybrid or alternative cloud infrastructure.

 

The ComplyTrust® SaaS Suite (CTSS) strategic plan for the data protection market is to first introduce Amazon Web Services (AWS) tools to help AWS customers better manage organizational data protection and compliance in an automated and cloud-native fashion. As customer attainment increases, additional planned CTSS features will be rolled out to perform additional applicable data governance and management functionality. Additional CTSS plans include integration with 3rd. party software providers to provide an automated single-pane-of-glass solution for enterprise organizations worldwide.

 

The Cloud-DPS plan is to re-evaluate the current potential addressable market and underlying architecture to determine next steps in the Cloud-DPS evolution, as it very well could become an additional component in the CTSS toolset. Limited past market adoption and revenues indicate the need for a new Cloud-DPS strategy going forward, stay tuned.

 

Proprietary Technologies

 

Our Forget-Me-Yes® patent-pending process locates, organizes and manages Data Subject RtbF and RoE personal information for FMY subscribers in a secure, efficient and persistent way. Automated and schedule compliance enables organizations to avoid regulatory distraction to focus on core business competencies. Our FMY zero-knowledge 3rd. party audit features provide arguable good faith and best practices to avoid litigation, fines, penalties and potential brand damage associated with bad publicity surrounding a data privacy compliance infraction.

 

 

Our DPS technology ‘personalizes’ protected documents, based on their content, thereby creating a format invariant watermarking system. A document converted into a PDF document is encrypted before delivery, such that it cannot be opened without providing proper credentials. The result is that a document watermarking system can be offered as a cloud-based software service that can:

 

 

Protect - Accept any incoming document through a web portal, watermark it and return the watermarked document as a PDF document.

 

Authenticate - The "document authenticator" is also a cloud-based software service that can accept the watermarked document and validate the authenticity of the documents.

 

Our DPS technology combines the access control security for electronic documents, forensic grade anti-tampering technology based on the document's content "understanding", and optional data storage into a single, unique solution. Because of its cloud-based scalable architecture, the DPS has potential to expand and grow into a complete document management, security and storage eco-system within the CTSS product suite, particularly in conjunction with FMY-specific unstructured data privacy scanning capabilities.

 

Products and Services

 

Our principal products are our new Forget-Me-Yes® (FMY) data privacy SaaS solution and CTSS data protection tools, along with our legacy Cloud-DPS solution.

 

Forget-Me-Yes® (FMY)

 

The Forget-Me-Yes® (FMY) Software-as-a-Service Platform specifically manages both Organizational and Individual Right-to-be-Forgotten (RtbF) and Right-of-Erase (RoE) compliance of data subject deletion requests of structured data for Brazil’s LGPD, Europe’s GDPR, California’s Consumer Privacy Act (CCPA), China’s Personal Information Protection Law (PIPL), Colorado’s Consumer Protection Act (CPA), Virginia’s Consumer Data Protection Act (CDPA) and Washington’s Privacy Act (WPA) regulations.

 

 

Features include easy integration, in-time and automated continuous compliance all from a secure subscription-based cloud-native application.

 

Locates, organizes and manages Data Subject personal information for FMY subscribers in a secure, efficient, and persistent way.  

 

Automated/scheduled compliance enables organizations to avoid regulatory distraction to focus on core business competencies.

 

Secure, zero-knowledge 3rd. Party audit features ensuring regulatory compliance.

 

Provides arguable good faith and best practices for companies to avoid litigation, penalties and brand damage associated with bad publicity.

 

 

FMY enables secure discovery and delete requests against multiple data sources, ensuring the data subject is never inadvertently “remembered.” FMY securely stores a single record of each data subject query request data to meet GDPR, LGPD and CCPA regulatory compliance. The open API-first design structure of FMY enables quick and seamless integration of future new US and global privacy law compliance regulations, along with the ability to be licensed for 3rd party application and platform integration.

 

ComplyTrust® SaaS Suite (CTSS)

 

The CTSS is designed to enhance cloud-native services efficiency and optionality for both legacy and integrated cloud services that contain significant gaps in feature coverage. Our initial CTSS product offering help customers with cloud-native compliance and operational efficiency while facilitating significant new cloud services opportunities for the public cloud sales teams directly. Additional planned CTSS optional tools include data privacy and security tools, for a variety of cloud services providers, including the AWS Cloud, Azure Cloud, Google Cloud platforms.

 

Cloud-DPS

 

Our Cloud-based DPS web service system architecture enhances already existing storage and collaboration solutions such as Box, DropBox and Google Drive, and more, by adding document tamper-proof protection and workflows such as document sign-offs, authentication, secure distribution and collaboration. The Cloud-DPS technology can be deployed and scaled in wide range of vertical markets such as Corporate agreements/contract management, IP protection, Real Estate contract management, HealthCare and Law Enforcement secure document management and a wide variety of Aerospace, Automotive and Engineering industrial applications.

 

 

Although the Cloud-DPS product is available today under a subscription-based licensing model, it is presently undergoing an engineering/architectural review to determine effort to modernize the underlying code-base into a cloud-native-based application that can also be bundled/integrated into and with the CTSS platform.

 

Customers and Markets

 

OVTZ intends to capture a significant portion of the cloud data privacy software and cloud native data protection service revenues within the $64.5B 2022 worldwide data protection market through a variety of OVTZ-developed cloud-native software tools within a 5-year timeframe. Global regulatory enforcement of data privacy legislation issued fines are breaking records each year, are non-insurable losses, and create unparalleled brand damage. The worldwide 2022 FinTech market fines of $7B increased by 50% from the previous year. OVTZ helps global organizations and individuals cost-effectively manage data privacy compliance. Currently OVTZ has no customers for our products and services. We are taking steps to monetize our new cloud-native CTSS and FMY solutions, as well as the legacy Cloud-DPS technology in FY23.

 

Forget-Me-Yes® (FMY)

 

FMY potential addressable markets cover a wide variety of data governance, data management, data privacy and data protection segments.

 

 

Global Enterprise Governance, Risk and Compliance (eGRC) 2022 market size was valued at $33.5B with a 15.7% CAGR reaching over $61B by 2026 (Source: Research&Markets)

 

GDPR services market alone is projecting 26% CAGR with revenues at $1.65B in 2022, while the GDPR Data Governance market exclusively is projecting 22% CAGR with revenues to reach $6B by 2026 (Source: Markets&Markets)

 

Global Enterprise data management platform market size of $84B in 2022 is forecasting a 12% CAGR (Source: GrandviewResearch)

 

Global Regulatory Technology (RegTech) market size of $7.9B in 2022 is forecasting a 20.4% CAGR thru 2026 (Source: Technavio)

 

Data Privacy Management FY22 revenues were $2.3B and are expected grow 40% annually thru 2026 (Source: FortuneBusinessInsights)

 

Initial FMY target market segment and customers will be Salesforce CRM organizations. Salesforce FY22 revenues were $26.49B, up 23% from prior year, with FY23 revenue guidance to $32.1B. With over 150,000 partners and customers across every vertical market segment, Saleforce is the #1 CRM platform worldwide. Top-10 customers include Accenture, Amazon Web Services, American Express, American Red Cross, CapGemini, Canon, Deloitte, IBM, NBC Universal, L’Oreal Americas and Toyota. Our initial FMY beta release was validated by The Corrao Group, who is the #5th. ranked Salesforce consulting partner worldwide. Additional initial FMY targets will be cloud DevOps service providers seeking to reduce compliance risk and Database-as-a-Service (DBaaS) providers.

 

ComplyTrust® SaaS Suite (CTSS)

 

CTSS potential addressable market opportunities cover a wide range within the data management and data protection segments.

 

 

Worldwide public cloud service revenues were $544B in FY22, with a forecasted 21% growth in FY23 (Source: SynergyResearch)

 

Worldwide FY22 public cloud market shares were AWS-34%, Azure-21%, AliBab-5%, GCP-11%, Other-29% (Source: Statista)

 

Worldwide FY22 cloud data storage market was $83B, forecasted to be $376B by 2029 (Source: FortuneBusiness)

 

Worldwide FY22 public cloud revenue represents only 12.3% of overall IT FY22 spend of $4.4Trillion. (Source: Gartner)

 

Enterprise business FY22 workloads were 57% within public cloud and 43% in private cloud (Source: Gartner)

 

Worldwide data protection market FY22 revenues were $120B, with a forecasted 16.89% CAGR thru 2029 (Source: MMR)

 

Worldwide cloud backup and recovery market segment was $12B in 2022, driven by an $8B FY22 Disaster Recovery-as-a-Service (DRaaS) market, forecasting a 34% CAGR thru 2026. (Source: Gartner)

     

 

CTSS customer focus will initially be within the cloud-native AWS segment within specific vertical markets including Aerospace, Financial Services, Genomics, Healthcare and Transportation. Follow-on cloud-native service enhancement targets include Azure, Digital Ocean, GCP, Rstor and Wasabi. Future CTSS offerings will include integration with other 3rd. party ISV’s and more.

 

Cloud-DPS

 

The original principal market for our Cloud-DPS product and services were businesses requiring digital document protection, authentication and storage. However, recent developments in the overall ‘digital watermark’ market lends a need to re-assess the current Cloud-DPS technology applications.

 

 

Worldwide digital signature and document services market has a forecasted growth of 20% Y/Y reaching $1.9B by 2023. (Source: Technavio)

 

DocuSign owns 76% of the worldwide digital document market, with their closest competitors Xink (12.6%), Adobe (3.2%), Nitro (2.4%) and SignNow (1.6%) marketshare. (Source: Datanyze)

 

Worldwide virtual data room market was $1.6B in FY22 forecasted to approach $4.3B by 2028 (Source: imarc)

 

Worldwide OTT content market revenues hit $1.6B in FY22 while losing 25-30% of revenues to content piracy (Source: Deloitte)

 

Worldwide automated content recognition market hit $4.6B in FY22 and is forecasted to reach $7.6B by 2026. (Source: Mordor)  

 

Potential new applications for Cloud-DPS technology include audio/audience monitoring marks, content integrity, content protection, forensics, reverse-image search, user tracing and most recently package identification, tracking and monitoring. One example is the recent ‘HolyGrail’ pilot project sponsored by the World Wildlife Fund, which is targeting businesses, government, individuals and industry for application of digital watermarks on post-consumer packaging for eco-friendly, Smart-City recycling of the high-volume plastic waste. The underlying digital watermark technology in Cloud-DPS could also be a potential candidate for the Digital Watermarks Initiative that strives for No Plastics In Nature by 2030 and supports seventeen (17) of the United Nations Sustainable Development Goals (SDG’s). To-date, there are over 80+ participants in the HolyGrail2.0 project striving for viability.

 

Materials and Supplies

 

We are actively in the process of building and implementing an integrated, highly-secure, agile software development and IT operations (DevSecOps) framework in conjunction with an independent 3rd party managed services and infrastructure provider. Our continuous integration/continuous delivery (CI/CD) pipeline process incorporates agile software development, test, QA and release tools, includes embedded security within our entire development and operations lifecycle. All components of our integrated project management and software development release process, inner-company and external communications processes, utilize state-of-the-art subscription-based software tools. All components and services employed by our company include backup/disaster recovery and high-availability infrastructure, processes and services. Both corporate and application-specific ISO/NIST security certifications and training are planned, as they will be required to successfully engage with our targeted Enterprise-class customers and markets. There are no seasonal limitations on our operations.

 

Competition

 

To successfully launch our products and services and derive revenues from our technology, we face competition from a number of companies with more established products and services within all our market sectors. Our specific key product technology differentiators, go-to-market efficiencies that clearly demonstrate OPEX cost benefits, will drive acceptance, adoption and relevance to meet and realize forecasted revenues. To the best of our knowledge and understanding of our competitive landscape, there are no seasonal limitations applicable. 

 

 

Forget-Me-Yes® (FMY)

 

 

OneTrust > Founded in 2016, with over $125M in FY22 revenues and a valuation of $5.1B (private), OneTrust is the leader in both data privacy management market share and revenues. Average subscription cost ranges from $27./month - $500./month+.

 

 

TrustArc > Founded in 1997, with over $31.8M in FY22 revenue, acquired Nymity for their data privacy management platform. Average subscription cost is available by custom quotation only.

 

 

BigID > Founded in 2015, with over $75M in FY22 revenue and a $1.25B valuation. Average subscription cost is available by custom quotation only.

 

 

ControlCase > Founded in 2004, with over $32.5M in FY22 revenues, are primarily focused on credit card PCI-DSS compliance. Average subscription cost starts at $500.+/month.

 

 

Privitar > Founded in 2014, with $12.9M in FY22 revenues, are primarily focused on Average subscription cost is available by custom quotation only.

 

All above competitors have ISO/NIST and other regulatory compliant data management certifications.

 

ComplyTrust® SaaS Suite (CTSS)

 

 

Daegis/OpenText > Originally founded in 1980 and acquired by OpenText in 2015 posted $2.9B in FY22 revenues, is primarily focused on Enterprise information management and data governance solutions.

 

 

StoredIQ > Founded in 2001 and acquired by IBM in 2012, with estimated $360M in FY22 revenues, a component of IBM’s Cloud data storage services suite.

 

 

Tibco > Founded in 1997, posted $540M FY22 revenues, with primary focus on Enterprise data governance.

 

 

Varonis > Founded in 2005, with revenues of $460M in FY22, primary focus on data security.

 

Cloud-DPS

 

Document Management-specific competitors

 

 

Adobe Doc Cloud > Founded in 2006 with revenues of $3.3B in FY22, is a close contender as the e-signature market share leader.

 

 

Docusign > Founded in 2003 with revenues of $2.1B in FY22, shares the overall lead market share with Adobe.

 

 

HelloSign > Founded in 2010 and acquired by Dropbox in 2019, reported revenues of $7.2M in FY22, primarily focused on digital document storage.

 

 

MSB Docs > Founded in 2003 with estimated FY22 revenues of $16.2M, signed a partnership with AuthBridge in December 2020 to provide an AI-driven OCR digital document signature solution.

 

 

OneSpan > Founded in 1991, a member of the FIDO Alliance and a partnership with Salesforce, reported FY22 revenues of $201M, and is primarily focused in the financial document management market.

 

 

SignNow > Founded in 2011 with estimated FY22 revenues of $18.3M, are primarily focused in the Healthcare document management market.

 

 

Digital Watermark-specific competitors

 

 

Advestigo > Founded in 2002 with estimated revenues of $4.5M in FY22, is primarily focused on theraography technology for content-based fingerprinting.

 

Digify > Founded in 2011 with estimated FY22 revenues of $3.1M, is partnered with Samsung (SEPCO) and primarily focused on mobile application content management.

 

Digimarc > Founded in 1995 with $30M in FY22 revenues, is the leader in digital identity management for all forms of media. Digimarc has been acquired by Ipsos.

 

Ipsos > Founded in 2008, acquired IntraSonics in 202l, with estimated FY22 revenues of $2.1B, is primarily focused on digital audio watermarking.

 

Sivisoft > Founded in 1997 and after acquiring Wetstone Technologies in 2022, with estimated revenues of $5.5M, is focused in the cyber security/computer forensics market.

 

Current participating members in the HolyGrail-2 Digital Watermark Project cross-value chain initiative are APK, Arburg, Arca, Arla, AveryDennison, Azul, BASF, Beiersdorf, Berry, Borealis, Bosch, Braskem, CCL, Ceflex, Citeo, City of Copenhagen, ClosedLoop, Coca-Cola, Colgate-Palmolive, Constantia, DagSam, Danon, Dansk, Digimarc, DM, Dow, Elif, Elopak, Esko, Essity, Expra, FiliGrade, Finat, FlintGroup, Foboha,, Formika, FujiSeal, General Mills, Gizeh, Graham, Greiner, GS1, Henkel, HL-Repro, HTP, Indorama, Intermat, IPL, ITC, Jabil, Johnson & Johnson, Jokey, Kellog’s, Kellpo, Kiefel, Korsini, KraftHeinz, L’OREAL, MacDermid, Masterpress, MikoPac, Milliken, Mondelez, Mondi, MSS, Muller, Nestle, NYCO, Orkla, PAC, Paccor, ReturPack, PepsiCo, Proctor&Gamble, Reclay, Rewe, Reynders, Rossman, Scibic, SaicaFlex, Saueressig, Seeberger, SGK, Schulstad, Schwartz, Siegwerk, Sleever, Sonoco, Storaenso, Styrenics, Suez, Sulayr, Sun Chemical, TetraPak, Tomra, Unilever, Ghent University, Vandemoortele, Veolia, Verpa, Viappiani, Wipak, Wrap and more.

 

Research and Development

 

Our current research and development is split between our Cloud-DPS ‘Wavelet’ digital watermark adaptive content protection technology and our new CTSS and FMY cloud-native microservices technology.

 

Forget-Me-Yes® (FMY)

 

 

Cloud-native data extraction query engine(s) for Extract-Transform-Load (ELT) and Extract-Load-Transform (ELT) processing of both structured and unstructured data

 

Zero-knowledge symmetric encryption services

 

Cloud-native AI-driven bulk ingress/egress data processing services engine

 

Cloud-native multi-cloud services alerting/logging AI-driven engine

 

CTSS ComplyScan® (CS)

 

 

Cloud-native backup compliance reporting

 

Backup snapshot validation services

 

Snapshot metadata indexing

 

Multi-cloud DR services

 

Cloud-DPS

 

 

Image (Radiology-Xray) and Photo content protection for mobile Healthcare and Social Media markets

 

Mobile (Android/iOS) content security manager for Google Play store download

 

Block chain capable Consumer Package tagging/watermarking for sorting and cross-value chain product management

 

Our fiscal 2022 research and development expenditures were $1,137,883.

 

 

Acquisition of ComplyTrust Inc. (formerly OCL Technologies Corp.)

 

On June 5th, 2020, the Company completed the acquisition of 100% of the shares of ComplyTrust Inc. (“CTI”), formerly OCL Technologies Corp. (“OCL”), www.ocltechnologies.com, a Delaware Corporation, with its head office located in the technology hub of San Diego, California. CTI is specifically focused on providing enterprise organizations and individuals with highly-secure data privacy tools that provide sustained and continuous global regulatory compliance of data subject rights, while independently protecting all parties. With the burgeoning growth of privacy regulation worldwide coupled with strict regulatory oversight, companies are dedicating significant resources to achieve and maintain compliance. In the past two years alone, initiatives such as the EU GDPR (General Data Protection Regulation effective May 25, 2018) as well as the CCPA (California Consumer Privacy Act passed June 28, 2018 and effective January 1, 2020) have mandated privacy rights and data protection for entities and individuals contemplated within their legislative frameworks. In addition to these, there are additional data privacy legislative initiatives on-going in Asia and both North and South America which will require data protection solutions. Oculus believes that the acquisition of CTI is a tremendous fit within its core objective of developing robust cutting-edge technologies that address focused customer data protection requirements on a global scale.

 

Consideration for the acquisition of CTI was 12,500,000 common shares of the Company and 12,500,000 share purchase warrants exercisable for a period of five years from date of issuance. The share purchase warrants are exercisable only upon specific performance criteria being met. Such criteria being 1) targeted revenue sales projections met, or 2) listing on a major US exchange, or 3) change of control as defined below:

 

 

i.

Meeting sales forecasts:

 

 

-

(100V/$125,000,000) of the warrants shall vest on June 4, 2021 (2022 and 2023), wherein “V” is the Gross Revenue of the business (as hereinafter defined) between the period June 4, 2020 – June 4, 2025;

 

 

-

“Gross Revenue” means all monetary sums earned less any credits issued for returns and allowances, and, for certainty, Gross Revenue does not include Deferred Revenue;

 

 

-

eg: if the CTI warrant holders earn 60% of projected revenue in Year 1 then all option holders would also vest 60% .

 

 

ii.

the listing of the Company on any national securities exchange registered with the United States Securities and Exchange Commission under section 6 of the United States Securities Exchange Act of 1934, as amended, such as, but not limited to, the New York Stock Exchange, the NYSE American, and NASDAQ Stock Market; or

 

 

iii.

a Change of Control Event meaning, with reference to the Company: (a) the acquisition of a sufficient number of voting securities in the capital of the Company so that the acquirer (as referenced in the CTI Share Purchase Agreement dated for reference June 5, 2020) becomes entitled, directly or indirectly, to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company (provided that, prior to the acquisition, the acquirer was not entitled to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company); (b) an occurrence when a majority of the directors elected at any annual or extraordinary general meeting of shareholders of the Company are not individuals nominated by the Company’s then-incumbent board; or (c) sale of one or more assets of the Company (but for certainty excludes sales made in the normal course of Business) after the Closing Date (as defined in the CTI Share Purchase Agreement) resulting in the collection of monetary sums that is collectively more than 50% of the Gross Revenue of the Company during the twelve (12) month period immediately preceding the Closing Date (as defined in the CTI Share Purchase Agreement).

 

 

Intellectual Property

 

Our success is dependent, in part, upon our proprietary technology. We generally rely upon patents, trademarks, and trade secret laws to establish and maintain our proprietary rights in our technology products and services.

 

On June 19, 2001, United States Patent Application No. 09/884,787, "Method and Apparatus for Digitally Fingerprinting Videos", was officially filed with the U.S. Patent and Trademark Office. This patent is for "MediaSentinel™". This patent expired in February of 2010. At this time, we have elected not to patent our Cloud-DPS technology until additional software development review is initiated to determine Cloud-DPS refresh requirements to be viable in today’s cloud-native world.

 

Potential patent-pending technology encompassing the Forget-Me-Yes® data privacy architecture includes our hybrid Zero-Knowledge data security process along with proprietary query engine and automated re-query services processes.

 

In October 2020, trademark applications were made by OVTZ for both Forget-Me-Yes® and ComplyTrust® and was formally accepted and granted in November 2021. Additional trademark application for ComplyScan® was accepted and granted in June 2022.

 

Laws and Regulations

 

Our operations are or may be subject to various international, federal, provincial, state and local laws, regulations and recommendations relating to the marketing of products and relationships with data protection, intellectual property protection, the export of technology products to certain countries and privacy protection. Although we believe that we are compliance with all international, federal, provincial, state and local regulations, the risk of claims and actions against us for breach of the aforesaid laws cannot be eliminated completely. In the event of a breach of these laws, we could be held liable for any damages that result. The amount of such damages could have a materially adverse effect on our results of operations and financial condition.

 

Employees

 

We currently have three employees, as we primarily engage independent contractors to provide services as necessary. Compensation for current and future work will be conducted on a contract basis. 

 

The loss of the services of any key management could have a materially adverse effect on the Company. We do not maintain key man life insurance on the life of its officers. In addition, our future success will depend in part upon its continuing ability to hire, train, motivate and retain key senior management and skilled technical and marketing personnel. Competition for technical personnel in the industry we compete in is intense. Our future success will depend in part on our continued ability to contract, assimilate and retain qualified personnel. To date, we have had limited success in recruiting qualified contractors, but there is no assurance that we will continue to do so in the future. Attracting qualified expertise is contingent on raising sufficient working capital and project advancement.

 

Oculus' Website

 

Our website address is https://ovtz.com/. Information found on our website is not incorporated by reference into this annual report. We make available free of charge through our website our Securities and Exchange Commission ("SEC"), filings filed pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after it electronically files such material with, or furnish it to, the SEC through its website on EDGAR www.sec.gov/edgar/search-and-access. We will also make available all financial reports filed in accordance with United States generally accepted accounting principles ("US GAAP") on SEDAR through its website https://sedar.com/. We invite investors and interested parties to sign up for "Email Alerts" on our website to receive information such as press releases as they become available.

 

 

 

Item 1A.

Risk Factors.

 

Our business and operations are subject to a number of risks and uncertainties as described below. However, the risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we may currently deem immaterial, may become important factors that harm our business, financial condition or operations. If any of the following risks actually occur, our business, financial condition or operations could suffer.

 

Impact of Pandemics

 

Pandemics, epidemics or outbreaks of an infectious disease in Canada or worldwide, including COVID-19 or any other similar illnesses, could have an adverse impact on the Company’s results, business, financial condition or liquidity.

 

On March 11, 2020, the World Health Organization declared the outbreak of a strain of novel coronavirus disease, COVID-19, a global pandemic. The COVID-19 pandemic has negatively impacted the Canadian, U.S., and global economies; disrupted Canadian, U.S., and global supply chains; disrupted financial markets; contributed to a decrease in interest rates; resulted in ratings downgrades, credit deterioration and defaults in many industries; forced the closure of many businesses, led to loss of revenues, increased unemployment and bankruptcies; and necessitated the imposition of quarantines, physical distancing, business closures, travel restrictions, and sheltering-in-place requirements in Canada, the U.S., and other countries. If the pandemic is prolonged, including through subsequent waves, or if additional variants of COVID-19 emerge which are more transmissible or cause more severe disease, or if other diseases emerge with similar effects, the adverse impact on the economy could worsen. Moreover, it remains uncertain how the macroeconomic environment, and societal and business norms will be impacted following this COVID-19 pandemic. Unexpected developments in financial markets, regulatory environments, or consumer behavior may also have adverse impacts on the Company's results, business, financial condition or liquidity, for a substantial period of time.

 

The COVID-19 pandemic has also created additional operational risks for the Company, including the need to provide enhanced safety measures for its employees and customers; comply with rapidly changing regulatory guidance; address the risk of, attempted fraudulent activity and cybersecurity threat behavior; and protect the integrity and functionality of the Company's systems, networks, and data as a larger number of employees work remotely. The Company is also exposed to human capital risks due to issues related to health and safety matters, and other environmental stressors as a result of measures implemented in response to the COVID-19 pandemic, as well as the potential for a significant proportion of the Company's employees, including key executives, to be unable to work effectively, because of illness, quarantines, sheltering-in-place arrangements, government actions or other restrictions in connection with the pandemic.

 

The extent to which the COVID-19 pandemic continues to impact the Company's results, business, financial condition or liquidity will depend on future developments in Canada, the U.S. and globally, including the development and widespread availability of efficient and accurate testing options, and effective treatment options or vaccines. Despite the approval of certain vaccines by the regulatory bodies in Canada and the U.S., the ongoing evolution of the development and distribution of an effective vaccine also continues to raise uncertainty.

 

Our limited operating history makes it difficult to evaluate our business and prospects.

 

We have a very limited operating history in the context of document protection products and services and have yet to develop an extensive record regarding the sale of our products and services. As a result, our ability to accurately forecast our future operating results is limited and subject to a number of uncertainties, including our ability to:

 

 

·

maintain or develop relationships with suppliers and marketing partners;

 

·

establish a customer base;

 

·

continue to develop and upgrade our technology, products and services;

 

·

provide superior customer service;

 

·

respond to competitive developments; and

 

·

retain and motivate qualified personnel.

 

 

In addition, we have and will continue to be subject to the risks and uncertainties frequently experienced by growing companies in rapidly changing industries. If our assumptions regarding these risks and uncertainties are incorrect or change due to market factors, or if we are unsuccessful in addressing these risks, our business could suffer.

 

We have incurred substantial losses; we expect to incur losses in the future and may never achieve profitability.

 

To date, we have not generated a profit or significant revenue from operations and in fact have incurred substantial losses. For the year ended December 31, 2022, we maintained $415,417 of working capital and sustained a net loss of $1,699,589 and had an accumulated deficit of $47,795,434.

 

Management has forecasted the Company will not have sufficient working capital to operate for the ensuing 12 months. We intend to fund operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management. As a result, we expect operating losses and negative cash flows to increase for the foreseeable future.

 

If we are unable to obtain substantial additional financing, we may not be able to remain in business.

 

We require substantial working capital to fund our business. We have had significant operating losses and negative cash flow from operations since the inception of our current business and expect to continue to do so for the foreseeable future. Our capital requirements will depend on several factors, including our ability to establish and expand a client base, to grow our sales and to employ effective marketing efforts. Our capital needs will also be influenced by the rate of market acceptance of our products and services.

 

We expect that we will require approximately $3,000,000 to $5,000,000 in financing to expand the research and development, and marketing of ComplyTrust’s suite of products for 2023 and further financing thereafter. If our capital requirements vary materially from those currently planned, we may require additional financing. We have no arrangements or commitments for any financing. Financing may not be available when needed on terms favorable to us, or at all. If adequate funds are not available or are not available on acceptable terms, we may be unable to further develop or enhance our products and services, take advantage of future opportunities or respond to competitive pressures, or ultimately, to remain in business.

 

Our operating results in future periods are expected to be subject to significant fluctuations, which would likely affect the trading price of our common shares.

 

Our quarterly and annual operating results are likely to fluctuate significantly in the future due to a variety of factors, many of which are outside of our control. Some of these factors include:

 

 

·

our ability to attract and retain customers;

 

·

the introduction of new enhancements in digital watermarking;

 

·

price competition;

 

·

our ability to remain competitive in our product and service offerings;

 

·

our ability to attract new personnel; and

 

·

U.S. and foreign regulations relating to the Internet.

 

As a result of the factors listed above, and others, period-to-period comparisons of our operating results may not be meaningful in predicting our future performance. It is possible that our operating results will not meet market expectations in some future quarter or quarters, which would likely result in a significant decline in our stock price.

 

The data privacy and data protection markets are highly competitive, and our failure to successfully compete will limit our ability to attain, retain and increase our market share.

 

The data privacy and data protection markets are rapidly evolving and extremely competitive. We expect competition to intensify in the future. We compete with companies that provide all or certain aspects of our services, including other data privacy and data protection providers and data-management companies. Our current market share is insignificant.

 

The data privacy market is currently dominated by a small number of larger revenue-bearing companies, while the data protection market includes a wide variety of small, medium and large providers in many different vertical segments. Most of our competitors have longer operating histories, larger customer bases, stronger brand recognition and significantly greater financial, marketing and other resources than us. In addition, larger, well-established and well-financed entities may acquire, invest in or form joint ventures with online competitors as the use of online cloud services increases.

 

 

The document protection market is highly competitive, and our failure to compete successfully would limit our ability to retain and increase our market share.

 

The cyber document security, and its superset, cyber data security are rapidly evolving and extremely competitive sectors and we expect that competition will intensify in the future. We compete with other companies that provide all or certain aspects of our services, including other cyber/document protection systems based on document digital watermarking, and others, and expect that additional competition in the future will be provided by those types of providers. Our current market share is insignificant.

 

The document protection market is currently dominated by a small number of larger companies, including ContractBook, DocHub, DocuSign, HelloSign, PandaDoc, RightSignature, SignNow and others. Most of our competitors have longer operating histories, larger customer bases, stronger brand recognition and significantly greater financial, marketing and other resources than us. In addition, larger, well-established and well-financed entities may acquire, invest in or form joint ventures with on-line competitors as the use of the Internet-centric, Cloud-based cyber document security services increases. In addition, cyber document security and cloud document management technologies and the expansion of existing B2B and B2C document protection technologies are expected to result in additional competition.

 

We may not be able to compete successfully against current and future competitors, and the inability to do so could decrease our revenues, prevent us from achieving profitability and adversely affect our ability to establish, maintain and increase our market share.

 

The video digital watermarking business is highly competitive, and our failure to compete successfully would limit our ability to retain and increase our market share.

 

The video digital watermarking market is rapidly evolving and extremely competitive. We expect competition to intensify in the future. We compete with companies that provide all or certain aspects of our services, including other media-streaming providers, content encoders, video production companies, and Internet data-management companies. Our current market share is insignificant.

 

The video digital watermarking market is currently dominated by a small number of larger companies, including Irdeto, Nagra, Synamedia and Verimatrix. Most of our competitors have longer operating histories, larger customer bases, stronger brand recognition and significantly greater financial, marketing and other resources than us. In addition, larger, well-established and well-financed entities may acquire, invest in or form joint ventures with online competitors as the use of the Internet and other online services increases. In addition, new automatic content recognition (ACR) technologies and the expansion of existing technologies are expected to result in additional competition.

 

We may not be able to compete successfully against current and future competitors, and the inability to do so could decrease our revenues, prevent us from achieving profitability and adversely affect our ability to establish, maintain and increase our market share.

 

We are subject to rapid technological change, which could render our products and services obsolete.

 

Our future success will depend in part on our ability to offer products and services that incorporate leading technology and address the increasingly sophisticated and varied needs of our current and prospective customers. Our market is characterized by rapidly changing and unproven technology, evolving industry standards, changes in customer needs, emerging competition and frequent new service introductions. These changes and developments may render our products and technologies obsolete in the future. As a result, our success depends on our ability to adapt to these changes, particularly to develop new products and services, adapt our current products and services or to acquire new products and services that can compete successfully. There can be no assurance that we will be successful in these efforts.

 

In addition, future advances in technology may not be beneficial to or compatible with our business and we may not be able to incorporate technological advances into our products and services in a cost-effective and timely manner. Keeping pace with technological advances may require substantial expenditures and lead time, particularly with respect to acquiring updated hardware and infrastructure components for our systems. We may require additional financing to fund such purchases. Any such financing may not be available on commercially reasonably terms, if at all, when needed and may result in a loss of earnings and market share.

 

 

We are dependent upon vendors and other third-party service provider and will be competing with some of these companies.

 

We are and will continue to be dependent on vendors and other providers to supply the hardware, software and co-location resources that comprise our products and services. We have no long-term or exclusive contracts or arrangements with any of these vendors or providers. We cannot be certain that our current and proposed vendors and service providers will continue to do business with us or that we will be able to establish relationships with new vendors and service providers if necessary. If we are unable to establish and maintain satisfactory relationships and arrangements with these third parties, our business could be harmed. In addition, we will be dependent upon our third-party vendors and other suppliers to adequately test their products before release, and to provide support for their products after delivery. Failure to do so could have a material adverse effect on our business.

 

Further, we currently compete with, and expect to compete with in the future, providers of some of our technology or system components. If we are unable to effectively balance our need to cooperate and compete with these companies, our business may be harmed.

 

Our services are technically complex and we may not be able to prevent defects that could decrease their market acceptance, result in product liability or harm our reputation.

 

Our document security, digital water marketing, streaming media, data privacy and data protection products and services are complex, and the steps we take to ensure that they are free of errors or defects, particularly when first introduced or when new versions or enhancements are released, may not be successful. We cannot guarantee that current versions or enhanced versions or our products will be free of significant software defects or bugs. Despite our testing, and testing by our third-party vendors and providers, current or future products may contain serious defects. Serious defects or errors could result in lost revenue or a delay in market acceptance of our products and could seriously harm our business and operating results. Errors in our products may be caused by defects in third-party hardware or software incorporated into our products. If so, we may be unable to fix these defects without the co-operation of these third-party providers. Because these defects may not be as significant to these providers as they are to us, we may not receive the rapid co-operation that we may require. Errors, defects or other performance problems with our products could also harm our customers' businesses or result in potential product liability claims. Even if unsuccessful, a product liability claim brought against us would likely be time-consuming, costly and harmful to our reputation. Nor can there be any assurance that our product liability insurance coverage will be sufficient to satisfy any successful claim.

 

Any loss of our personnel or inability to acquire new personnel could harm our business.

 

Our continued operations and future success is significantly reliant on the continued services and performance of our senior management. The loss of the services of any member of our senior management team could cause significant disruption in our business. We have no long-term employment agreements with senior management, do not currently maintain any "key person" life insurance and have no employees. As such, our future success depends on our ability to retain current senior management and to identify, attract, hire, train, retain and motivate other highly skilled technical, managerial, operations, customer service, and sales and marketing personnel. Competition for such personnel is intense, and we may not successfully attract, assimilate or retain sufficiently qualified personnel. The failure to retain and attract the necessary personnel could impede our future success.

 

Failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and operating results and shareholders could lose confidence in our financial reporting.

 

Effective internal controls are necessary for the Company to provide reliable financial reports and effectively prevent fraud. If we cannot provide reliable financial reports or prevent fraud, our operating results could be harmed. Failure to achieve and maintain an effective internal control environment, regardless of whether the Company is required to maintain such controls, could also cause investors to lose confidence in our reported financial information, which could have a material adverse effect on the Company's share price. Although we are not aware of anything that would impact its ability to maintain effective internal controls, we have not obtained an independent audit of the Company's internal controls and, as a result, we are not aware of any deficiencies which would result from such an audit. Further, at such time as the Company is required to comply with the internal control requirements of the Sarbanes-Oxley Act, we may incur significant expenses in having its internal controls audited and in implementing any changes which are required.

 

 

We do not currently have any paying customers.

 

Our sales were $Nil in 2022 and 2021. We expect that a small number of customers will account for a substantial portion of our revenue in the foreseeable future. The inability to increase the number of customers could limit our ability to maintain or increase our market share or could cause revenue to drop quickly and unexpectedly.

 

Our business may suffer if we cannot protect our intellectual property.

 

We seek to protect our proprietary rights through a combination of patents, trade secrets, trademark laws, confidentiality procedures and contractual provisions with employees and third parties. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our products or obtain and use information that we have proprietary rights over. Litigation may be necessary to enforce our intellectual property rights, to protect our trade secrets and to determine the validity and scope of our proprietary rights. Any litigation could result in substantial costs and diversion of management and other resources with no assurance of success and could seriously harm our business and operating results.

 

Our products may infringe the intellectual property rights of others, causing us to incur significant costs or prevent us from licensing our products.

 

Other companies, including our competitors, may have or obtain patents or other proprietary rights that would prevent, limit or interfere with our ability to make, use or license our products. We cannot be certain that our products do not and will not infringe patents or the proprietary rights of others. We may be subject to legal proceedings, including claims of alleged infringement by others of the intellectual property rights of third parties. If a successful claim of infringement is brought against us and we fail to or are unable to license the infringed technology on commercially reasonable terms, our business and operating results could be significantly harmed. Companies in the technology sector are increasingly bringing suits alleging infringement of their proprietary rights, particularly patent rights. Although we are not currently subject to any litigation or claims, any future claims, whether or not valid, could result in substantial costs and diversion of resources with no assurance of success. Intellectual property litigation or claims could force us to do one or more of the following:

 

 

·

cease selling, incorporating or using products or services that incorporate the infringed intellectual property;

   

 

 

·

obtain a license from the rights-holder or owner of the infringed intellectual property, which license may not be available on commercially reasonable terms, or at all; or

   

 

 

·

re-design our products or services.

 

If we are forced to take any of these actions, our business could be substantially harmed.

 

Our success depends on the continued growth in demand for e-business applications.

 

Our primary business strategy involves the development of products and services that enable users to transmit video over the Internet. As a result, our future sales and any future profits will be substantially dependent upon the widespread acceptance and use of the Internet as an effective medium of business by consumers and businesses. To be successful, consumers and businesses that have historically used traditional means of commerce to transact business must continue to accept and utilize the Internet as a medium for conducting business and exchanging information. Consumers and businesses may reject the Internet as a viable commercial medium for a number of reasons, including potentially inadequate network infrastructure, slow development of enabling technologies, insufficient commercial support and privacy concerns. In addition, delays in the development or adoption of new standards and protocols required to handle increased levels of Internet activity or increased government regulation could cause the Internet to lose its viability as a commercial medium. If the demand for e-business applications does not grow or grows more slowly than anticipated, demand for our products and services would be reduced and our revenue would suffer.

 

 

Government regulation and legal uncertainties could add additional costs and risks to doing business on the Internet.

 

We are not currently subject to direct regulation by any governmental agency, other than regulations applicable to businesses generally, export control laws and laws or regulations directly applicable to electronic commerce. However, due to the increasing popularity and use of the Internet, it is possible that a number of laws and regulations may be adopted with respect to the Internet covering issues such as: user privacy, pricing, content, copyrights, distribution and characteristics and quality of products and services.

 

Furthermore, the growth and development of the market for electronic commerce may prompt calls for more stringent consumer protection laws that may impose additional burdens on companies conducting business online. The adoption of additional laws or regulations may decrease the growth of the Internet or other online services, which could, in turn, decrease the demand for our products and services and increase our cost of doing business.

 

The applicability of existing laws to the Internet, property ownership, copyrights, encryption and other intellectual property issues, taxation, libel, export or import matters, obscenity and personal privacy is uncertain. The vast majority of such laws were adopted prior to the advent of the Internet and related technologies. As a result, they do not contemplate or address the unique issues of the Internet and related technologies. Changes to such laws intended to address these issues, including some recently proposed changes, could create uncertainty in the Internet marketplace. Such uncertainty could reduce demand for our products and services or increase the cost of doing business due to increased costs of litigation or increased service delivery costs.

 

Our share price has been and could be highly volatile, which could result in substantial losses to investors.

 

The trading price of our common shares has been and is likely to continue to be highly volatile and could be subject to wide fluctuations in response to a number of factors including variations in quarterly operating results, new products or services offered by us or our competitors, conditions or trends in the Internet and online commerce industries, changes in the economic performance and/or market valuations of other Internet and online service companies, and other events or factors, many of which are beyond our control. In addition, the stock market in general, and the market for Internet-related and technology companies in particular, has experienced extreme price and volume fluctuations, including large price drops in 2017, 2015, 2011, 2010, 2009, 2008, 2003, 2002 and 2001, that have often been unrelated or disproportionate to the operating performance of such companies. These broad market and industry factors may materially adversely affect the market price of our common shares, regardless of our actual operating performance. In the past, following periods of volatility in the market price of a company's securities, securities class-action litigation has often been instituted against affected companies. Such litigation, if instituted, could result in substantial costs and a diversion of management's attention and resources.

 

We have not paid cash dividends in the past and does not expect to pay cash dividends in the foreseeable future. Any return on investment may be limited to the value of the Company's common shares.

 

We have never paid cash dividends on its capital stock and does not anticipate paying cash dividends on its capital stock in the foreseeable future. The payment of dividends on the Company's capital stock will depend on its earnings, financial condition and other business and economic factors affecting the Company at such time as the board of directors may consider relevant. If we do not pay dividends, its common shares may be less valuable because a return on your investment will only occur if the common shares price appreciates.

 

Securities analysts may not initiate coverage or continue to cover the Company's common shares, and this may have a negative impact on its market price.

 

The trading market for the Company's securities could depend in part on the research and reports that securities analysts publish about Oculus' business and the Company. We do not have any control over these analysts. There is no guarantee that securities analysts will cover the Company's securities. If securities analysts do not cover the Company, the lack of research coverage may adversely affect the market prices of the Company's common shares. If the Company is covered by securities analysts, and its securities are the subject of an unfavorable report, the prices for the Company's securities would likely decline. If one or more of these analysts ceases to cover the Company or fails to publish regular reports on the Company, the Company could lose visibility in the financial markets, which could cause its share price and/or trading volume to decline.

 

Anti-takeover provisions in our charter documents could prevent or delay a change in control of the company.

 

Our articles of continuance and bylaws contain anti-takeover provisions that could discourage, delay or even prevent an acquisition of our company at a premium price or at all. Any of these provisions might prevent the market price of our common shares from increasing in response to takeover attempts and could prevent our shareholders from realizing a premium over the then-prevailing market price for the common shares. 

 

 

We intend to issue additional equity securities, which may dilute the interests of current shareholders or carry rights or preferences senior to the common shares.

 

We intend to issue additional equity securities in order to raise working capital. Accordingly, existing shareholders may experience additional dilution of their percentage ownership interest in our company. In addition, the new equity securities may have rights, preferences or privileges senior to those of our existing common shares.

 

The exercise of options and warrants and other issuances of common shares or securities convertible into or exercisable for common shares will dilute the ownership interests of the Company's current shareholders and may adversely affect the future market price of the Company's common shares.

 

We may use stock options, stock grants and other equity-based incentives, to provide motivation and compensation to our officers, employees and key independent consultants. The award of any such incentives will result in an immediate and potentially substantial dilution to our existing shareholders and could result in a decline in the value of the Company's share price. The exercise of these options and the sale of the underlying common shares and the sale of common shares issued pursuant to stock grants may have an adverse effect upon the price of the Company's common shares.

 

Limited liability of executive officers and directors may discourage shareholders from bringing a lawsuit against them.

 

Our bylaws contain provisions that limit the liability of directors for monetary damages and provide for indemnification of officers and directors. These provisions may discourage shareholders from bringing a lawsuit against officers and directors for breaches of their fiduciary duty and may also reduce the likelihood of derivative litigation against officers and directors even though such action, if successful, might otherwise have benefited the shareholders. In addition, a shareholder's investment in Oculus may be adversely affected to the extent that costs of settlement and damage awards against officers or directors are paid by Oculus pursuant to the indemnification provisions of the bylaws.

 

Requirements of the SEC with regard to low-priced "penny stocks" may adversely affect the ability of shareholders to sell their shares in the secondary market.

 

"Penny stocks" are low-priced, and usually highly speculative, stock selling at less than $5.00 per share. Our securities are subject to Rule 15g-9 under the Exchange Act, which imposes additional sales practice requirements on broker-dealers who sell such securities to persons other than established customers and "accredited investors" (generally, an individual with a net worth in excess of $1,000,000 or an annual income exceeding $200,000, or $300,000 together with his or her spouse). For transactions covered by this rule, a broker-dealer must make a special suitability determination for the purchaser and have received the purchaser's written consent to the transaction prior to sale. The rule also requires the delivery, prior to the transaction, of a risk disclosure document mandated by the SEC relating to the penny stock market. The broker-dealer must also disclose the commissions payable for the transaction, current quotations for the stock, and, if applicable, the fact that it is the sole market maker in the stock. Consequently, the rule may adversely affect the ability of broker-dealers to sell our securities and may adversely affect the ability of shareholders to sell their shares in the secondary market

 

We do not anticipate paying dividends to shareholders in the foreseeable future.

 

We have not paid dividends on our common shares and we intend, for the foreseeable future, to invest any earnings in the further development of our business. Accordingly, shareholders should not expect to receive any dividends on their shares.

 

We may be exposed to adverse currency exchange rate fluctuations, which could harm our financial results and cash flows.

 

Substantially all of our assets and operations are located and conducted in the United States and Canada. As a result, our primary exposure to movements in foreign currency rates relate to Canadian dollar operating expenses, assets and liabilities. A decline in the Canadian dollar would decrease the U.S. dollar value of our Canadian assets while a rise in the Canadian dollar would increase the U.S. dollar value of Canadian operating expenses and liabilities.

 

International transactions are settled in U.S. dollars. As a result, weaknesses in foreign currencies could adversely affect demand for our products.

 

Service outages and disruption of our infrastructure may harm our adversely impact business operations and injure reputation.

 

We may experience outages or disruptions to our services or infrastructure before, during or after the transition to a cloud platform, including information technology system failures and network disruptions. Such events could interrupt our customers' access to our services, adversely affect their perception of our services' reliability and consequently reduce our revenue. 

 

 

Security vulnerabilities in our products and services or any breach of our security measures may injure our reputation and disrupt our business.

 

We intend to host a digital Cloud platform with various features including document storage. While this Cloud service will have security features, Cloud-based content has been, and continues to be, targeted by malicious cyber-attacks. Should our security features be breached as a result of third-party attacks or due any error, negligence, product defect or otherwise, and should such a breach compromise the confidentiality, integrity or availability of our cloud services, the business may suffer and its reputation may be injured. In addition, if an actual or perceived security breach occurs, we may become subject to significant liability through lawsuits or claims and lose future sales and customers and there is no assurance that our product liability insurance coverage will be sufficient to satisfy any successful claims.

 

Techniques used to defeat online security measures are constantly evolving and may not be discovered until after the secured information has already been compromised. Therefore, we may be unable to anticipate these techniques, react in a timely manner, or implement adequate preventative measures.

 

The financial reporting obligations of being a public company in the United States are expensive, time consuming, and may place significant demands on the Company's management.

 

The obligations of being a public company in the United States require significant expenditures and place certain demands on our management, including costs resulting from public company reporting obligations under the Exchange Act and the rules and regulations regarding corporate governance practices, including those under the Sarbanes-Oxley Act of 2002, and the Dodd-Frank Wall Street Reform and Consumer Protection Act. Our management and other personnel devote a substantial amount of time to ensure that the Company complies with all of these requirements. Moreover, despite recent reforms made possible by the Jumpstart Our Business Startups Act, the reporting requirements, rules and regulations increase the Company's legal and financial compliance costs and will make some activities more time-consuming and costly. Any changes that the Company makes to comply with these obligations may not be sufficient to allow it to satisfy its obligations as a public company on a timely basis, or at all.

 

We also expect these rules and regulations to make it more difficult and more expensive for it to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. These factors also could make it more difficult for us to attract and retain qualified persons to serve on its board of directors, particularly to serve on its audit and compensation committees, or as executive officers.

 

Our failure to manage or adequately address any one or more of these risks could result in our business suffering a material adverse effect.

 

 

Item 1B.

Unresolved Staff Comments.

 

None.

 

 

Item 2.

Description of Properties.

 

The Company's corporate headquarters are located at Suite 507, 837 West Hastings Street, Vancouver, British Columbia and are subject to an office space lease on a month-to-month basis. The monthly base rent is $4,100 CAD (Canadian Dollars).

 

 

Item 3.

Legal Proceedings.

 

From time to time the Company may be a defendant or plaintiff in various legal proceedings arising in the normal course of the Company's business. The Company is unaware of any material, active, pending or threatened proceeding against the Company, nor is the Company involved as a plaintiff or defendant in any material proceeding or pending litigation.

 

 

Item 4.

Mine Safety Disclosures.

 

Not applicable.

 

 

PART II

 

 

Item 5.

Market for Registrant's Common Equity and Related Stockholder Matters.

 

There is a limited public market for our common shares. Our common shares trade on the TSX Venture Exchange (the “TSXV”) under the trading symbol "OVT", and on the OTCQB under the symbol "OVTZ".

 

The following table shows the high and low sales prices (in Canadian dollars) of our common shares as reported by the TSXV for the periods indicated (post 15 to 1 reverse split December 2011).

 

TSX (Symbol OVT)

 

Period

 

High

(CAD $)

   

Low

(CAD $)

 

First Quarter 2021

    2.80       0.485  

Second Quarter 2021

    1.08       0.44  

Third Quarter 2021

    0.80       0.50  

Fourth Quarter 2021

    1.30       0.52  

First Quarter 2022

    0.70       0.46  

Second Quarter 2022

    0.39       0.28  

Third Quarter 2022

    0.38       0.25  

Fourth Quarter 2022

    0.23       0.13  

 

The following table shows the high and low prices of our common shares on the OTCQB. The following quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual transactions:

 

OTC Bulletin Board (Symbol OVTZ)

 

Period

 

High

(US $)

   

Low

(US $)

 

First Quarter 2021

    1.63       0.369  

Second Quarter 2021

    0.90       0.36  

Third Quarter 2021

    0.725       0.363  

Fourth Quarter 2021

    1.08       0.374  

First Quarter 2022

    0.60       0.36  

Second Quarter 2022

    0.35       0.19  

Third Quarter 2022

    0.27       0.15  

Fourth Quarter 2022

    0.17       0.07  

 

Transfer Agent

 

The Registrar and Transfer Agent for our shares of common stock is Computershare Trust Company of Canada located at 324 - 8th Avenue SW, Suite 800, Calgary, Alberta, T2P 2Z2.

 

Holders

 

As of March 28, 2023, there were 91,422,469 common shares outstanding, held by 1,285 shareholders of record. However, beneficial holders of the Company's common shares who hold their shares in an account with an investment dealer or broker are represented by one nominee. Therefore, although the number of registered shareholders is 1,285, the number of registered holders may not be representative of the number of beneficial owners.

 

 

Options

 

Details of options outstanding as at date of the report are as follows:

 

Exercise price (CAD)

   

Number of

options

outstanding

 

Expiry date

 

Number of options

exercisable

   

Remaining

contractual life (years)

 
                               
$ 0.350       3,600,000  

July 21, 2023

    2,880,000       0.55  
$ 0.450       250,000  

December 21, 2023

    200,000       0.97  
$ 1.200       500,000  

January 29, 2024

    300,000       1.08  
$ 0.800       375,000  

June 10, 2024

    225,000       1.44  
$ 0.600       590,000  

October 14, 2024

    236,000       1.79  
$ 0.800       100,000  

January 31, 2025

    20,000       2.09  
                               
          5,415,000         3,861,000          

 

Warrants

 

Details of warrants outstanding as at date of the report are as follows:

 

Exercise price

     

Number of

warrants

outstanding

 

Expiry date

 

Number of

warrants

exercisable

   

Remaining

contractual life (years)

 
                                 
$ 1.00  

(CAD)

    4,900,000  

April 19, 2023

    4,900,000       0.30  
$ 0.001  

(1) (US)

    12,500,000  

June 4, 2025

    -       2.43  
                                 
            17,400,000         4,900,000          

 

 

(1)

No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) targeted revenue sales projections met, or 2) listing on a major US exchange, or 3) change of control.

 

Dividends

 

The Company has not declared or paid any dividends in the previous two years. The Company currently intends to retain future earnings, if any, for use in its business. The Company does not anticipate paying dividends on the common shares in the foreseeable future. Any determination to pay any future dividends will remain at the discretion of the board of directors of the Company (the “Board of Directors”) and will be made taking into account the Company’s financial condition and other factors deemed relevant by the Board of Directors.

 

 

Equity Compensation Plan Information

 

As at December 31, 2022 there were 9,142,257 securities authorized for issuance under the under the Company’s existing stock option plan dated effective August 28, 2020 (the “2021 Stock Option Plan”). Since the last financial year end of December 31, 2022, as at March 28, 2023, the following securities were authorized for issuance under the 2020 and 2021 Stock Option Plan:

 

   

Number of securities to be

   

Weighted-average exercise

   

Number of securities

 
   

issued upon exercise of

   

price of outstanding

   

remaining available for

 

Plan Category

 

outstanding options,

   

options, warrants and

   

future issuance under

 
   

warrants and rights

   

rights

   

equity compensation plans

 
                   

(excluding securities

 
                   

reflected in column (a))

 

Equity compensation plans approved by security holders

    5,415,000               3,727,257  

Equity compensation plans not approved by security holders

    N/A       N/A       N/A  

Total

    5,415,000               3,727,257  

 

Stock Option Plan

 

The Board of Directors of the Company adopted a new share option plan dated for reference October 15, 2021 (the “2021 Share Option Plan”). The 2021 Share Option Plan, supersedes and replaces the 2020 Stock Option Plan, which was approved by shareholders at the Company’s annual general and special meeting on October 15, 2021. The purpose of the 2020 Share Option Plan is to provide incentive to qualified parties to increase their proprietary interest in the Company and thereby encourage their continuing association with the Company.

 

Previous grants will be taken into account when considering new grants under the 2020 Share Option Plan and a maximum of 10% of the number of the issued and outstanding common shares of the Company are available for issuance under the 2020 Share Option Plan. There are currently 3,850,000 options issued under the 2020 Stock Option Plan and 1,565,000 option issued under the 2021 Stock Option Plan for a total of 5,415,000.

 

The additional terms and conditions attached to the Option represented by this Option Commitment are as follows:

 

 

1.

The Options will not be exercisable unless and until they have vested and then only to the extent that they have vested. The Options will vest in accordance with the following:

 

 

Vesting Provisions

 

To vest as to 20% on the date that is six months from the date of grant, and a further 20% on each successive date that is six months from the date of the previous vesting in accordance with the conditions below:

 

All options will be considered vested if one of the following criteria are met by the Company:

 

 

i.

Meeting sales forecasts:

 

  - The greater of either the 20% vesting every six months or the pro rata percentage of revenue earned by the Company’s subsidiary, Comply Trust (“CTI”) in years 1, 2, 3
     
 

-

(100V/$125,000,000) of the warrants shall vest on June 4, 2021 (2022 and 2023), wherein “V” is the Gross Revenue of the business (as hereinafter defined) between the period June 4, 2020 – June 4, 2025;

 

 

-

“Gross Revenue” means all monetary sums earned less any credits issued for returns and allowances, and, for certainty, Gross Revenue does not include Deferred Revenue;

 

 

-

eg: if the CT warrant holders earn 60% of projected revenue in Year 1 then all option holders would also vest 60% .

 

 

ii.

the listing of the Company on any national securities exchange registered with the United States Securities and Exchange Commission under section 6 of the United States Securities Exchange Act of 1934, as amended, such as, but not limited to, the New York Stock Exchange, the NYSE American, and NASDAQ Stock Market; or

 

 

iii.

a Change of Control Event meaning, with reference to the Company: (a) the acquisition of a sufficient number of voting securities in the capital of the Company so that the acquirer (as referenced in the CT Share Purchase Agreement dated for reference June 5, 2020) becomes entitled, directly or indirectly, to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company (provided that, prior to the acquisition, the acquirer was not entitled to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company); (b) an occurrence when a majority of the directors elected at any annual or extraordinary general meeting of shareholders of the Company are not individuals nominated by the Company’s then-incumbent board; or (c) sale of one or more assets of the Company (but for certainty excludes sales made in the normal course of Business) after the Closing Date (as defined in the CTI Share Purchase Agreement) resulting in the collection of monetary sums that is collectively more than 50% of the Gross Revenue of the Company during the twelve (12) month period immediately preceding the Closing Date (as defined in the CT Share Purchase Agreement).

 

 

Performance Graph

 

The graph below matches Oculus VisionTech Inc.'s cumulative 5-Year total shareholder return on common stock with the cumulative total returns of the Russell 2500 index and the Dow Jones US Software index. The graph tracks the performance of a $100 investment in our common stock and in each index (with the reinvestment of all dividends) from 12/31/2017 to 12/31/2022.

 

o01.jpg
 
   

12/17

   

12/18

   

12/19

   

12/20

   

12/21

   

12/22

 
                                                 

Oculus VisionTech Inc.

    100.00       119.58       179.37       612.86       1464.87       173.32  

Russell 2500

    100.00       90.00       114.99       137.98       163.06       133.11  

Dow Jones US Software

    100.00       117.53       171.47       251.46       334.86       224.57  

 

The stock price performance included in this graph is not necessarily indicative of future stock price performance.

 

 

 

Begin:

12/31/2016

 

Period End:

12/31/2022

Oculus Visiontech Inc

   

OVTZ

   

 

 

Beginning

                                         
                                                           

Date*

Transaction

Type

 

Closing

Price**

   

No. Of

Shares***

   

Dividend

per Share

   

Dividend

Paid

   

Shares

Reinvested

   

Ending

Shares

   

Cum. Tot.

Return

 
                                                           

31-Dec-16

Begin

    0.161       256.41       -       -       -       256.410       100.00  
                                                           

31-Dec-17

Year End

    0.067       256.41       -       -       -       256.410       41.28  
                                                           

31-Dec-18

Year End

    0.080       256.41       -       -       -       256.410       17.15  
                                                           

31-Dec-19

Year End

    0.120       256.41       -       -       -       256.410       20.51  
                                                           

31-Dec-20

Year End

    0.410       256.41       -       -       -       256.410       30.77  
                                                           

31-Dec-21

Year End

    0.980       256.41       -       -       -       256.410       30.77  
                                                           

31-Dec-22

Year End

    0.145       256.41       -       -       -       256.410       30.77  

 

*  Specified ending dates or ex-dividends dates.

** All Closing Prices and Dividends are adjusted for stock splits and stock dividends.

*** 'Begin Shares' based on $100 investment.

 

Recent Sales of Unregistered Securities

 

Not applicable. 

 

Issuer Purchases of Equity Securities

 

Not applicable.

 

Item 6.

Selected Financial Data.

 

Not applicable.

 

 

 

Item 7.

Management's Discussion and Analysis of Financial Conditions and Results of Operation.

 

You should read the following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and related notes appearing elsewhere in this annual report on Form 10-K. This discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. The actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including, but not limited to, those set forth under ‘‘Risk Factors’’ and elsewhere in this annual report on Form 10-K.

 

Overview

 

We design and market to business customers digital watermarking, streaming video and video-on-demand (VOD) systems, services and source-to-destination digital media delivery solutions that allow live or recorded digitized and compressed video to be transmitted through Internet, intranet, satellite or wireless connectivity. The Company’s systems, services and delivery solutions include digital watermark solutions and video content production, content encoding, media asset management, media and application hosting, multi-mode content distribution, transaction data capture and reporting, e-commerce, specialized engineering services, and Internet streaming hardware.

 

The Company’s products and services are based on its data privacy, data protection and media delivery infrastructure, software and services. It has developed a number of specific products and services that include Cloud-DPS, CTSS and Forget-Me-Yes™.

 

As more fully discussed below we have not been profitable, and our revenues for 2022 and 2021 were $Nil. We cannot predict our revenue levels for the next 12 months, or thereafter, nor when, or if, our operations will become profitable. We will require additional financing, both for the remainder of fiscal 2021 and thereafter, to continue to operate and expand our business. There is no assurance that such financing will be available on commercially reasonable terms, if at all.

 

CRITICAL ACCOUNTING POLICIES

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.  On an ongoing basis, we evaluate these estimates, including those related to bad debts, intangible assets, income taxes, impairment or disposal of long-lived assets, contingencies and litigation.  We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions.

 

We have identified the policies below as critical to our business operations and to the understanding of our financial results. The impact and any associated risks related to these policies on our business operations is discussed throughout management’s discussion and analysis of financial condition and results of operations where such policies affect our reported and expected financial results:

 

 

Impairment or disposal of long-lived assets;

 

Deferred taxes;

 

Accounting for stock-based compensation; and

 

Commitments and contingencies.

 

IMPAIRMENT OR DISPOSAL OF LONG-LIVED ASSETS.  Long-lived assets are reviewed in accordance with ASC Topic 360-10-05.  Impairment or disposal of long-lived assets losses are recognized in the period the impairment or disposal occurs.  

 

DEFERRED TAXES.  We record a valuation allowance to reduce deferred tax assets when it is more likely than not that some portion of the amount may not be realized.  

 

ACCOUNTING FOR STOCK-BASED COMPENSATION.    Under ASC Topic 718, Stock Compensation, the Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value for awards that are expected to vest is then amortized on a straight-line basis over the requisite service period of the award, which is generally the option vesting term. The amount of expense attributed is based on estimated forfeiture rate, which is updated based on actual forfeitures as appropriate. This option pricing model requires the input of highly subjective assumptions, including the expected volatility of the Company’s common stock, pre-vesting forfeiture rate and an option’s expected life. The financial statements include amounts that are based on the Company’s best estimates and judgments. 

 

 

COMMITMENTS AND CONTINGENCIES.     We account for commitments and contingencies in accordance with ASC Topic 450 Contingencies. We record a liability for commitments and contingencies when the amount is both probable and reasonably estimable.

 

Results of Operations

 

For the Year Ended December 31, 2022

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses, consisting of product marketing expenses, consulting fees, office, professional fees and other expenses to execute our business plan and for our day-to-day operations, increased in the year ended December 31, 2022.  We continue to develop and market C-DPS – Cloud Document Protection System and the “Right-to-be-Forgotten” and “Right-to-Erase” platform. Administrative expenses have decreased/increased moderately as a result of insignificant fluctuations in general costs.

 

Selling, general and administrative expenses for the year ended December 31, 2022 decreased by $31,224 to $399,467 from $430,691 for the year ended December 31, 2021. This included professional expenses for the year ended December 31, 2022 which decreased to $104,801 from $133,134 for the comparable period in 2021. We incurred decreased costs in 2022 due to minimal corporate and filing activities during the fiscal year.

 

Research and development for the year ended December 31, 2022 increased to $1,137,883 from $818,269 for the comparable period in 2021. This was a result of the Company’s effort to improve the platform by conducting further research and development.

 

We have arranged for additional staff and consultants to engage in marketing activities in an effort to identify and assess appropriate market segments, develop business arrangements with prospective partners, create awareness of new products and services, and communicate to the industry and potential customers. Other components of selling, general and administrative expenses did not change significantly.

 

Research and Development

 

Research and development costs for the three months ended December 31, 2022, decreased to $224,991 from $239,270 for the comparable period in 2021. We incurred comparable costs in 2022 as the management maintain its decision in 2021, to develop CTSS (ComplyScan®) as well as the on-going development of our subsidiary’s Forget-Me-Yes® zero trust data privacy platform. (“Right-to-be-Forgotten” and “Right-to-Erase”).

 

Net Losses

 

To date, we have not achieved profitability and expect to incur substantial losses for the foreseeable future. Our net loss for fiscal 2022 was $1,649,589, compared with a net loss of $1,986,665 for fiscal 2021. Our total comprehensive loss for fiscal 2022 was $1,608,543, compared with a comprehensive loss of $1,992,855, which includes currency translation differences of $41,046.

 

 

Liquidity and Capital Resources

 

At December 31, 2022 our cash position was $687,602, a decrease from $2,208,451 at December 31, 2021. We had a working capital of $415,417 and an accumulated deficit of $47,795,434 at December 31, 2022.

 

We have historically satisfied our capital needs primarily by shareholders’ loans and issuing equity securities to our officers, directors, employees and a small group of investors, and from short-term bridge loans from members of management.

 

As of December 31, 2022, we had $687,602 in cash. Management has forecasted the Company will not have sufficient working capital to operate for the ensuing 12 months. We will require an additional $3 million to $5 million to finance operations for the fiscal 2023 and we intend to obtain such financing through sales of our equity securities. While the Company has been successful in the past in obtaining financing, there can be no assurance that the Company will be able to obtain adequate financing, or that such financing will be on terms acceptable to the Company, to meet future operational needs which may result in the delay, reduction, or discontinuation of ongoing development programs.

 

Assuming the aforementioned $3 million to $5 million in financing is obtained, continuing operations for the longer-term will be supported through anticipated growth in revenues and through additional sales of our securities. Although longer-term financing requirements may vary depending upon our sales performance, management expects that we will require additional financing of $3 million to $5 million for fiscal 2023. We have no binding commitments or arrangements for additional financing, and there is no assurance that management will be able to obtain any additional financing on terms acceptable to us, if at all.

 

Statement of Cash Flows

 

The Company had cash and cash equivalents of $687,602 (2021 - $2,208,451) as of December 31, 2022.

 

The decrease in cash and cash equivalents during the year ended December 31, 2022 was primarily due to cash used in operating activities during the fiscal year.

 

Cash Flow used in Operating Activities

 

Cash and cash equivalents used in operating activities were $1,484,369 (2021 - $1,350,175) for the year ended December 31, 2022. Operating activities were affected by the change in non-cash working capital balances because of a increase in prepaid expense and other current assets of $2,441, a increase in accounts payable and accrued expenses of $180,387, and a increase in accounts payable and accrued expenses due to related parties of $Nil.

 

Cash Flow provided by Financing Activities

 

Cash provided by financing activities was $Nil (2021 - $3,062,246) for the year ended December 31, 2022 for the proceeds from sales of common stocks of $Nil (2021 - $3,098,616).

 

Off-Balance Sheet Arrangements

 

As of fiscal 2022 we have no off-balance sheet arrangements.

 

 

Item 7A.

Quantitative and Qualitative Disclosure About Market Risk.

 

As a smaller reporting issuer, the Company is not required to provide the information under this Item.

 

 

Item 8.

Financial Statements and Supplementary Data.

 

The financial statements and supplementary financial information required to be filed under this item are presented on pages F-1 through F-14 of this Report and are included. 

 

 

 

 

OCULUS VISIONTECH, INC AND SUBSIDIARY

 

 

CONSOLIDATED FINANCIAL STATEMENTS

 

DECEMBER 31, 2022 AND 2021

 

 

 

 

 

 

OCULUS VISIONTECH, INC. AND SUBSIDIARY

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2022 AND 2021

 


 

 

Index – Consolidated Financial Statements

32

Report of Independent Registered Public Accounting Firm - [Davidson & Company LLP / Vancouver, BC. Canada /  Auditor Firm ID#: 731]

33

                                                                                                       

 

Consolidated Financial Statements:

 
  

Consolidated Balance Sheets 

35

Consolidated Statements of Operations and Comprehensive Loss

36

Consolidated Statements of Stockholders Equity

37

Consolidated Statements of Cash Flows

38

Notes to Consolidated Financial Statements

39

 

 
o02.jpg

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

To the Shareholders and Directors of

Oculus VisionTech Inc.

 

 

Opinion on the consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of Oculus VisionTech Inc. (the “Company”) as of December 31, 2022 and 2021, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity, and cash flows for the years ended December 31, 2022 and 2021, and the related notes and schedules (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the years ended December 31, 2022 and 2021, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has incurred losses from inception and does not currently have the financial resources to sustain operations in the long-term. As shown in the financial statements, the Company has incurred a loss of $1,649,589 for the year ended December 31, 2022. As of December 31, 2022, the Company had an accumulated deficit of $47,795,434 and working capital of $415,417. These matters raise substantial doubt upon the Company’s ability to continue as a going concern. Management's plans in regards to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

 

o03.jpg
1200 - 609 Granville Street, P.O. Box 10372, Pacific Centre, Vancouver, B.C., Canada V7Y 1G6
Telephone (604) 687-0947  Davidson-co.com
 

 

Critical Audit Matters

 

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

We have determined that there are no critical audit matters to communicate in our auditor’s report.

 

We have served as the Company’s auditor since 2022.

 

 

 /s/ DAVIDSON & COMPANY LLP
  
  
Vancouver, Canada         Chartered Professional Accountants

 

March 28, 2023

 

 

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

(Stated in US Dollars)

 

 

 

  

 

December 31,

2022

  

December 31,

2021

 
         

ASSETS

        
         

Current Assets:

        

Cash and cash equivalents

 $687,602  $2,208,451 

Prepaid expenses and other current assets (Note 4)

  30,238   37,832 

Total Assets

 $717,840  $2,246,283 
         

LIABILITIES AND STOCKHOLDERS' EQUITY

        
         

Current Liabilities:

        

Accounts payable and accrued expenses (Note 5)

 $276,585  $96,198 

Accounts payable and accrued expenses - related parties

  25,838   26,425 

Total current liabilities

  302,423   122,623 
         

Stockholders' Equity:

        

Preferred stock - no par value; authorized 250,000,000 shares, none issued

        

Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 91,422,569

  46,850,710   46,850,710 

Additional paid-in capital

  1,394,997   998,477 

Commitment to issue shares

  -   414,128 

Accumulated other comprehensive income (loss)

  (34,856)  6,190 

Accumulated deficit

  (47,795,434)  (46,145,845)

Stockholders' equity

  415,417   2,123,660 

Total Liabilities and Stockholders' Equity

 $717,840  $2,246,283 

 

The accompanying notes from an integral part of these consolidated financial statements.

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Stated in US Dollars)

 

 

For the Years Ended December 31,

 

 

2022

   

2021

 
                 

Expenses:

               

Consulting

  $ 135,000     $ 24,021  

Research and development (Note 10)

    1,137,883       818,269  

Selling, general and administrative (Note 9, 13)

    399,467       430,691  

Share-based compensation (Notes 7, 13)

    396,520       713,684  
                 

Loss from operations

    (2,068,870 )     (1,986,665 )

Interest income

    5,153       -  

Gain on reduction of commitment to issue shares (Note 6)

    414,128       -  
                 

Net loss

    (1,649,589 )     (1,986,665 )
                 

Other comprehensive loss

               

Currency translation differences

    41,046       (6,190 )
                 

Total comprehensive loss

  $ (1,608,543 )   $ (1,992,855 )
                 

Net loss per share – basic and diluted

  $ (0.02 )   $ (0.02 )
                 

Weighted average number of common shares outstanding – basic and diluted

    91,422,569       89,968,723  

 

The accompanying notes from an integral part of these consolidated financial statements.

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Stated in US Dollars)

 

 

 

   

Common Stock and Additional

Paid in Capital

                                         
   

Shares

   

Amount

   

Additional

Paid In

Capital

   

Commitment to

Issue Shares

   

Accumulated

Other

Comprehensive

Income (Loss)

   

Accumulated

Deficit

   

Stockholders

Equity

 
                                                         

Balance at December 31, 2020

    86,522,569     $ 43,788,464     $ 284,793     $ 414,128     $ -     $ (44,159,180 )   $ 328,205  
                                                         

Sale of common stock

    4,900,000       3,098,616       -       -       -       -       3,098,616  

Share issuance costs – cash

    -       (36,370 )     -       -       -       -       (36,370 )

Share-based compensation

    -       -       713,684       -       -       -       713,684  

Currency translation differences

    -       -       -       -       6,190       -       6,190  

Net loss

    -       -       -       -       -       (1,986,665 )     (1,986,665 )
                                                         

Balance at December 31, 2021

    91,422,569       46,850,710       998,477       414,128       6,190       (46,145,845 )     2,123,660  
                                                         

Share-based compensation

    -       -       396,520       -       -       -       396,520  

Reduction of commitment to issue shares

    -       -       -       (414,128 )     -       -       (414,128 )

Currency translation differences

    -       -       -       -       (41,046 )     -       (41,046 )

Net loss

    -       -       -       -       -       (1,649,589 )     (1,649,589 )
                                                         

Balance at December 31, 2022

    91,422,569     $ 46,850,710     $ 1,394,997     $ -     $ (34,856 )   $ (47,795,434 )   $ 415,417  

 

The accompanying notes from an integral part of these consolidated financial statements.

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Stated in US Dollars)

 

 

Years ended December 31,

 

 

 

2022

   

2021

 
                 

Cash flows from operating activities:

               

Net loss

  $ (1,649,589 )   $ (1,986,665 )

Add back non-cash share-based compensation

    396,520       713,684  

Gain on reduction of commitment to issue shares

    (414,128 )     -  

Adjustments to reconcile net loss to net cash used in operating activities:

               

Changes in operating assets and liabilities:

               

(Increase) decrease in prepaid expenses and other current assets

    2,441       (32,230 )

Increase in accounts payable and accrued expenses

    180,387       63,869  

(Decrease) increase in accounts payable and accrued expenses due to related parties

          (108,833 )

Net cash used in operating activities

    (1,484,369 )     (1,350,175 )
                 

Cash flows from financing activities:

               

Proceeds from sale of common stock

    -       3,098,616  

Share issuance costs

    -       (36,370 )

Net cash provided by financing activities

    -       3,062,246  
      -       -  
                 

Cash flows from investing activity:

               

Interest received

    5,153       -  

Net cash provided by investing activity

    5,153       -  
                 

Effect of foreign currency translation on cash

    (41,633 )     6,190  
                 

Net increase (decrease) in cash and cash equivalents

    (1,520,849 )     1,718,261  

Cash and cash equivalents at beginning of year

    2,208,451       490,190  

Cash and cash equivalents at end of year

  $ 687,602     $ 2,208,451  
                 
                 

Supplemental disclosures of cash flow information:

               
                 

Cash paid during the year for interest

  $ -     $ -  

Cash paid during the year for income taxes

  $ -     $ -  

 

The accompanying notes from an integral part of these consolidated financial statements. 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

 
 

1.

BASIS OF PRESENTATION AND BUSINESS

 

The accompanying consolidated financial statements include the accounts of Oculus Visiontech Inc. (“Oculus”) and its wholly-owned subsidiary, ComplyTrust Inc. (“CTI”), (together “the Company”). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included.

 

The Company is a designer of digital watermarking services and solutions. At December 31, 2022 and for the two-year period then ended, substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.

 

 
 

2.

GOING CONCERN

 

These consolidated financial statements are prepared on a going concern basis which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses from inception and does not currently have the financial resources to sustain operations in the long-term. As shown in the financial statements, the Company has incurred a loss of $1,649,589 for the year ended December 31, 2022 and, in addition the Company incurred losses of $1,986,665 for the year ended December 31, 2021. As of December 31, 2022, the Company had an accumulated deficit of $47,795,434 and working capital of $415,417. As a result of the Company’s current financial position and challenging access to capital, there can be no assurance that the Company will be able raise additional funds in the future, in which case the Company will be unable to meet its financial obligations. These material uncertainties raise substantial doubt upon the Company’s ability to continue as a going concern. The financial statements do not include adjustments to amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue operations. The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  

 

There are many external factors that can adversely affect general workforces, economies and financial markets globally. Examples include, but are not limited to, the COVID-19 global pandemic and political conflict in other regions. It is not possible for the Company to predict the duration or magnitude of adverse results of such external factors and their effect on the Company’s business or ability to raise funds.

 

 
 

3.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of consolidation

 

These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On March 28, 2023, the Board approved the consolidated financial statements dated December 31, 2022.

 

These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.

 

Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than 50% of the voting rights or currently exercisable potential voting rights of a Company’s capital stock. All significant intercompany transactions and balances have been eliminated.

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

The controlled entities are listed in the following table:

 

Name of Subsidiary

Country of

Incorporation

 

Ownership

Interest at

December 31,

2022

  

Ownership

Interest at

December 31,

2021

 

Principal Activity

           

ComplyTrust Inc.

US/Delaware

  100%  100%

Software Development

 

Significant judgments, estimates and assumptions

 

The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.

 

The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are not limited to the following:

 

Significant judgments

 

the determination of functional currencies; and

 

share-based compensation and warrants issued in connection with private placements, using the fair value method. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based compensation. This estimate also requires determining the most appropriate inputs to the valuation model. The main factor affecting the estimates of the fair value of stock options is the stock price, expected volatility used and the expected duration of the instrument. The Company currently estimates the expected volatility of its common shares based on historical stock price information. The Company recognizes the commitment to issue shares, based on the trading price at the date of the commitment on a percentage basis on the likelihood of the completion of the event.

 

Cash and cash equivalents

 

Cash equivalents include highly liquid investments with original maturities of twelve months or less, and which are subject to an insignificant risk of change in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.

 

Impairment of long-lived assets and long-lived assets to be disposed of

 

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount and the fair value less costs to sell.

 

Research and development

 

Expenditure on research activities is recognized on the consolidated statements of operations and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at December 31, 2022, it was not yet able to demonstrate with sufficient certainty that it is probable that any economic benefits will flow to the Company. Accordingly, all research and development costs incurred to date have been expensed. 

 

40

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

Intangible asset

 

Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses.

 

The useful lives of intangible assets are assessed as either finite or indefinite.

 

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually and whenever there is an indication that the intangible asset may be impaired. The amortization period and method for an intangible asset with a finite useful life are reviewed at least at each financial year-end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in profit or loss.

 

Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets may be impaired.

 

Income taxes

 

The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion or the entire deferred tax asset will not be recognized.

 

Net loss per share

 

Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that may require the issuance of common shares in the future were converted, unless the impact is anti-dilutive. For the year ended December 31, 2022 and 2021, this calculation proved to be anti-dilutive, and therefore the Company’s 5,415,000 (2021: 5,315,000) stock options and 17,400,000 (2021: 17,400,000) warrants were excluded from the calculation.

 

Right of use asset

 

The Company recognizes a right of use asset and a lease liability at the lease commencement date. The right of use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove or to restore the underlying asset or the site on which it is located, less any lease incentives received.

 

The right of use assets are subsequently amortized from the commencement date to the earlier of the end of the useful life of the right of use asset or the end of the lease term using the straight line method.

 

41

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

Lease liability

 

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate.

 

Lease payments included in the measurement of the lease liability comprise the following payments during the lease term: fixed payments (including in-substance fixed payments), and the exercise price under a purchase option that the Company is reasonably certain to exercise.

 

The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising mainly if the Company changes its assessment of whether it will exercise a purchase, renewal or termination option, or if there is a revised in substance fixed lease payment.

 

When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right of use asset, or is recorded in profit or loss if the carrying amount of the right of use asset has been reduced to zero.

 

Stock-based compensation

 

The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section 718 “Compensation - Stock Compensation”, which establishes accounting for equity-based compensation awards to be accounted for using the fair value method. Equity-settled share-based payment arrangements are initially measured at fair value at the date of grant and recorded within shareholders’ equity. Arrangements considered to be cash-settled are initially recorded at fair value and classified as accrued liabilities, and subsequently re-measured at fair value at each reporting date. The Company’s stock option plan is an equity-settled arrangement.

 

The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.

 

Functional currency

 

The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus is the Canadian (“CAD” or “C”) dollar and the functional currency of CTI is the U.S. dollar.

 

In accordance with ASC 830, Foreign Currency Matters, for companies that have a functional currency other than the US dollar, the Company translates the assets and liabilities into U.S. dollars using the rate of exchange prevailing at the balance sheet date and the statements of operations and comprehensive loss and cash flows are translated at an average rate during the reporting period. Adjustments resulting from the translation from CAD into U.S. dollars are recorded in shareholders' equity as part of accumulated other comprehensive (income) loss.

 

Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are not re-translated at period end are measured at historical cost (translated using the exchange rates at the transaction date), except for non-monetary items measured at fair value, which are translated using the exchange rates as at the date when fair value was determined. Gains and losses are recorded in the statement of operations and comprehensive loss.

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

Recently adopted accounting pronouncements

 

The Company has reviewed new and revised accounting pronouncements that have been issued but are not yet effective. The Company does not expect any material impact from future accounting pronouncements.

 

 
 

4.

PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets consist of the following:

 

   

December 31,

   

December 31,

 
   

2022

   

2021

 
                 

Prepaid expenses

  $ 28,028     $ 28,141  

Tax Receivable – Canadian GST

    2,210       9,691  
    $ 30,238     $ 37,832  

 

 
 

5.

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consist of the following:

 

   

December 31,

   

December 31,

 
   

2022

   

2021

 
                 

Accounts payable

  $ 224,716     $ 61,836  

Accrued fees and expenses

    51,869       34,362  
    $ 276,585     $ 96,198  

 

 
 

6.

COMMON STOCK 

 

The Company has no par value common stock with 500,000,000 authorized shares and 91,422,569 outstanding on December 31, 2022 and 2021.

 

The Company has authorized the issuance of 250,000,000 non-voting preferred shares without par value, none issued.

 

As of December 31, 2022, there were 1,875,000 common shares held in escrow.

 

On June 14, 2021, the Company closed a non-brokered private placement financing of 4,900,000 units of the Company at a price of CDN$0.80 per unit for gross proceeds of $3,920,000CDN ($3,098,616). Each unit consisted of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share of the Company at an exercise price of $1.00CDN for a period of 24 months from the date of closing. The expiry date of the warrants may be accelerated at the Company’s discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than $2.50CDN for a minimum of ten consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant. In connection to the private placement, the Company paid $45,500CDN ($36,370) as share issuance costs.

 

During the year ended December 31, 2022, the Company wrote-off the commitment to issue shares of $414,128 due to the uncertainty in the Company meeting the required performance conditions.

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

 
 

7.

STOCK OPTIONS  

 

During the year ended December 31, 2022 and 2021, the Company adopted a Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares may be reserved for granting of stock options. All of the options granted vest 20% every six months.

 

However, all options will be considered vested if one of the following criteria are met by the Company:

 

 

i.

Meeting sales forecasts:

 

 

-

The greater of either the 20% vesting every six months or based on a pro rata percentage of revenue earned by the Company’s subsidiary.

 

 

ii.

the listing of the Company on any national securities exchange.

   
 

iii.

a Change of Control Event.

 

 

During the year ended December 31, 2022, the Company:

 

i) granted 100,000 stock options to a consultant, exercisable into 100,000 shares at an exercise price of $0.80CAD and an expiry date of January 31, 2025. The options have a fair value of $54,600CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 119.10%; (ii) Term of 3 years; (iii) Discount rate of 1.24%; (iv) Dividend rate of Nil; and (v) market stock price of $0.78CAD. The options vest 20% every 6 months starting August 1, 2022. During the year ended December 31, 2022, the Company recorded $36,511CAD ($28,162) of share-based compensation relating to the vesting period.

 

During the year ended December 31, 2021, the Company:

 

i) granted 500,000 stock options to consultants, exercisable into 500,000 shares at an exercise price of $1.20CAD and an expiry date of January 29, 2024. The options have a fair value of $424,300CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125.00%; (ii) Term of 3 years; (iii) Discount rate of 0.14%; (iv) Dividend rate of Nil; and (v) market stock price of $1.18CAD. The options vest 20% every 6 months starting July 29, 2021. During the year ended December 31, 2021, the Company recorded $285,557CAD ($230,215) of share-based compensation relating to the vesting period. During the year ended December 31, 2022, the Company recorded $115,811CAD ($89,648) of share-based compensation relating to the vesting period.

 

ii) granted 375,000 stock options to consultants, exercisable into 375,000 shares at an exercise price of $0.80CAD and an expiry date of June 10, 2024. The options have a fair value of $211,700CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 120.80%; (ii) Term of 3 years; (iii) Discount rate of 0.25%; (iv) Dividend rate of Nil; and (v) market stock price of $0.80CAD. The options vest 20% every 6 months starting December 10, 2021. During the period ended September 30, 2021, the Company recorded $101,058CAD ($83,342) of share -based compensation relating to the vesting period. During the year ended December 31, 2022, the Company recorded $83,351CAD ($64,460) of share-based compensation relating to the vesting period.

 

iii) granted 590,000 stock options to consultants, exercisable into 590,000 shares at an exercise price of $0.60CAD and an expiry date of October 14, 2024. The options have a fair value of $219,100CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 119.89%; (ii) Term of 3 years; (iii) Discount rate of 0.63%; (iv) Dividend rate of Nil; and (v) market stock price of $0.54CAD. The options vest 20% every 6 months starting April 14, 2021. During the year ended December 31, 2021, the Company recorded $42,819CAD ($33,964) of share -based compensation relating to the vesting period. During the year ended December 31, 2022, the Company recorded $128,164AD ($99,315) of share-based compensation relating to the vesting period. 

 

44

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

During the year ended December 31, 2020, the Company:

 

i) granted 3,600,000 stock options to consultants, directors and officers exercisable into 3,600,000 shares at an exercise price of $0.35CAD and an expiry date of July 21, 2023. The options have a fair value of $909,900CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.27%; (iv) Dividend rate of Nil; and (v) market stock price of $0.35CAD. The options vest 20% every 6 months starting January 21, 2021. During the year ended December 31, 2021, the Company recorded $406,133CAD ($324,132) of stock-based compensation relating to the vesting period. During the year ended December 31, 2022, the Company recorded $129,990CAD ($100,848) of share-based compensation relating to the vesting period.

 

ii) granted 250,000 stock options to consultants, directors and officers exercisable into 250,000 shares at an exercise price of $0.45CAD and an expiry date of December 21, 2023. The options have a fair value of $75,800CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.02%; (iv) Dividend rate of Nil; and (v) market stock price of $0.425CAD. The options vest 20% every 6 months starting June 21, 2021. During the year ended December 31, 2021, the Company recorded $52,835CAD ($42,031) of stock-based compensation relating to the vesting period. During the year ended December 31, 2022, the Company recorded $18,207CAD ($14,087) of share-based compensation relating to the vesting period.

 

The changes in options are as follows:

 

  

Number of

options

  

Weighted

average exercise

price

(CAD)

  

Aggregate

Intrinsic Value

 
             

Options outstanding, December 31, 2020

  3,850,000  $0.36  $3,363,000 

Granted

  1,465,000   0.86   - 

Options outstanding, December 31, 2021

  5,315,000   0.49   3,910,950 

Granted

  100,000   0.80   - 

Options outstanding, December 31, 2022

  5,415,000  $0.50  $- 

 

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for the options that were in-the-money at December 31, 2022.

 

Details of options outstanding as at December 31, 2022 are as follows: 

 

Exercise price (CAD)

  

Number of

options

outstanding

 

Expiry date

 

Number of options

exercisable

  

Remaining

contractual life (years)

 
                
$0.350   3,600,000 

July 21, 2023

  2,880,000   0.55 
$0.450   250,000 

December 21, 2023

  200,000   0.97 
$1.200   500,000 

January 29, 2024

  300,000   1.08 
$0.800   375,000 

June 10, 2024

  225,000   1.44 
$0.600   590,000 

October 14, 2024

  236,000   1.79 
$0.800   100,000 

January 31, 2025

  20,000   2.09 
                
     5,415,000    3,861,000     

 

45

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

The following weighted average assumptions were used for the Black-Scholes valuation of stock options granted:

 

  

December 31, 2022

  

December 31, 2021

 
         

Risk-free interest rate

  1.24%  0.37%

Exercise price (CAD)

 $0.80  $0.86 

Expected life of options (in years)

  3.00   3.00 

Expected annualized volatility

  119.10%  121.87%

Fair value of options granted (CAD)

 $0.55  $0.58 

Expected dividend rate

  -   - 

 

 
 

8.

WARRANTS  

 

The changes in warrants are as follows:

 

   

Number of

warrants

   

Weighted

average exercise

price

(CAD)

   

Aggregate

Intrinsic Value

 
                         

Warrants outstanding, December 31, 2020

    12,500,000     $ 0.001     $ -  

Granted

    4,900,000       1.00       -  

Warrants outstanding, December 31, 2022 and 2021

    17,400,000     $ 0.28     $ -  

 

Details of warrants outstanding as at December 31, 2022 are as follows:

 

Exercise price

     

Number of

warrants

outstanding

 

Expiry date

 

Number of warrants

exercisable

   

Remaining

contractual life (years)

 
                                 
$ 1.00  

(CAD)

    4,900,000  

April 19, 2023

    4,900,000       0.30  
$ 0.001  

(1) (USA)

    12,500,000  

June 4, 2025

    -       2.43  
                                 
            17,400,000         4,900,000          

 

 

(1)

No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) targeted revenue sales projections met, or 2) listing on a major US exchange, or 3) change of control.

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

 
 

9.

SELLING, GENERAL AND ADMINISTRATIVE  

 

The breakdown of selling, general and administrative for the year ended December 31, 2022 and 2021 is as follows:

 

   

 

2022

   

2021

 
                 

Filing and regulatory fees

  $ 40,158     $ 38,396  

Marketing

    76,459       41,374  

Professional fees

    104,801       133,134  

Rent

    38,922       39,134  

Office and administration

    139,127       178,653  
                 
    $ 399,467     $ 430,691  

 

 
 

10.

RESEARCH AND DEVELOPMENT  

 

The breakdown of research and development for the year ended December 31, 2022 and 2021 is as follows:

 

   

 

2022

   

2021

 
                 

Project management

  $ 11,990     $ 144,000  

Software development

    820,996       585,953  

Business development

    133,588       60,533  

Payroll

    171,309       27,783  
                 
    $ 1,137,883     $ 818,269  

 

 
 

11.

FINANCIAL INSTRUMENTS AND RISKS  

 

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are described below.

 

Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2 – inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and

Level 3 - inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

Fair value of financial instruments

 

The Company has various financial instruments including cash, receivables, accounts payable and accrued liabilities and a loan payable. The carrying values of receivables, accounts payable and accrued liabilities, and loan payable approximate their fair values due to the short-term nature of these financial instruments.

 

Cash is carried at a level 1 fair value measurement.

 

47

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

 

The Company’s risk exposures and the impact on the Company’s financial instruments are summarized below:

 

Credit risk

The Company is exposed to credit risk only with respect to uncertainties as to timing and amount of collectability of receivables. The Company believes its credit risk is low because a portion of receivables are comprised of goods and services tax (GST) and other government refunds, which is recoverable from the governing body in Canada. Management does not believe the receivables are impaired. The Company doesn’t believe there is significant credit risk associated with cash as these amounts are held with major Canadian banks.

 

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company’s approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities when due. As at December 31, 2021, the Company had a cash balance of $687,602 (2021 – $2,208,451) to settle current liabilities of $302,423 (2021 – $122,623). All of the Company’s financial liabilities have contractual maturities of 30 days or due on demand and are subject to normal trade terms.

 

Interest rate risk

Interest rate risk is the risk that the future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The risk that the Company will realize such a loss is limited as it does not have any significant interest-bearing financial instruments.

 

Foreign currency risk

As at December 31, 2022 and 2021, the Company is exposed to foreign currency risk as certain monetary financial instruments are denominated in Canadian currency. The Company’s sensitivity analysis suggests that reasonably expected changes in the rates of exchange in Norway, and the United States would change foreign exchange gain or loss by an insignificant amount.

 

 
 

12.

INCOME TAXES  

 

A reconciliation of income taxes at statutory rates with the reported taxes is as follows:

 

  

 

December 31,

2022

  

December 31,

2021

 
         

Loss before taxes for the year

 $(1,649,589) $(1,986,665)
         

Expected income tax (recovery)

 $(461,000) $(417,000)

Effect of change in tax rates

  37,000   (64,000)

Permanent differences

  (5,000)  150,000 

Adjustment to prior years provision

  (5,000)  2,147,000 

Change in unrecognized deductible temporary

  434,000   (1,816,000)
         

Total income taxes

 $-  $- 
         

Current income tax

 $-  $- 

Deferred tax recovery

 $-  $- 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

The significant components of the Company’s deferred tax assets that have not been included on the consolidated statement of financial position are as follows:

 

  

 

December 31,

2022

  

December 31,

2021

 
         

Non-capital losses

 $5,445,227  $5,010,903 
         
  $5,445,227  $5,010,903 

Unrecognized deferred tax assets

  (5,445,227)  (5,010,903)

Net deferred tax assets

 $-  $- 

 

The significant components of the Company’s temporary differences, unused tax credits and unused tax losses that have not been included on the consolidated statement of financial position are as follows: 

 

  

2022

  

Expiry Date

Range

  

2021

  

Expiry Date

Range

 

Temporary Differences

                

Non-capital losses available for future periods

 $25,155,000   2026to2041  $23,473,000   2026to2041 

Canada

 $18,334,000   2023to2037  $18,334,000   2023to2037 

USA

 $6,821,000  

No expiry date

  $5,139,000  

No expiry date

 

 

 
 

13.

RELATED PARTIES  

 

Related parties include the Board of Directors, officers, close family members and enterprises that are controlled by these individuals as well as certain persons performing similar functions.

 

The Company defines its key management as the Board of Directors, Chief Executive Officer, President, and Chief Financial Officer. Remuneration of directors and key management personnel of the Company was as follows:

 

  

 

Year ended

December 31,

 
  

2022

  

2021

 
         

Selling general and administrative

 $215,331  $124,972 

Share-based compensation to directors and officers

  47,062   151,261 
  $262,393  $276,233 

 

The Company for the years ended December 31, 2022 and 2021 reimbursed a related party $215,331 and $124,972 , respectively, for selling, general and administrative expenses paid on behalf of the Company. The Company also recorded share-based compensation of $47,062 (2021 - $151,261) for options vested to related parties during the years ended December 31, 2022 and 2021. The Company incurred no expenses from a related party for research and development for the years ended December 31, 2022 and 2021.

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

 

14.

OPERATING LEASES  

 

The Company has one operating leases with unrelated third parties for office space at the Vancouver, Canada.

 

The lease at the Vancouver, Canada location is on a month-to-month basis with monthly rental payments of $3,950 (CND). For the years ended December 31, 2022 and 2021 rent expense was $36,894 and $36,340, respectively.

 

 
 

15.

SEGMENTED INFORMATION  

 

The Company currently operates in a single reportable operating segment. All of the Company’s assets and expenditures are located in the United States. Since the Company does not have any revenue producing activities, there is no segment information by revenues.

 

 

 
 

Item 9A

Control and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures, as defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this report.

 

In designing and evaluating our disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

 

No system of controls can prevent errors and fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur. Controls can also be circumvented by individual acts of some people, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with its policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

Subject to the limitations above, management believes that the consolidated financial statements and other financial information contained in this report, fairly present in all material respects our financial condition, results of operations, and cash flows for the periods presented.

 

Based on the evaluation of the effectiveness of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) were not effective as a result of the weaknesses in the design of our internal control over financial reporting.

 

Based upon their evaluation of our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer have concluded that our internal controls over financial reporting are ineffective.  The material weaknesses in our internal controls related to a lack of segregation of duties due to inadequate staffing within our accounting department and upper management, the assignment of authority and responsibility, lack of consistent policies and procedures, inadequate monitoring controls and inadequate disclosure controls.

 

There were no changes in our internal controls that occurred during the period covered by this report that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

 

We are committed to improving our financial organization.  As part of this commitment, we will create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to our company.

 

In addition, management believes that preparing and implementing sufficient written policies and checklists will remedy the following material weaknesses (i) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements; and (ii) ineffective controls over period end financial close and reporting processes. Further, management believes that the hiring of additional personnel who have the technical expertise and knowledge will result in proper segregation of duties and provide more checks and balances within the department. Additional personnel will also provide the cross training needed to support our company if personnel turn over issues within the department occur.

 

We will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.  

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting.  Management's report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit our company to provide only management's report in this annual report.

 

 

 

Item 9B.

Other Information

 

Not applicable

 

 

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 

Not applicable

 

 

 

PART III

 

 

Item 10.

Directors and Executive Officers of the Registrant.

 

Our current directors and executive officers and their respective ages as of March 28, 2023, are as follows:

 

Name and Province or State
  and Country of Residence

Age

Position

Period of

Service

Rowland Perkins
Alberta, Canada

70

Director, President and Chief Executive Officer

Since 2005

Anton J. Drescher 1
British Columbia, Canada

66

Director, Chief Financial Officer and Corporate Secretary

Since 1994

Fabrice Helliker,
Broadstone, UK

55

Director

Since 2020

Maurice Loverso 1
Quebec, Canada

62

Director

Since 2003

Tom Perovic
Ontario, Canada

70

Director

Since 2011

Ron Wages 1
North Carolina, USA

60

Director

Since 2011

 

Note:

 

1

Member of audit committee.

 

Rowland Perkins President, Chief Executive Officer and Director

Mr. Perkins was formerly the President & Chief Executive Officer of ebackup Inc. (2001-2015) (a private corporation), a digital cloud data service provider specializing in cloud services, data backup and business continuity. Mr. Perkins has over 45 years of business experience and 30 years with various public companies. Mr. Perkins is a former director of one other publicly trade company: Corvus Gold Inc, since August 2010 to 2021. Mr. Perkins was also a former director of Xiana Mining Inc. (TSXV) from 2011 to 2018, of International Tower Hill Mines Ltd. from 2005 to 2010, of Blue Rhino Capital Corp. in 2020 to 2021, and of Lamaska Capital Corp in 2020 to 2021. Mr. Perkins has a degree in Economics from the University of Manitoba.

 

Anton J. Drescher - Chief Financial Officer, Secretary and Director

Mr. Drescher has been a Chartered Professional Accountant, Certified Management Accountant since 1981. He is currently involved with several public companies including as: a director (since 1991) of International Tower Hill Mines Ltd., a public mining company listed on the TSX and the NYSE-MKT; a director (since 1996) and Chief Financial Officer (since 2012) of Xiana Mining Inc., a public mineral exploration company listed on the TSXV/NEX; a director (since 2007) and the Chief Financial Officer of Oculus VisionTech Inc., a public company involved in watermarking of film and data listed on the TSXV and the OTC Bulletin Board; a director (since 2014) of CENTR Brands Corp., a public company listed on the CSE; a former director (since 2020 -2023) of Zeb Nickle Corp. (formerly Blue Rhino Capital Corp.), a public company listed on the TSXV; a former director (2020-2021) of Lamaska Capital Corp., a public company listed on the TSXV. Mr. Drescher is also the President (since 1979) of Westpoint Management Consultants Limited, a private company engaged in tax and accounting consulting for business reorganizations, and the President (since 1998) of Harbour Pacific Capital Corp., a private company involved in regulatory filings for businesses in Canada.

 

Fabrice Helliker Director

Mr. Helliker is currently an advisor to ComplyTrust Inc. (formerly OCL Technologies Corp.), and a long time executive and entrepreneur in the data protection and compliance market. He is currently the head of a software engineering division responsible for data protection automation and orchestration solutions for Hitachi Vantara, where he joined in 2012 upon the acquisition of a company he co-founded, Cofio Software. He was also a co-founder of BakBone Software, which was traded on the Toronto Exchange and later acquired by Quest Software Corp.

 

Maurice Loverso Director

Mr. Loverso has been an independent director of Oculus since May 2003. He has been President of 3336298 Canada Inc. since 1996, providing financial consultation services to small capital public and private companies and has been a director of Group Intercapital Inc. since 1996, assisting a small cap venture capital firm with financial advice.

 

 

Tom Perovic Director

Mr. Perovic has over 30 years of experience in high technology management, from research and development to high-level and top development and executive positions in businesses including automotive industry, in particular in developing and releasing autonomous driving AD Perception products , and ADAS (Advanced Driver Assistance Systems), based on AI - Machine/Deep learning models, for major OEMs, including Daimler, BMW, Toyota, Honda Ford and GM, electronics (embedded hardware, imaging/video processing based products), real-time automotive grade, functional safety compliant embedded software development, running on intelligent RTOS (Real Time Operating System), sensor fusion (camera, LiDAR, Radar, ultrasonic) data capture, and real-time processed by deep learning Neural Networks, Internet centric streaming video content (movies) watermarking products for the entertainment industry, machine vision, IP based video communications, PCB production/development equipment, professional video (TV broadcasting), Internet imaging, security video surveillance, contract manufacturing, material handling/logistics and production/distribution. He has been a co-founder, President and CTO of ASPRO Technologies, a digital security/surveillance technology start-up from 1992-2002, General Manager of Magna International Inc. and Global Director of Engineering at Magna Electronics (Magna Vectrics) from 2002 to 2018 where he was responsible for restructuring since a takeover, P/L, development strategy, operational team building and leadership, and since 2018 till present Sr. Director, Toronto Automotive Center of Excellence (TACoE), LeddarTech Inc, LiDAR high technology company. He established TACoE AI based AD/ADAS/Perception division of LeddarTech from scratch, including building the scientific, engineering, and vehicle integration and quality teams, OPEX and CAPEX. Tom has been instrumental in several technology companies M&A process.

 

Ron Wages Director

Mr. Wages is an innovative and results-driven corporate professional with an impressive 30 year record of success in delivering record profit growth and solid project performance in multiple markets worldwide. He is the Director, Transmission Project Controls at Duke Energy where he leads a team of project management professionals that manage a $9B portfolio of Transmission Capital Projects. Previously, he was the founder and Chief Executive Officer of Vagues Solid State Lighting, a manufacturer of LED based lighting. He was President and General Manager of MEMScAP Inc./JDS Uniphase, a public company in the semiconductors industry. He managed the day-to-day operations for sales, marketing, manufacturing, legal and finance. Mr. Wages has a B.S. in Electrical Engineering from the University of Maryland College Park and an MBA (Honors) from the University of Houston Executive MBA Program.

 

The Board of Directors has no reason to believe that any nominee will not serve if elected. If any nominee is unable to serve as a director, the shares represented by all valid proxies may be voted for the election for such other person(s) as the Board may recommend, unless the Board chooses to reduce the number of directors serving on the Board. Proxies will be voted FOR each nominee unless the shareholder specifies otherwise.

 

The Board of Directors unanimously recommends a vote FOR the election of each of the nominees named in this Proxy Statement. Proxies solicited by the Board of Directors will be so voted unless shareholders specify otherwise on the accompanying Proxy.

 

Term of Office

All of our directors, when elected, hold office until the next annual meeting of our stockholders or until their successors are elected and qualified. Our officers are appointed by our Board of Directors and hold office until their successors are appointed and qualified.

 

Significant Employees

 

There are no significant employees of the Company other than our executive officers, however, our subsidiary, ComplyTrust Inc. (“CTI”), formerly OCL Technologies Corp. (“OCL”), entered into an employment contract with Mike Johnson (age 65), who is the co-founder, President and a director of CTI, effective February 1, 2022, whereby Mr. Johnson provides product manager services for product development based on proprietary ideas developed by CTI. The term of the employment contract ends on January 31, 2023, or upon a mutually agreed upon date, agreed to in writing by CTI and Mr. Johnson. Mr. Johnson was a director and officer of CTI from June 12, 2020 to January 31, 2023. From March 2017 to February 2020, Mr. Johnson was a Business Development Director with the Archival Solutions Division at Sony Electronics where he provided clarity and thought-leadership for introduction of PetaByte-class enterprise storage solutions to the autonomous vehicle/IoT, big data and high-performance compute markets worldwide. Mr. Johnson obtained and undergraduate degree in Audio Engineering from SoundMaster Institute located in Hollywood, California in 1980, and obtained undergraduate degrees in Business and Computer Science from Fullerton College located in Fullerton, California in 1984. Subsequent to Mr. Johnson’s resignation, Anton J. Drescher will act as the interim President and CEO while the Company initiates plans to build out a new CTI executive leadership team focused on continued software development, new customers acquisition and revenue generation.

 

Family Relationships

There is no family relationship between any of our executive officers or directors.

 

 

Involvement in Certain Legal Proceedings

 

Except as disclosed in this proxy statement, during the past ten years none of the following events have occurred with respect to any of our directors and officers:

 

 

1.

A petition under any legislation relating to bankruptcy laws or insolvency laws was filed by or against, or a receiver, fiscal agent or similar officer was appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing;

 

 

2.

Such person was convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses);

 

 

3.

Such person was the subject of any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from, or otherwise limiting, the following activities:

 

 

i.

Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;

 

 

ii.

Engaging in any type of business practice; or

 

 

iii.

Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of applicable securities legislation, whether federal, state or provincial or any applicable commodities legislation;

 

 

4.

Such person was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in paragraph (3)(i) above, or to be associated with persons engaged in any such activity;

 

 

5.

Such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;

 

 

6.

Such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;

 

 

7.

Such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:

 

 

i.

Any Federal or State securities or commodities law or regulation; or

 

 

ii.

Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or

 

 

iii.

Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

 

 

8.

Such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the U.S. Securities Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

There are currently no legal proceedings to which any of our directors or officers is a party adverse to us or in which any of our directors or officers has a material interest adverse to us. 

 

 

Code of Business Conduct and Ethics

 

The company has adopted and operates under a strict code to conduct its affairs in accordance with all applicable laws, rules and regulations of the countries in which it does business. This Code of Business Conduct (“Code”) applies to the Company’s officers, directors, non-employee directors and contractors, and includes the Company’s principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions. This Code is the Company’s “code of ethics” and is designed to promote:

 

 

honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

 

 

full, fair, accurate, timely and understandable disclosure in the reports and documents the Company files with, or submits to, the U.S. Securities and Exchange Commission and in other public communications made by the Company;

 

 

compliance with applicable governmental laws, rules and regulations;

 

 

the prompt internal reporting to the appropriate person of violations of this Code; and

 

 

accountability for adherence to this Code.

 

The company has established standards for behavior that affects the Company, officers, directors, contractors and future employees that should pattern their daily performance in compliance with those standards.

 

This Code covers a wide range of business practices and procedures. It does not cover every issue that may arise, but it sets out basic principles to guide you. Corporate policies and procedures provide details pertinent to many of the provisions of the Code.

 

For more details, please refer to Exhibit A, Code of Business Conduct and Ethics.

 

Executive Officers and Directors of the Company:

 

Audit Committee

 

The Audit Committee of the Board of Directors consists of Maurice Loverso, Anton J. Drescher and Ron Wages, who serves as Chairman. The Board of Directors had determined that each Audit Committee member has sufficient knowledge in financial and accounting matters to serve on the Committee and that Anton J. Drescher is an “audit committee financial expert” as defined by SEC rules.

 

The Audit Committee meets with our independent auditors at least quarterly to discuss the results of the annual audit or interim periodic reviews and to review the financial statements; appoints the independent auditors to be retained; oversees the independence of the independent accountants; evaluates the independent auditors’ performance; approves fees paid to independent auditors and receives and considers the independent auditors’ comments as to controls, adequacy of staff and management performance and procedures in connection with audit and financial controls. The Audit Committee met informally by telephone conference during fiscal 2022.

 

The Audit Committee is primarily concerned with the effectiveness of our audits by our internal audit staff and by our independent auditors. Its duties include: (1) recommending the selection of independent auditors; (2) reviewing the scope of the audit to be conducted by them, as well as the results of their audit; (3) reviewing the organization and scope of our internal system of audit and financial controls; (4) appraising our financial reporting activities (including our Proxy Statement and Annual Report) and the accounting standards and principles followed; and (5) examining other reviews relating to compliance by employees with important policies and applicable laws. The Audit Committee operates under a written Charter adopted by the Board of Directors, a copy of which is attached to this Proxy Statement as Schedule “A”.

 

Compensation Committee

 

At present, the company does not have a formal Compensation Committee. All compensation is controlled, managed, and reviewed by the company Board of Directors. As of December 31, 2022, company executives or directors received no compensation for services rendered other than granted stock options.

 

 

 

Item 11.

Executive Compensation

 

The following table sets forth compensation awarded to, earned by or paid to Oculus's Chief Executive Officer (CEO), and to other persons serving as executive officers for the last three completed fiscal years , whose salary and bonus for such year exceeded $100,000 (collectively, the "Named Executive Officers").

 

                             

Long Term Compensation

 
 

Summary Compensation

Annual Compensation

   

Awards

   

Payouts

 

Name and

Principal

Position

Year

 

Salary

   

Bonus

   

Other

Annual

Compen-

sation

   

Restricted

Stock

Award(s)

   

Securities

Underlying

Options/SARs

(#)1

   

LTIP

Payouts

   

All Other

Compen-

sation

 
                                                           
                                                           

Drescher,

2022

    -0-       -0-       135,000       -0-       -0-       -0-       -0-  

Anton

2021

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

CFO

2020

    -0-       -0-       -0-       -0-       630,000       -0-       -0-  
                                                           

Perkins,

2022

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

Rowland

2021

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

CEO

2020

    -0-       -0-       -0-       -0-       210,000       -0-       -0-  

 

The following table sets forth certain information concerning exercises of stock options by the Named Executive Officers during the year ended December 31, 2022 and stock options held at year end.

 

Aggregated Option / SAR Exercises in Last Fiscal Year and FY-End Option / SAR Values

 

                 

Number of Securities

Underlying Unexercised

Options / SARs at Fiscal year End

December 31, 2022

 

Value of Unexercised In-the-

Money Options / SARs at

Fiscal Year End ($)

 

Name

 

Shares

Acquired on

Exercise (#)1

   

Value

Realized ($)

 

Exercisable/ Unexercisable

 

Exercisable/ Unexercisable

 

Drescher, Anton

    630,000       -0-  

252,000

/ 630,000     173,853

/

260,780  

Perkins, Rowland

    210,000       -0-  

84,000

/ 210,000     57,951

/

86,927  

 

1The additional terms and conditions attached to the Option represented by this Option Commitment are as follows:

 

 

1.

The Options will not be exercisable unless and until they have vested and then only to the extent that they have vested. The Options will vest in accordance with the following:

 

 

Vesting Provisions

 

To vest as to 20% on the date that is six months from the date of grant, and a further 20% on each successive date that is six months from the date of the previous vesting in accordance with the table below:

 

All options will be considered vested if one of the following criteria are met by the Company:

 

 

iv.

Meeting sales forecasts:

 

 

-

The greater of either the 20% vesting every six months or the pro rata percentage of warrants earned by the Company’s subsidiary, ComplyTrust Inc. (“CTI”) in years 1, 2 and 3

 

 

-

(100V/$125,000,000) of the warrants shall vest on June 4, 2021 (2022 and 2023), wherein “V” is the Gross Revenue of the business (as hereinafter defined) between the period June 4, 2020 – June 4, 2025;

 

 

-

“Gross Revenue” means all monetary sums earned less any credits issued for returns and allowances, and, for certainty, Gross Revenue does not include Deferred Revenue;

 

 

-

eg: if the CTI warrant holders earn 60% of projected revenue in Year 1 then all option holders would also vest 60% .

 

 

v.

the listing of the Company on any national securities exchange registered with the United States Securities and Exchange Commission under section 6 of the United States Securities Exchange Act of 1934, as amended, such as, but not limited to, the New York Stock Exchange, the NYSE American, and NASDAQ Stock Market; or

 

 

vi.

a Change of Control Event meaning, with reference to the Company: (a) the acquisition of a sufficient number of voting securities in the capital of the Company so that the acquirer (as referenced in the CTI Share Purchase Agreement dared for reference June 5, 2020) becomes entitled, directly or indirectly, to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company (provided that, prior to the acquisition, the acquirer was not entitled to exercise more than 50% of the voting rights attaching to the outstanding voting securities in the capital of the Company); (b) an occurrence when a majority of the directors elected at any annual or extraordinary general meeting of shareholders of the Company are not individuals nominated by the Company’s then-incumbent board; or (c) sale of one or more assets of the Company (but for certainty excludes sales made in the normal course of Business) after the Closing Date (as defined in the CTI Share Purchase Agreement) resulting in the collection of monetary sums that is collectively more than 50% of the Gross Revenue of the Company during the twelve (12) month period immediately preceding the Closing Date (as defined in the CTI Share Purchase Agreement).

 

 

Compensation of Directors

 

Directors receive no compensation for their service as such.

 

The following table sets forth compensation awarded to, earned by or paid to Oculus's directors for the last three completed fiscal years.

 

                             

Long Term Compensation

 
 

Summary Compensation

Annual Compensation

   

Awards

   

Payouts

 

Name and

Principal

Position

Year

 

Salary

   

Bonus

   

Other

Annual

Compen-

sation

   

Restricted

Stock

Award(s)

   

Securities

Underlying

Options/SARs

(#)1

   

LTIP

Payouts

   

All Other

Compen-

sation

 
                                                           
                                                           

Loverso,

2022

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

Maurice

2021

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

Director

2020

    -0-       -0-       -0-       -0-       210,000       -0-       -0-  
                                                           

Pervic,

2022

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

Tom

2021

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

Director

2020

    -0-       -0-       -0-       -0-       210,000       -0-       -0-  
                                                           

Wages

2022

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

Ron

2021

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

Director

2020

    -0-       -0-       -0-       -0-       210,000       -0-       -0-  
                                                           

Helliker

2022

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

Fabrice

2021

    -0-       -0-       -0-       -0-       -0-       -0-       -0-  

Director

2020

    -0-       -0-       -0-       -0-       210,000       -0-       -0-  

 

The following table sets forth certain information concerning exercises of stock options by directors during the year ended December 31, 2022 and stock options held at year end.

 

Aggregated Option / SAR Exercises in Last Fiscal Year and FY-End Option / SAR Values

 
                 

Number of Securities

Underlying Unexercised

Options / SARs at Fiscal year End

December 31, 2022

 

Value of Unexercised In-the-

Money Options / SARs at

Fiscal Year End ($)

 

Name

 

Shares

Acquired on

Exercise (#)1

   

Value

Realized ($)

 

Exercisable/ Unexercisable

 

Exercisable/ Unexercisable

 

Loverso, Maurice

    210,000       -0-  

168,000

/ 42,000   -0-

/

-0-  

Pervic, Tom

    210,000       -0-  

168,000

/ 42,000   -0-

/

-0-  

Wages, Ron

    210,000       -0-  

168,000

/ 42,000   -0-

/

-0-  

Helliker, Fabrice

    210,000       -0-  

168,000

/ 42,000   -0-

/

-0-  

 

Employment Contracts

 

We do not have an employment contract with Mr. Rowland Perkins and Anton Drescher. We have no obligation to provide any compensation to Mr. Perkins or any other Named Executive Officer in the event of his resignation, retirement or termination, or a change in control of our company, or a change in any Named Executive Officers' responsibilities following a change in control.

 

We may in the future create retirement, pension, profit sharing and medical reimbursement plans covering our Executive Officers and Directors.

 

 

 

Item 12.

Security Ownership of Certain Beneficial Owners and Management.

 

The following table sets forth information regarding the beneficial ownership of our common stock as of March 28, 2023, by:

 

 

each person who is known by us to beneficially own more than 5% of our shares of common stock; and

 

 

each executive officer, each director and all of our directors and executive officers as a group.

 

The number of shares beneficially owned and the related percentages are based on 91,422,469 shares of common stock outstanding as of March 28, 2023.

 

For the purposes of the information provided below, Common Shares that may be issued upon the exercise or conversion of stock options, warrants and other rights to acquire shares of our common stock that are exercisable or convertible within 60 days following December 31, 2022, when there were deemed to be 91,422,469 shares of common stock (“Common Shares”) of the Company outstanding and beneficially owned by the stockholders for the purpose of computing the number of Common Shares and percentage ownership of each holder are reported below, but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person.

 

Name and Address of Beneficial Owner (1)

Amount and Nature of
Beneficial Ownership (1)

Percentage of
Beneficial Ownership

Directors and Officers:

   
     

Anton J. Drescher, Chief Financial Officer, Corporate Secretary and Director
c/o #507, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

13,804,540(2)

15.10%

     

Maurice Loverso, Director
c/o #507, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

Nil

Nil

     

Rowland Perkins, President, Chief Executive Officer and Director
c/o #507, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

8,600,000(3)

9.41%

     

Tom Perovic, Director
c/o #057, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

1,895,000(4)

2.07%

     

Ron Wages, Director
c/o #507, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

200,000(5)

.222

     

Fabrice Helliker, Director

c/o #507, 837 West Hastings Street
Vancouver, British Columbia, Canada, V6C 3N6

325,000(6)

.352

     

All directors and executive officers as a group (6 persons)

24,840,540

27.15%

 

Notes:

 

*

Less than one percent.

 

(1)

Under Rule 13d-3 of the Exchange Act, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares: (i) voting power, which includes the power to vote, or to direct the voting of such security; and (ii) investment power, which includes the power to dispose or direct the disposition of the security. Certain shares of common stock may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares of common stock are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares of common stock outstanding is deemed to include the amount of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of common stock of any person as shown in this table does not necessarily reflect the person’s actual ownership or voting power with respect to the number of shares of common stock actually outstanding as of the date of this Proxy Statement. As of March 15, 2021, there were 86,522,569 shares of common stock of the Company issued and outstanding.

 

 

 

(2)

This figure represents 13,704,540 shares of common stock held directly by Anton J. Drescher.

 

(3)

This figure represents 8,600,000 shares of common stock held directly by Rowland Perkins.

 

(4)

This figure represents (i) 1,800,000 shares of common stock held by 4C Inc., an entity controlled by Tom Perovic, and (ii) 95,000 shares of common stock held directly by Mr. Perovic.

 

(5)

This figure represents 200,000 shares of common stock held directly by Ron Wages.

 

(6)

This figure represents 325,000 shares of common stock help by 14D9OCL LLC, an entity in which Fabrice Helliker has a 20% ownership interest.

 

Name

   

Shares Owned

   

Percentage of Class

 
N/A       -0-       0.00%  

Person known to us to beneficial own more than 5%

      -0-       0.00%  

 

 

Item 13.

Certain Relationships and Related Transactions.

 

The Company for the years ended December 31, 2022 and 2021 reimbursed a related party $215,331 and $124,972 , respectively, for selling, general and administrative expenses paid on behalf of the Company. The Company also recorded share-based compensation of $47,062 (2021 - $151,261) for options vested to related parties during the years ended December 31, 2022 and 2021. The Company incurred no expenses from a related party for research and development for the years ended December 31, 2022 and 2021.

 

 

Item 14.

Principle Accountant Fees and Services

 

Audit and Non-Audit Fees

 

The following table presents fees for the professional audit services rendered by Davidson and Company LLP, for the audit of our annual financial statements for the years ended December 31, 2022 and 2021.

 

Year ended December 31

 

2022

   

2021

 

Audit fees

  $ 22,400     $ 23,000  

Audit-related fees

    -       -  

Tax fees

    8,500       8,000  

All other fees

    -       -  

Total

  $ 30,900     $ 31,000  

 

The Audit Committee reviews all audit and non-audit related fees at least annually. The Audit Committee pre-approved all audit and non-audit related services in fiscal 2022 and 2021.

 

 

 

PART IV

 

 

Item 15.

Exhibits and Financial Statements Schedules

 

 

 

3.1

Articles of Amendment (Wyoming) filed January 26, 2012.

 

 

3.2

Articles of Continuance (Wyoming) filed February 16, 1995 (incorporated by reference from Exhibit 3.1 to the registrant's Form 10).

 

 

The following exhibits are filed as part of this Annual Report.

 

 

3.3

Articles of Amendment (Alberta) filed January 3, 1995 (incorporated by reference from Exhibit 3.2 to the registrant's Form 10).

 

 

3.4

Articles of Amendment (Alberta) filed June 28, 1993 (incorporated by reference from Exhibit 3.3 to the registrant's Form 10).

 

 

3.5

Articles of Amendment (Alberta) filed April 6, 1992 (incorporated by reference from Exhibit 3.3 to the registrant's Form 10).

 

 

3.6

Articles of Amendment (Alberta) filed September 1, 1989 (incorporated by reference from Exhibit 3.5 to the registrant's Form 10).

 

 

3.7

Articles of Incorporation (Alberta) filed April 18, 1986 (incorporated by reference from Exhibit 3.6 to the registrant's Form 10).

 

 

3.8

Bylaws (incorporated by reference from Exhibit 3.7 to the registrant's Form 10).

 

 

4.3

Share Option Plan (incorporated by reference from Exhibit 4.3 to the registrant's Form 10).

 

 

10.4

Alliance Partner Agreement dated November 11, 1999, between Exodus Communications, Inc. and registrant (incorporated by reference from Exhibit 10.4 to the registrant's Form 10).

 

 

21.

Subsidiaries of the Registrant:

 

Name

State of Incorporation

Status

USA Video (California) Corporation

Nevada

Dissolved

USA Video Corporation

Texas

Dissolved

Old Lyme Video Productions Inc.

Wyoming

Dissolved

USA Video Technology Corporation

Wyoming

Dissolved

USVO, Inc.

Connecticut

Dissolved

ComplyTrust® Inc. (Formerly OCL Technologies Corp.)

Delaware

Active

 

 

31.1

Certification of the Chief Executive Officer Pursuant To Rule 13a-14 Or 15d-14 of the Securities Exchange Act Of 1934,as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

31.2

Certification of the Chief Financial Officer Pursuant To Rule 13a-14 Or 15d-14 of the Securities Exchange Act of 1934,as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

32.1

Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

32.2

Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

101.INS

Inline XBRL Instance Document

 

101.SCH

Inline XBRL Taxonomy Extension Schema Document

 

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

 

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

104

Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

 

 

Item 16.

Form 10-K Summary

 

None.

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

OCULUS VISIONTECH, INC.

 

 

Dated: March 28, 2023

By: /s/ Rowland Perkins         

Rowland Perkins

Chief Executive Officer

(Principal Executive Officer)

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

         

/s/ Rowland Perkins

 

Chief Executive Officer (Principal

Executive Officer), Director

 

March 28, 2023

Rowland Perkins

       
         

/s/ Anton J. Drescher

 

Chief Financial Officer, (Principal

financial officer and principal

accounting officer), Director

 

March 28, 2023

Anton J. Drescher

       
         

/s/ Maurice Loverso

 

Director

 

March 28, 2023

Maurice Loverso

       
         

/s/ Tom Perovic

 

Director

 

March 28, 2023

Tom Perovic

       
         

/s/ Ron Wages

 

Director

 

March 28, 2023

Ron Wages

       
         

/s/ Fabrice Helliker

 

Director

 

March 28, 2023

Fabrice Helliker

       

 

64
EX-31.1 2 ex_491983.htm EXHIBIT 31.1 ex_491983.htm

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, Rowland Perkins, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Oculus VisionTech Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

       
       

Date: March 28, 2023

By:

/s/ Rowland Perkins

 
   

Rowland Perkins

 
   

Chief Executive Officer

 
   

(Principal Executive Officer)

 

 

 
EX-31.2 3 ex_491984.htm EXHIBIT 31.2 ex_491984.htm

EXHIBIT 31.2

 

CERTIFICATIONS

 

I, Anton J. Drescher, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Oculus VisionTech Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

       
       

Date: March 28, 2023

By:

/s/ Anton J. Drescher

 
   

Anton J. Drescher

 
   

Chief Financial Officer

 
   

(Principal Financial and Accounting Officer)

 

 

 

 
EX-32.1 4 ex_491985.htm EXHIBIT 32.1 ex_491985.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Oculus VisionTech Inc. (the “Company”), for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Rowland Perkins, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

       
       

Date: March 28, 2023

By:

/s/ Rowland Perkins

 
   

Rowland Perkins

 
   

Chief Executive Officer

 
   

(Principal Executive Officer)

 

 

 

 
EX-32.2 5 ex_491986.htm EXHIBIT 32.2 ex_491986.htm

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of Oculus VisionTech Inc. (the “Company”), for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Anton J. Drescher of Oculus VisionTech Inc., Chief Financial Officer for the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

       
       

Date: March 28, 2023

By:

/s/ Anton J. Drescher

 
   

Chief Financial Officer

 
   

(Principal Financial and Accounting Officer)

 

 

 

 
EX-101.SCH 6 ovtz-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Basis of Presentation and Business link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Going Concern link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Common Stock link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Stock Options link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Warrants link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Selling, General and Administrative link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Research and Development link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 11 - Financial Instruments and Risks link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 13 - Related Parties link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 14 - Operating Leases link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 15 - Segmented Information link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 7 - Stock Options (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 8 - Warrants (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 9 - Selling, General and Administrative (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 10 - Research and Development (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 12 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 13 - Related Parties (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 2 - Going Concern (Details Textual) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 3 - Summary of Significant Accounting Policies - Summary of Subsidiary (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 6 - Common Stock (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 7 - Stock Options (Details Textual) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 7 - Stock Options - Changes in Options (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 7 - Stock Options - Details of Options Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 8 - Warrants - Schedule of Warrants (Details) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 10 - Research and Development - Research and Development (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 11 - Financial Instruments and Risks (Details Textual) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 12 - Income Taxes - Net Deferred Tax Assets (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 12 - Income Taxes - Components of Temporary Difference (Details) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 13 - Related Parties (Details Textual) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 13 - Related Parties - Related Party Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 14 - Operating Leases (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 ovtz-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 ovtz-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 ovtz-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Expected dividend rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Exercise price (CAD) (in CAD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) Note To Financial Statement Details Textual Significant Accounting Policies Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Note 3 - Summary of Significant Accounting Policies Note 4 - Prepaid Expenses and Other Current Assets Risk-free interest rate Note 5 - Accounts Payable and Accrued Expenses us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions Note 7 - Stock Options Note 8 - Warrants Note 9 - Selling, General and Administrative Expected annualized volatility Note 10 - Research and Development Note 12 - Income Taxes Accumulated other comprehensive income (loss) Income Tax Disclosure [Text Block] Note 13 - Related Parties Note 3 - Summary of Significant Accounting Policies - Summary of Subsidiary (Details) Foreign Currency Transactions and Translations Policy [Policy Text Block] Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Add back non-cash share-based compensation Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Lessee, Leases [Policy Text Block] us-gaap_LiabilitiesCurrent Liabilities, Current, Total Total current liabilities Note 7 - Stock Options - Changes in Options (Details) Accounts payable and accrued expenses - related parties Note 7 - Stock Options - Details of Options Outstanding (Details) Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details) Note 8 - Warrants - Schedule of Warrants (Details) Expected life of options (in years) (Year) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year) Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) Earnings Per Share, Policy [Policy Text Block] Note 10 - Research and Development - Research and Development (Details) Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) Note 12 - Income Taxes - Net Deferred Tax Assets (Details) Note 12 - Income Taxes - Components of Temporary Difference (Details) Note 13 - Related Parties - Related Party Expenses (Details) Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Notes To Financial Statements Notes To Financial Statements [Abstract] Income Tax, Policy [Policy Text Block] Share-Based Payment Arrangement, Option, Activity [Table Text Block] Currency translation differences Currency translation differences Research and Development Expense, Policy [Policy Text Block] Other comprehensive loss us-gaap_SharesIssued Balance (in shares) Balance (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) Share-Based Payment Arrangement [Policy Text Block] Stockholders' Equity Note Disclosure [Text Block] Granted, aggregate intrinsic value (in dollars per share) Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares) Remaining contractual life (Year) Options outstanding, aggregate intrinsic value Fair value of options granted (CAD) (in dollars per share) Tax Receivable – Canadian GST Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 91,422,569 Exercise price (in CAD per share) Options outstanding, weighted average exercise price (in dollars per share) Options outstanding, weighted average exercise price (in dollars per share) Common stock, shares authorized (in shares) Common Stock, Shares Authorized (in shares) Accounts payable and accrued expenses (Note 5) Accounts Payable and Accrued Liabilities, Current, Total Common stock, shares issued (in shares) Common stock, no par value (in dollars per share) Common Stock, No Par Value (in dollars per share) us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Granted, weighted average exercise price (in dollars per share) us-gaap_DeferredTaxAssetsValuationAllowance Unrecognized deferred tax assets Lessee, Operating Leases [Text Block] us-gaap_AccountsPayableCurrent Accounts payable Ownership [Domain] $Number of options outstanding (in shares) Options outstanding (in shares) Options outstanding (in shares) us-gaap_DeferredTaxAssetsNet Net deferred tax assets Preferred stock - no par value; authorized 250,000,000 shares, none issued Ownership [Axis] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued (in shares) Cash paid during the year for interest us-gaap_PolicyTextBlockAbstract Accounting Policies Cash paid during the year for income taxes Prepaid expenses Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Preferred stock, no par value (in dollars per share) Goodwill and Intangible Assets, Policy [Policy Text Block] us-gaap_DeferredTaxAssetsGross Deferred Tax Assets, Gross, Total Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized (in shares) Accrued fees and expenses Expiry date us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Financial Instruments Disclosure [Text Block] Current Liabilities: Vesting [Axis] Vesting [Domain] Share-Based Payment Arrangement, Tranche One [Member] us-gaap_Assets Total Assets Supplemental disclosures of cash flow information: Plan Name [Axis] Interest income Plan Name [Domain] Consulting The aggregate costs incurred for consultation. Other Assets Disclosure [Text Block] Rent Operating Lease, Expense ovtz_WorkingCapitalDeficit Working Capital (Deficit) Represents the amount of difference between Current Assets and Current Liabilities. Commitment to issue shares Statement [Line Items] Commitment to Issue Shares [Member] Represents commitment to issue shares. Additional paid-in capital Share-Based Payment Arrangement [Text Block] AOCI Attributable to Parent [Member] Stockholders' Equity: Segment Reporting Disclosure [Text Block] Award Type [Domain] Non-capital losses Net loss us-gaap_NetIncomeLoss Net Income (Loss) Attributable to Parent, Total Net loss Award Type [Axis] us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year ASSETS Private Placement [Member] Effect of foreign currency translation on cash us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net increase (decrease) in cash and cash equivalents us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by financing activities Sale of Stock [Axis] Sale of Stock [Domain] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] us-gaap_OperatingIncomeLoss Loss from operations Share-Based Payment Arrangement, Option [Member] us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities Warrant [Member] us-gaap_PrepaidExpenseAndOtherAssetsCurrent Prepaid expenses and other current assets (Note 4) Prepaid Expense and Other Assets, Current us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash provided by investing activity ovtz_EquityOfferingPricePerUnitIssued Equity Offering, Price Per Unit Issued (in CAD per share) The price per unit issued in the equity offering. ovtz_EquityOfferingNumberOfCommonSharesPerUnit Equity Offering, Number of Common Shares Per Unit (in shares) The number of common shares per unit in the equity offering. Antidilutive Securities [Axis] ovtz_EquityOfferingNumberOfWarrantsPerUnit Equity Offering, Number of Warrants Per Unit (in shares) The number of warrant per unit in the equity offering. Antidilutive Securities, Name [Domain] ovtz_ClassOfWarrantOfRightStockPriceTrigger Class of Warrant of Right, Stock Price Trigger (in CAD per share) Price of the entity's common stock which would be required to be attained for the conversion of warrant or right to be accelerated Warrants Issued in Connection with Private Placement [Member] Represents the warrants issued in connection with the private placement. ovtz_EquityOfferingNumberOfUnitsIssued Equity Offering, Number of Units Issued (in shares) The number of units issued during the period in the equity offering. us-gaap_PaymentsForProceedsFromOtherInterestEarningAssets Interest received ovtz_ClassOfWarrantOrRightThresholdConsecutiveTradingDays Class of Warrant or Right, Threshold Consecutive Trading Days Threshold period of specified consecutive trading days within which common stock price to conversion price of warrant or right must exceed threshold percentage for specified number of trading days to trigger conversion feature. us-gaap_PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs Share issuance costs Canada Revenue Agency [Member] Range Six [Member] Represents the range six. us-gaap_ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity, Total Expenses: Cash flows from investing activity: Retained Earnings [Member] Selling general and administrative Related Party Transaction, Expenses from Transactions with Related Party ovtz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value Represents the fair value of options under the share-based compensation. Proceeds from sale of common stock Increase in accounts payable and accrued expenses us-gaap_RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction Additional Paid-in Capital [Member] Common Stock [Member] Related Party Transactions Disclosure [Text Block] Schedule of Related Party Transactions [Table Text Block] us-gaap_IncomeTaxExpenseBenefit Total income taxes Employee Stock Option, Expiration Date of July 21, 2023 [Member] Represents stock option with an expiration date of July 21, 2023. Equity Components [Axis] Equity Component [Domain] Current income tax Exercise price (in CAD per share) us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights (in CAD per share) Employee Stock Option, Expiration Date of January 29, 2024 [Member] Represents stock option with an expiration date of January 29, 2024. Class of Warrant or Right [Axis] Employee Stock Option, Expiration Date of June10, 2024 [Member] Represents stock option with an expiration date of June 10, 2024. Class of Warrant or Right [Domain] us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares) Employee Stock Option, Expiration Date of December 21, 2023 [Member] Represents stock option with an expiration date of December 21, 2023. Number of warrants outstanding (in shares) us-gaap_ClassOfWarrantOrRightOutstanding Warrants outstanding (in shares) Warrants outstanding (in shares) Loss before taxes for the year Reimbursement [Member] Represents the related party transaction for reimbursement. ICFR Auditor Attestation Flag Office and administration Vancouver, CA Operating Lease [Member] Represents the operating lease for the Vancouver, Candada location. ovtz_OperatingLeasesMonthlyRentExpense Operating Leases, Monthly Rent Expense Amount of monthly rent expense incurred under the operating lease. (Decrease) increase in accounts payable and accrued expenses due to related parties Vesting Every Six Months [Member] Represents the options vested every 6 months. Cash and cash equivalents us-gaap_CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value, Total Income Tax Authority, Name [Axis] Income Tax Authority, Name [Domain] Internal Revenue Service (IRS) [Member] Income Tax Authority [Axis] Income Tax Authority [Domain] Share-based compensation (Notes 7, 13) Share-Based Payment Arrangement, Expense Domestic Tax Authority [Member] Foreign Tax Authority [Member] Document Annual Report Cash and Cash Equivalents, Policy [Policy Text Block] Amendment Flag Entity Incorporation, State or Country Code Accounting Policies [Abstract] Significant Accounting Policies [Text Block] us-gaap_ComprehensiveIncomeNetOfTax Total comprehensive loss Document Transition Report City Area Code Use of Estimates, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Selling, General and Administrative Expenses [Member] Entity Interactive Data Current Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding, Ending Balance (in shares) Current Fiscal Year End Date Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block] us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (Increase) decrease in prepaid expenses and other current assets Research and Development Expense [Member] Selling, General and Administrative Disclosure [Text Block] The entire disclosure for selling, general and administrative expenses. Document Fiscal Period Focus Document Fiscal Year Focus Consolidation, Policy [Policy Text Block] Schedule of Selling, General and Administrative Expenses [Table Text Block] Tabular disclosure of selling, general and administrative expenses. Document Period End Date Income Statement Location [Axis] Income Statement Location [Domain] Entity File Number Entity Emerging Growth Company Document Type Filing and regulatory fees Expenditures for filing and regulatory. Entity Small Business Entity Shell Company Auditor Name Document Information [Line Items] Document Information [Table] Entity Public Float Entity Filer Category Auditor Firm ID Entity Current Reporting Status Entity Voluntary Filers Auditor Location Entity Well-known Seasoned Issuer us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue Share-based compensation Entity Tax Identification Number Entity Central Index Key Operatinting loss Entity Registrant Name Entity [Domain] Legal Entity [Axis] Summary of Operating Loss Carryforwards [Table Text Block] Statement [Table] ComplyTrust Inc. Entity Address, Address Line One Statement of Financial Position [Abstract] Weighted average number of common shares outstanding – basic and diluted (in shares) Accounts Payable and Accrued Liabilities Disclosure [Text Block] Entity Address, City or Town Entity Address, Postal Zip Code Net loss per share – basic and diluted (in dollars per share) Entity Address, State or Province Statement of Cash Flows [Abstract] Entity Common Stock, Shares Outstanding Lease Contractual Term [Domain] Statement of Stockholders' Equity [Abstract] Lease Contractual Term [Axis] Income Statement [Abstract] Professional fees Marketing Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Local Phone Number Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] us-gaap_TableTextBlock Notes Tables ComplyTrust Inc. [Member] Represents ComplyTrust Inc. ovtz_CommonStockSharesHeldInEscrow Common Stock, Shares Held in Escrow (in shares) Number of common stock held in escrow. Selling, general and administrative (Note 9, 13) Selling, General and Administrative Expense, Total Employee Stock Option, Expiration Date of October 14, 2024 [Member] Represents Employee Stock Option, Expiration Date of October 14, 2024. . Granted, options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) Cash flows from financing activities: us-gaap_WarrantsAndRightsOutstandingTerm Warrants and Rights Outstanding, Term (Month) Range Five [Member] Represents range five. Effect of change in tax rates Class of Warrant or Right [Text Block] The entire disclosure for warrant or right. Adjustment to prior years provision Schedule of Warrants or Right [Table Text Block] Tabular disclosure of an entity's warrants or rights. Range One [Member] Represents range one. Sale of common stock (in shares) Range Two [Member] Represents range two. Range Three [Member] Represents range three. Range Four [Member] Represents range four. us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Stockholders' Equity Number of warrants exercisable (in shares) ovtz_ClassOfWarrantOrRightExercisable Number of warrants or rights exercisable. Remaining contractual life (Year) ovtz_ClassOfWarrantOrRightRemainingContractualTerm Remaining contractual term of class of warrant or right. Warrants Expiring on April 19, 2023 [Member] Represents warrants expiring on April 19, 2023. Warrants Expiring on June 4, 2025 [Member] Represents warrants expiring on June 4, 2025. Sale of common stock Related Party Transaction [Axis] Granted, warrants (in shares) Number of warrants or right granted. Related Party Transaction [Domain] ovtz_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice Warrants outstanding, weighted average exercise price (in dollars per share) Warrants outstanding, weighted average exercise price (in dollars per share) Weighted average price of class of warrant or right outstanding. Granted, weighted average exercise price (in dollars per share) Weighted average per share of class of warrant or right granted. Payroll Research and development expense during the period related to payroll. Accumulated deficit Retained Earnings (Accumulated Deficit), Total Share-based Compensation [Member] Represents share-based compensation. Research and development (Note 10) Research and Development Expense, Total Schedule of Research and Development Expenses [Table Text Block] Tabular disclosure of research and development expenses. Project management Research and development expense during the period related to project management. Research, Development, and Computer Software Disclosure [Text Block] Software development Business development Research and development expense during the period related to business development. Expected income tax (recovery) Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to expected income tax (recovery). Changes in operating assets and liabilities: us-gaap_StockholdersEquity Stockholders' equity Balance Balance ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved The percent of issued and outstanding common shares reserved in a share-based compensation. Reduction of commitment to issue shares Represents a reduction of the commitment to issue shares. us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Substantial Doubt about Going Concern [Text Block] ovtz_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue Warrants outstanding, Aggregate Intrinsic Value Warrants outstanding, Aggregate Intrinsic Value Intrinsic value of warrants. Granted, Aggregate Intrinsic Value Intrinsic value of warrants. Permanent differences Change in unrecognized deductible temporary Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to change in unrecognized deductible temporary. Class of Stock [Axis] Gain on reduction of commitment to issue shares (Note 6) Gains (Losses) on Commitment to Issue Shares Gain on reduction of commitment to issue shares Gain (loss) related to the commitment to issue shares. Rolling Stock Option Plan [Member] Related to the Rolling Stock Option Plan. ovtz_AdjustmentsToAdditionalPaidInCapitalStockIssuanceCosts Share issuance costs – cash Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. Employee Stock Option, Expiration Date of January 31, 2025 [Member] Represents stock option with an expiration date of January 31, 2025. Deferred tax recovery Exercise Price Range [Axis] Exercise Price Range [Domain] EX-101.PRE 10 ovtz-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 11 o01.jpg begin 644 o01.jpg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�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end
GRAPHIC 12 o02.jpg begin 644 o02.jpg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o03.jpg begin 644 o03.jpg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ovtz20221231_10kimg001.jpg begin 644 ovtz20221231_10kimg001.jpg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htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2022
Mar. 28, 2023
Jun. 30, 2022
Document Information [Line Items]      
Entity Central Index Key 0001107280    
Entity Registrant Name OCULUS VISIONTECH INC.    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2022    
Document Transition Report false    
Entity File Number 000-29651    
Entity Incorporation, State or Country Code WY    
Entity Tax Identification Number 06-1576391    
Entity Address, Address Line One #507, 837 West Hastings Street    
Entity Address, City or Town Vancouver    
Entity Address, State or Province BC    
Entity Address, Postal Zip Code V6C 3N6    
City Area Code 604    
Local Phone Number 685-1017    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 37,800,000
Entity Common Stock, Shares Outstanding   91,422,469  
Auditor Name Davidson & Company LLP    
Auditor Location Vancouver, BC. Canada    
Auditor Firm ID 731    
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
ASSETS    
Cash and cash equivalents $ 687,602 $ 2,208,451
Prepaid expenses and other current assets (Note 4) 30,238 37,832
Total Assets 717,840 2,246,283
Current Liabilities:    
Accounts payable and accrued expenses (Note 5) 276,585 96,198
Accounts payable and accrued expenses - related parties 25,838 26,425
Total current liabilities 302,423 122,623
Stockholders' Equity:    
Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 91,422,569 46,850,710 46,850,710
Additional paid-in capital 1,394,997 998,477
Commitment to issue shares 0 414,128
Accumulated other comprehensive income (loss) (34,856) 6,190
Accumulated deficit (47,795,434) (46,145,845)
Stockholders' equity 415,417 2,123,660
Total Liabilities and Stockholders' Equity $ 717,840 $ 2,246,283
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets (Parentheticals) - $ / shares
$ / shares in Thousands
Dec. 31, 2022
Dec. 31, 2021
Preferred stock, no par value (in dollars per share) $ 0 $ 0
Preferred stock, shares authorized (in shares) 250,000,000 250,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, no par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 91,422,569 91,422,569
Common stock, shares outstanding (in shares) 91,422,569 91,422,569
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Expenses:    
Consulting $ 135,000 $ 24,021
Research and development (Note 10) 1,137,883 818,269
Selling, general and administrative (Note 9, 13) 399,467 430,691
Share-based compensation (Notes 7, 13) 396,520 713,684
Loss from operations (2,068,870) (1,986,665)
Interest income 5,153 0
Gain on reduction of commitment to issue shares (Note 6) 414,128 0
Net loss (1,649,589) (1,986,665)
Other comprehensive loss    
Currency translation differences 41,046 (6,190)
Total comprehensive loss $ (1,608,543) $ (1,992,855)
Net loss per share – basic and diluted (in dollars per share) $ (0.02) $ (0.02)
Weighted average number of common shares outstanding – basic and diluted (in shares) 91,422,569 89,968,723
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Commitment to Issue Shares [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2020 86,522,569          
Balance at Dec. 31, 2020 $ 43,788,464 $ 284,793 $ 414,128 $ 0 $ (44,159,180) $ 328,205
Sale of common stock (in shares) 4,900,000          
Sale of common stock $ 3,098,616 0 0 0 0 3,098,616
Share issuance costs – cash (36,370) 0 0 0 0 (36,370)
Share-based compensation 0 713,684 0 0 0 713,684
Currency translation differences 0 0 0 6,190 0 6,190
Net loss $ 0 0 0 0 (1,986,665) (1,986,665)
Balance (in shares) at Dec. 31, 2021 91,422,569          
Balance at Dec. 31, 2021 $ 46,850,710 998,477 414,128 6,190 (46,145,845) 2,123,660
Share-based compensation 0 396,520 0 0 0 396,520
Currency translation differences 0 0 0 (41,046) 0 (41,046)
Net loss 0 0 0 0 (1,649,589) (1,649,589)
Reduction of commitment to issue shares $ 0 0 (414,128) 0 0 (414,128)
Balance (in shares) at Dec. 31, 2022 91,422,569          
Balance at Dec. 31, 2022 $ 46,850,710 $ 1,394,997 $ 0 $ (34,856) $ (47,795,434) $ 415,417
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Net loss $ (1,649,589) $ (1,986,665)
Add back non-cash share-based compensation 396,520 713,684
Gain on reduction of commitment to issue shares (414,128) 0
Changes in operating assets and liabilities:    
(Increase) decrease in prepaid expenses and other current assets 2,441 (32,230)
Increase in accounts payable and accrued expenses 180,387 63,869
(Decrease) increase in accounts payable and accrued expenses due to related parties (108,833)
Net cash used in operating activities (1,484,369) (1,350,175)
Cash flows from financing activities:    
Proceeds from sale of common stock 0 3,098,616
Share issuance costs 0 (36,370)
Net cash provided by financing activities 0 3,062,246
Cash flows from investing activity:    
Interest received 5,153 0
Net cash provided by investing activity 5,153 0
Effect of foreign currency translation on cash (41,633) 6,190
Net increase (decrease) in cash and cash equivalents (1,520,849) 1,718,261
Cash and cash equivalents at beginning of year 2,208,451 490,190
Cash and cash equivalents at end of year 687,602 2,208,451
Supplemental disclosures of cash flow information:    
Cash paid during the year for interest 0 0
Cash paid during the year for income taxes $ 0 $ 0
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Note 1 - Basis of Presentation and Business
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
 

1.

BASIS OF PRESENTATION AND BUSINESS

 

The accompanying consolidated financial statements include the accounts of Oculus Visiontech Inc. (“Oculus”) and its wholly-owned subsidiary, ComplyTrust Inc. (“CTI”), (together “the Company”). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included.

 

The Company is a designer of digital watermarking services and solutions. At December 31, 2022 and for the two-year period then ended, substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.

XML 22 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Note 2 - Going Concern
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]
 

2.

GOING CONCERN

 

These consolidated financial statements are prepared on a going concern basis which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses from inception and does not currently have the financial resources to sustain operations in the long-term. As shown in the financial statements, the Company has incurred a loss of $1,649,589 for the year ended December 31, 2022 and, in addition the Company incurred losses of $1,986,665 for the year ended December 31, 2021. As of December 31, 2022, the Company had an accumulated deficit of $47,795,434 and working capital of $415,417. As a result of the Company’s current financial position and challenging access to capital, there can be no assurance that the Company will be able raise additional funds in the future, in which case the Company will be unable to meet its financial obligations. These material uncertainties raise substantial doubt upon the Company’s ability to continue as a going concern. The financial statements do not include adjustments to amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue operations. The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  

 

There are many external factors that can adversely affect general workforces, economies and financial markets globally. Examples include, but are not limited to, the COVID-19 global pandemic and political conflict in other regions. It is not possible for the Company to predict the duration or magnitude of adverse results of such external factors and their effect on the Company’s business or ability to raise funds.

XML 23 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Note 3 - Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
 

3.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of consolidation

 

These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On March 28, 2023, the Board approved the consolidated financial statements dated December 31, 2022.

 

These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.

 

Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than 50% of the voting rights or currently exercisable potential voting rights of a Company’s capital stock. All significant intercompany transactions and balances have been eliminated.

 

The controlled entities are listed in the following table:

 

Name of Subsidiary

Country of

Incorporation

 

Ownership

Interest at

December 31,

2022

  

Ownership

Interest at

December 31,

2021

 

Principal Activity

           

ComplyTrust Inc.

US/Delaware

  100%  100%

Software Development

 

Significant judgments, estimates and assumptions

 

The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.

 

The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are not limited to the following:

 

Significant judgments

 

the determination of functional currencies; and

 

share-based compensation and warrants issued in connection with private placements, using the fair value method. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based compensation. This estimate also requires determining the most appropriate inputs to the valuation model. The main factor affecting the estimates of the fair value of stock options is the stock price, expected volatility used and the expected duration of the instrument. The Company currently estimates the expected volatility of its common shares based on historical stock price information. The Company recognizes the commitment to issue shares, based on the trading price at the date of the commitment on a percentage basis on the likelihood of the completion of the event.

 

Cash and cash equivalents

 

Cash equivalents include highly liquid investments with original maturities of twelve months or less, and which are subject to an insignificant risk of change in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.

 

Impairment of long-lived assets and long-lived assets to be disposed of

 

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount and the fair value less costs to sell.

 

Research and development

 

Expenditure on research activities is recognized on the consolidated statements of operations and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at December 31, 2022, it was not yet able to demonstrate with sufficient certainty that it is probable that any economic benefits will flow to the Company. Accordingly, all research and development costs incurred to date have been expensed. 

 

Intangible asset

 

Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses.

 

The useful lives of intangible assets are assessed as either finite or indefinite.

 

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually and whenever there is an indication that the intangible asset may be impaired. The amortization period and method for an intangible asset with a finite useful life are reviewed at least at each financial year-end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in profit or loss.

 

Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets may be impaired.

 

Income taxes

 

The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion or the entire deferred tax asset will not be recognized.

 

Net loss per share

 

Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that may require the issuance of common shares in the future were converted, unless the impact is anti-dilutive. For the year ended December 31, 2022 and 2021, this calculation proved to be anti-dilutive, and therefore the Company’s 5,415,000 (2021: 5,315,000) stock options and 17,400,000 (2021: 17,400,000) warrants were excluded from the calculation.

 

Right of use asset

 

The Company recognizes a right of use asset and a lease liability at the lease commencement date. The right of use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove or to restore the underlying asset or the site on which it is located, less any lease incentives received.

 

The right of use assets are subsequently amortized from the commencement date to the earlier of the end of the useful life of the right of use asset or the end of the lease term using the straight line method.

 

Lease liability

 

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate.

 

Lease payments included in the measurement of the lease liability comprise the following payments during the lease term: fixed payments (including in-substance fixed payments), and the exercise price under a purchase option that the Company is reasonably certain to exercise.

 

The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising mainly if the Company changes its assessment of whether it will exercise a purchase, renewal or termination option, or if there is a revised in substance fixed lease payment.

 

When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right of use asset, or is recorded in profit or loss if the carrying amount of the right of use asset has been reduced to zero.

 

Stock-based compensation

 

The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section 718 “Compensation - Stock Compensation”, which establishes accounting for equity-based compensation awards to be accounted for using the fair value method. Equity-settled share-based payment arrangements are initially measured at fair value at the date of grant and recorded within shareholders’ equity. Arrangements considered to be cash-settled are initially recorded at fair value and classified as accrued liabilities, and subsequently re-measured at fair value at each reporting date. The Company’s stock option plan is an equity-settled arrangement.

 

The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.

 

Functional currency

 

The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus is the Canadian (“CAD” or “C”) dollar and the functional currency of CTI is the U.S. dollar.

 

In accordance with ASC 830, Foreign Currency Matters, for companies that have a functional currency other than the US dollar, the Company translates the assets and liabilities into U.S. dollars using the rate of exchange prevailing at the balance sheet date and the statements of operations and comprehensive loss and cash flows are translated at an average rate during the reporting period. Adjustments resulting from the translation from CAD into U.S. dollars are recorded in shareholders' equity as part of accumulated other comprehensive (income) loss.

 

Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are not re-translated at period end are measured at historical cost (translated using the exchange rates at the transaction date), except for non-monetary items measured at fair value, which are translated using the exchange rates as at the date when fair value was determined. Gains and losses are recorded in the statement of operations and comprehensive loss.

 

Recently adopted accounting pronouncements

 

The Company has reviewed new and revised accounting pronouncements that have been issued but are not yet effective. The Company does not expect any material impact from future accounting pronouncements.

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Note 4 - Prepaid Expenses and Other Current Assets
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Other Assets Disclosure [Text Block]
 

4.

PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets consist of the following:

 

   

December 31,

   

December 31,

 
   

2022

   

2021

 
                 

Prepaid expenses

  $ 28,028     $ 28,141  

Tax Receivable – Canadian GST

    2,210       9,691  
    $ 30,238     $ 37,832  

 

XML 25 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Note 5 - Accounts Payable and Accrued Expenses
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
 

5.

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consist of the following:

 

   

December 31,

   

December 31,

 
   

2022

   

2021

 
                 

Accounts payable

  $ 224,716     $ 61,836  

Accrued fees and expenses

    51,869       34,362  
    $ 276,585     $ 96,198  

 

XML 26 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Note 6 - Common Stock
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
 

6.

COMMON STOCK 

 

The Company has no par value common stock with 500,000,000 authorized shares and 91,422,569 outstanding on December 31, 2022 and 2021.

 

The Company has authorized the issuance of 250,000,000 non-voting preferred shares without par value, none issued.

 

As of December 31, 2022, there were 1,875,000 common shares held in escrow.

 

On June 14, 2021, the Company closed a non-brokered private placement financing of 4,900,000 units of the Company at a price of CDN$0.80 per unit for gross proceeds of $3,920,000CDN ($3,098,616). Each unit consisted of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share of the Company at an exercise price of $1.00CDN for a period of 24 months from the date of closing. The expiry date of the warrants may be accelerated at the Company’s discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than $2.50CDN for a minimum of ten consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant. In connection to the private placement, the Company paid $45,500CDN ($36,370) as share issuance costs.

 

During the year ended December 31, 2022, the Company wrote-off the commitment to issue shares of $414,128 due to the uncertainty in the Company meeting the required performance conditions.

XML 27 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Note 7 - Stock Options
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]
 

7.

STOCK OPTIONS  

 

During the year ended December 31, 2022 and 2021, the Company adopted a Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares may be reserved for granting of stock options. All of the options granted vest 20% every six months.

 

However, all options will be considered vested if one of the following criteria are met by the Company:

 

 

i.

Meeting sales forecasts:

 

 

-

The greater of either the 20% vesting every six months or based on a pro rata percentage of revenue earned by the Company’s subsidiary.

 

 

ii.

the listing of the Company on any national securities exchange.

   
 

iii.

a Change of Control Event.

 

 

During the year ended December 31, 2022, the Company:

 

i) granted 100,000 stock options to a consultant, exercisable into 100,000 shares at an exercise price of $0.80CAD and an expiry date of January 31, 2025. The options have a fair value of $54,600CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 119.10%; (ii) Term of 3 years; (iii) Discount rate of 1.24%; (iv) Dividend rate of Nil; and (v) market stock price of $0.78CAD. The options vest 20% every 6 months starting August 1, 2022. During the year ended December 31, 2022, the Company recorded $36,511CAD ($28,162) of share-based compensation relating to the vesting period.

 

During the year ended December 31, 2021, the Company:

 

i) granted 500,000 stock options to consultants, exercisable into 500,000 shares at an exercise price of $1.20CAD and an expiry date of January 29, 2024. The options have a fair value of $424,300CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125.00%; (ii) Term of 3 years; (iii) Discount rate of 0.14%; (iv) Dividend rate of Nil; and (v) market stock price of $1.18CAD. The options vest 20% every 6 months starting July 29, 2021. During the year ended December 31, 2021, the Company recorded $285,557CAD ($230,215) of share-based compensation relating to the vesting period. During the year ended December 31, 2022, the Company recorded $115,811CAD ($89,648) of share-based compensation relating to the vesting period.

 

ii) granted 375,000 stock options to consultants, exercisable into 375,000 shares at an exercise price of $0.80CAD and an expiry date of June 10, 2024. The options have a fair value of $211,700CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 120.80%; (ii) Term of 3 years; (iii) Discount rate of 0.25%; (iv) Dividend rate of Nil; and (v) market stock price of $0.80CAD. The options vest 20% every 6 months starting December 10, 2021. During the period ended September 30, 2021, the Company recorded $101,058CAD ($83,342) of share -based compensation relating to the vesting period. During the year ended December 31, 2022, the Company recorded $83,351CAD ($64,460) of share-based compensation relating to the vesting period.

 

iii) granted 590,000 stock options to consultants, exercisable into 590,000 shares at an exercise price of $0.60CAD and an expiry date of October 14, 2024. The options have a fair value of $219,100CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 119.89%; (ii) Term of 3 years; (iii) Discount rate of 0.63%; (iv) Dividend rate of Nil; and (v) market stock price of $0.54CAD. The options vest 20% every 6 months starting April 14, 2021. During the year ended December 31, 2021, the Company recorded $42,819CAD ($33,964) of share -based compensation relating to the vesting period. During the year ended December 31, 2022, the Company recorded $128,164AD ($99,315) of share-based compensation relating to the vesting period. 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

During the year ended December 31, 2020, the Company:

 

i) granted 3,600,000 stock options to consultants, directors and officers exercisable into 3,600,000 shares at an exercise price of $0.35CAD and an expiry date of July 21, 2023. The options have a fair value of $909,900CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.27%; (iv) Dividend rate of Nil; and (v) market stock price of $0.35CAD. The options vest 20% every 6 months starting January 21, 2021. During the year ended December 31, 2021, the Company recorded $406,133CAD ($324,132) of stock-based compensation relating to the vesting period. During the year ended December 31, 2022, the Company recorded $129,990CAD ($100,848) of share-based compensation relating to the vesting period.

 

ii) granted 250,000 stock options to consultants, directors and officers exercisable into 250,000 shares at an exercise price of $0.45CAD and an expiry date of December 21, 2023. The options have a fair value of $75,800CAD, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.02%; (iv) Dividend rate of Nil; and (v) market stock price of $0.425CAD. The options vest 20% every 6 months starting June 21, 2021. During the year ended December 31, 2021, the Company recorded $52,835CAD ($42,031) of stock-based compensation relating to the vesting period. During the year ended December 31, 2022, the Company recorded $18,207CAD ($14,087) of share-based compensation relating to the vesting period.

 

The changes in options are as follows:

 

  

Number of

options

  

Weighted

average exercise

price

(CAD)

  

Aggregate

Intrinsic Value

 
             

Options outstanding, December 31, 2020

  3,850,000  $0.36  $3,363,000 

Granted

  1,465,000   0.86   - 

Options outstanding, December 31, 2021

  5,315,000   0.49   3,910,950 

Granted

  100,000   0.80   - 

Options outstanding, December 31, 2022

  5,415,000  $0.50  $- 

 

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for the options that were in-the-money at December 31, 2022.

 

Details of options outstanding as at December 31, 2022 are as follows: 

 

Exercise price (CAD)

  

Number of

options

outstanding

 

Expiry date

 

Number of options

exercisable

  

Remaining

contractual life (years)

 
                
$0.350   3,600,000 

July 21, 2023

  2,880,000   0.55 
$0.450   250,000 

December 21, 2023

  200,000   0.97 
$1.200   500,000 

January 29, 2024

  300,000   1.08 
$0.800   375,000 

June 10, 2024

  225,000   1.44 
$0.600   590,000 

October 14, 2024

  236,000   1.79 
$0.800   100,000 

January 31, 2025

  20,000   2.09 
                
     5,415,000    3,861,000     

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO  CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2022 and 2021 

(Stated in US Dollars)

 

The following weighted average assumptions were used for the Black-Scholes valuation of stock options granted:

 

  

December 31, 2022

  

December 31, 2021

 
         

Risk-free interest rate

  1.24%  0.37%

Exercise price (CAD)

 $0.80  $0.86 

Expected life of options (in years)

  3.00   3.00 

Expected annualized volatility

  119.10%  121.87%

Fair value of options granted (CAD)

 $0.55  $0.58 

Expected dividend rate

  -   - 

 

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Note 8 - Warrants
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Class of Warrant or Right [Text Block]
 

8.

WARRANTS  

 

The changes in warrants are as follows:

 

   

Number of

warrants

   

Weighted

average exercise

price

(CAD)

   

Aggregate

Intrinsic Value

 
                         

Warrants outstanding, December 31, 2020

    12,500,000     $ 0.001     $ -  

Granted

    4,900,000       1.00       -  

Warrants outstanding, December 31, 2022 and 2021

    17,400,000     $ 0.28     $ -  

 

Details of warrants outstanding as at December 31, 2022 are as follows:

 

Exercise price

     

Number of

warrants

outstanding

 

Expiry date

 

Number of warrants

exercisable

   

Remaining

contractual life (years)

 
                                 
$ 1.00  

(CAD)

    4,900,000  

April 19, 2023

    4,900,000       0.30  
$ 0.001  

(1) (USA)

    12,500,000  

June 4, 2025

    -       2.43  
                                 
            17,400,000         4,900,000          

 

 

(1)

No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) targeted revenue sales projections met, or 2) listing on a major US exchange, or 3) change of control.

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Note 9 - Selling, General and Administrative
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Selling, General and Administrative Disclosure [Text Block]
 

9.

SELLING, GENERAL AND ADMINISTRATIVE  

 

The breakdown of selling, general and administrative for the year ended December 31, 2022 and 2021 is as follows:

 

   

 

2022

   

2021

 
                 

Filing and regulatory fees

  $ 40,158     $ 38,396  

Marketing

    76,459       41,374  

Professional fees

    104,801       133,134  

Rent

    38,922       39,134  

Office and administration

    139,127       178,653  
                 
    $ 399,467     $ 430,691  

 

XML 30 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Note 10 - Research and Development
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Research, Development, and Computer Software Disclosure [Text Block]
 

10.

RESEARCH AND DEVELOPMENT  

 

The breakdown of research and development for the year ended December 31, 2022 and 2021 is as follows:

 

   

 

2022

   

2021

 
                 

Project management

  $ 11,990     $ 144,000  

Software development

    820,996       585,953  

Business development

    133,588       60,533  

Payroll

    171,309       27,783  
                 
    $ 1,137,883     $ 818,269  

 

XML 31 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Note 11 - Financial Instruments and Risks
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Financial Instruments Disclosure [Text Block]
 

11.

FINANCIAL INSTRUMENTS AND RISKS  

 

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are described below.

 

Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2 – inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and

Level 3 - inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

Fair value of financial instruments

 

The Company has various financial instruments including cash, receivables, accounts payable and accrued liabilities and a loan payable. The carrying values of receivables, accounts payable and accrued liabilities, and loan payable approximate their fair values due to the short-term nature of these financial instruments.

 

Cash is carried at a level 1 fair value measurement.

 

The Company’s risk exposures and the impact on the Company’s financial instruments are summarized below:

 

Credit risk

The Company is exposed to credit risk only with respect to uncertainties as to timing and amount of collectability of receivables. The Company believes its credit risk is low because a portion of receivables are comprised of goods and services tax (GST) and other government refunds, which is recoverable from the governing body in Canada. Management does not believe the receivables are impaired. The Company doesn’t believe there is significant credit risk associated with cash as these amounts are held with major Canadian banks.

 

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company’s approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities when due. As at December 31, 2021, the Company had a cash balance of $687,602 (2021 – $2,208,451) to settle current liabilities of $302,423 (2021 – $122,623). All of the Company’s financial liabilities have contractual maturities of 30 days or due on demand and are subject to normal trade terms.

 

Interest rate risk

Interest rate risk is the risk that the future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The risk that the Company will realize such a loss is limited as it does not have any significant interest-bearing financial instruments.

 

Foreign currency risk

As at December 31, 2022 and 2021, the Company is exposed to foreign currency risk as certain monetary financial instruments are denominated in Canadian currency. The Company’s sensitivity analysis suggests that reasonably expected changes in the rates of exchange in Norway, and the United States would change foreign exchange gain or loss by an insignificant amount.

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Note 12 - Income Taxes
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
 

12.

INCOME TAXES  

 

A reconciliation of income taxes at statutory rates with the reported taxes is as follows:

 

  

 

December 31,

2022

  

December 31,

2021

 
         

Loss before taxes for the year

 $(1,649,589) $(1,986,665)
         

Expected income tax (recovery)

 $(461,000) $(417,000)

Effect of change in tax rates

  37,000   (64,000)

Permanent differences

  (5,000)  150,000 

Adjustment to prior years provision

  (5,000)  2,147,000 

Change in unrecognized deductible temporary

  434,000   (1,816,000)
         

Total income taxes

 $-  $- 
         

Current income tax

 $-  $- 

Deferred tax recovery

 $-  $- 

 

The significant components of the Company’s deferred tax assets that have not been included on the consolidated statement of financial position are as follows:

 

  

 

December 31,

2022

  

December 31,

2021

 
         

Non-capital losses

 $5,445,227  $5,010,903 
         
  $5,445,227  $5,010,903 

Unrecognized deferred tax assets

  (5,445,227)  (5,010,903)

Net deferred tax assets

 $-  $- 

 

The significant components of the Company’s temporary differences, unused tax credits and unused tax losses that have not been included on the consolidated statement of financial position are as follows: 

 

  

2022

  

Expiry Date

Range

  

2021

  

Expiry Date

Range

 

Temporary Differences

                

Non-capital losses available for future periods

 $25,155,000   2026to2041  $23,473,000   2026to2041 

Canada

 $18,334,000   2023to2037  $18,334,000   2023to2037 

USA

 $6,821,000  

No expiry date

  $5,139,000  

No expiry date

 

 

XML 33 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Note 13 - Related Parties
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
 

13.

RELATED PARTIES  

 

Related parties include the Board of Directors, officers, close family members and enterprises that are controlled by these individuals as well as certain persons performing similar functions.

 

The Company defines its key management as the Board of Directors, Chief Executive Officer, President, and Chief Financial Officer. Remuneration of directors and key management personnel of the Company was as follows:

 

  

 

Year ended

December 31,

 
  

2022

  

2021

 
         

Selling general and administrative

 $215,331  $124,972 

Share-based compensation to directors and officers

  47,062   151,261 
  $262,393  $276,233 

 

The Company for the years ended December 31, 2022 and 2021 reimbursed a related party $215,331 and $124,972 , respectively, for selling, general and administrative expenses paid on behalf of the Company. The Company also recorded share-based compensation of $47,062 (2021 - $151,261) for options vested to related parties during the years ended December 31, 2022 and 2021. The Company incurred no expenses from a related party for research and development for the years ended December 31, 2022 and 2021.

XML 34 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Note 14 - Operating Leases
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Lessee, Operating Leases [Text Block]

 

14.

OPERATING LEASES  

 

The Company has one operating leases with unrelated third parties for office space at the Vancouver, Canada.

 

The lease at the Vancouver, Canada location is on a month-to-month basis with monthly rental payments of $3,950 (CND). For the years ended December 31, 2022 and 2021 rent expense was $36,894 and $36,340, respectively.

XML 35 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Note 15 - Segmented Information
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
 

15.

SEGMENTED INFORMATION  

 

The Company currently operates in a single reportable operating segment. All of the Company’s assets and expenditures are located in the United States. Since the Company does not have any revenue producing activities, there is no segment information by revenues.

XML 36 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Consolidation, Policy [Policy Text Block]

Basis of consolidation

 

These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On March 28, 2023, the Board approved the consolidated financial statements dated December 31, 2022.

 

These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.

 

Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than 50% of the voting rights or currently exercisable potential voting rights of a Company’s capital stock. All significant intercompany transactions and balances have been eliminated.

 

The controlled entities are listed in the following table:

 

Name of Subsidiary

Country of

Incorporation

 

Ownership

Interest at

December 31,

2022

  

Ownership

Interest at

December 31,

2021

 

Principal Activity

           

ComplyTrust Inc.

US/Delaware

  100%  100%

Software Development

 

Use of Estimates, Policy [Policy Text Block]

Significant judgments, estimates and assumptions

 

The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.

 

The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are not limited to the following:

 

Significant judgments

 

the determination of functional currencies; and

 

share-based compensation and warrants issued in connection with private placements, using the fair value method. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based compensation. This estimate also requires determining the most appropriate inputs to the valuation model. The main factor affecting the estimates of the fair value of stock options is the stock price, expected volatility used and the expected duration of the instrument. The Company currently estimates the expected volatility of its common shares based on historical stock price information. The Company recognizes the commitment to issue shares, based on the trading price at the date of the commitment on a percentage basis on the likelihood of the completion of the event.

 

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and cash equivalents

 

Cash equivalents include highly liquid investments with original maturities of twelve months or less, and which are subject to an insignificant risk of change in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.

 

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

Impairment of long-lived assets and long-lived assets to be disposed of

 

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount and the fair value less costs to sell.

 

Research and Development Expense, Policy [Policy Text Block]

Research and development

 

Expenditure on research activities is recognized on the consolidated statements of operations and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at December 31, 2022, it was not yet able to demonstrate with sufficient certainty that it is probable that any economic benefits will flow to the Company. Accordingly, all research and development costs incurred to date have been expensed. 

 

Goodwill and Intangible Assets, Policy [Policy Text Block]

Intangible asset

 

Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses.

 

The useful lives of intangible assets are assessed as either finite or indefinite.

 

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually and whenever there is an indication that the intangible asset may be impaired. The amortization period and method for an intangible asset with a finite useful life are reviewed at least at each financial year-end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in profit or loss.

 

Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets may be impaired.

 

Income Tax, Policy [Policy Text Block]

Income taxes

 

The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion or the entire deferred tax asset will not be recognized.

 

Earnings Per Share, Policy [Policy Text Block]

Net loss per share

 

Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that may require the issuance of common shares in the future were converted, unless the impact is anti-dilutive. For the year ended December 31, 2022 and 2021, this calculation proved to be anti-dilutive, and therefore the Company’s 5,415,000 (2021: 5,315,000) stock options and 17,400,000 (2021: 17,400,000) warrants were excluded from the calculation.

 

Lessee, Leases [Policy Text Block]

Right of use asset

 

The Company recognizes a right of use asset and a lease liability at the lease commencement date. The right of use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove or to restore the underlying asset or the site on which it is located, less any lease incentives received.

 

The right of use assets are subsequently amortized from the commencement date to the earlier of the end of the useful life of the right of use asset or the end of the lease term using the straight line method.

 

Lease liability

 

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate.

 

Lease payments included in the measurement of the lease liability comprise the following payments during the lease term: fixed payments (including in-substance fixed payments), and the exercise price under a purchase option that the Company is reasonably certain to exercise.

 

The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising mainly if the Company changes its assessment of whether it will exercise a purchase, renewal or termination option, or if there is a revised in substance fixed lease payment.

 

When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right of use asset, or is recorded in profit or loss if the carrying amount of the right of use asset has been reduced to zero.

 

Share-Based Payment Arrangement [Policy Text Block]

Stock-based compensation

 

The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section 718 “Compensation - Stock Compensation”, which establishes accounting for equity-based compensation awards to be accounted for using the fair value method. Equity-settled share-based payment arrangements are initially measured at fair value at the date of grant and recorded within shareholders’ equity. Arrangements considered to be cash-settled are initially recorded at fair value and classified as accrued liabilities, and subsequently re-measured at fair value at each reporting date. The Company’s stock option plan is an equity-settled arrangement.

 

The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.

 

Foreign Currency Transactions and Translations Policy [Policy Text Block]

Functional currency

 

The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus is the Canadian (“CAD” or “C”) dollar and the functional currency of CTI is the U.S. dollar.

 

In accordance with ASC 830, Foreign Currency Matters, for companies that have a functional currency other than the US dollar, the Company translates the assets and liabilities into U.S. dollars using the rate of exchange prevailing at the balance sheet date and the statements of operations and comprehensive loss and cash flows are translated at an average rate during the reporting period. Adjustments resulting from the translation from CAD into U.S. dollars are recorded in shareholders' equity as part of accumulated other comprehensive (income) loss.

 

Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are not re-translated at period end are measured at historical cost (translated using the exchange rates at the transaction date), except for non-monetary items measured at fair value, which are translated using the exchange rates as at the date when fair value was determined. Gains and losses are recorded in the statement of operations and comprehensive loss.

 

New Accounting Pronouncements, Policy [Policy Text Block]

Recently adopted accounting pronouncements

 

The Company has reviewed new and revised accounting pronouncements that have been issued but are not yet effective. The Company does not expect any material impact from future accounting pronouncements.

XML 37 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Note 3 - Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]

Name of Subsidiary

Country of

Incorporation

 

Ownership

Interest at

December 31,

2022

  

Ownership

Interest at

December 31,

2021

 

Principal Activity

           

ComplyTrust Inc.

US/Delaware

  100%  100%

Software Development

XML 38 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Note 4 - Prepaid Expenses and Other Current Assets (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
   

December 31,

   

December 31,

 
   

2022

   

2021

 
                 

Prepaid expenses

  $ 28,028     $ 28,141  

Tax Receivable – Canadian GST

    2,210       9,691  
    $ 30,238     $ 37,832  
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Note 5 - Accounts Payable and Accrued Expenses (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
   

December 31,

   

December 31,

 
   

2022

   

2021

 
                 

Accounts payable

  $ 224,716     $ 61,836  

Accrued fees and expenses

    51,869       34,362  
    $ 276,585     $ 96,198  
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Note 7 - Stock Options (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Number of

options

  

Weighted

average exercise

price

(CAD)

  

Aggregate

Intrinsic Value

 
             

Options outstanding, December 31, 2020

  3,850,000  $0.36  $3,363,000 

Granted

  1,465,000   0.86   - 

Options outstanding, December 31, 2021

  5,315,000   0.49   3,910,950 

Granted

  100,000   0.80   - 

Options outstanding, December 31, 2022

  5,415,000  $0.50  $- 
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

Exercise price (CAD)

  

Number of

options

outstanding

 

Expiry date

 

Number of options

exercisable

  

Remaining

contractual life (years)

 
                
$0.350   3,600,000 

July 21, 2023

  2,880,000   0.55 
$0.450   250,000 

December 21, 2023

  200,000   0.97 
$1.200   500,000 

January 29, 2024

  300,000   1.08 
$0.800   375,000 

June 10, 2024

  225,000   1.44 
$0.600   590,000 

October 14, 2024

  236,000   1.79 
$0.800   100,000 

January 31, 2025

  20,000   2.09 
                
     5,415,000    3,861,000     
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

December 31, 2022

  

December 31, 2021

 
         

Risk-free interest rate

  1.24%  0.37%

Exercise price (CAD)

 $0.80  $0.86 

Expected life of options (in years)

  3.00   3.00 

Expected annualized volatility

  119.10%  121.87%

Fair value of options granted (CAD)

 $0.55  $0.58 

Expected dividend rate

  -   - 
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Note 8 - Warrants (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Warrants or Right [Table Text Block]
   

Number of

warrants

   

Weighted

average exercise

price

(CAD)

   

Aggregate

Intrinsic Value

 
                         

Warrants outstanding, December 31, 2020

    12,500,000     $ 0.001     $ -  

Granted

    4,900,000       1.00       -  

Warrants outstanding, December 31, 2022 and 2021

    17,400,000     $ 0.28     $ -  

Exercise price

     

Number of

warrants

outstanding

 

Expiry date

 

Number of warrants

exercisable

   

Remaining

contractual life (years)

 
                                 
$ 1.00  

(CAD)

    4,900,000  

April 19, 2023

    4,900,000       0.30  
$ 0.001  

(1) (USA)

    12,500,000  

June 4, 2025

    -       2.43  
                                 
            17,400,000         4,900,000          
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Note 9 - Selling, General and Administrative (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Selling, General and Administrative Expenses [Table Text Block]
   

 

2022

   

2021

 
                 

Filing and regulatory fees

  $ 40,158     $ 38,396  

Marketing

    76,459       41,374  

Professional fees

    104,801       133,134  

Rent

    38,922       39,134  

Office and administration

    139,127       178,653  
                 
    $ 399,467     $ 430,691  
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Note 10 - Research and Development (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Research and Development Expenses [Table Text Block]
   

 

2022

   

2021

 
                 

Project management

  $ 11,990     $ 144,000  

Software development

    820,996       585,953  

Business development

    133,588       60,533  

Payroll

    171,309       27,783  
                 
    $ 1,137,883     $ 818,269  
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Note 12 - Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
  

 

December 31,

2022

  

December 31,

2021

 
         

Loss before taxes for the year

 $(1,649,589) $(1,986,665)
         

Expected income tax (recovery)

 $(461,000) $(417,000)

Effect of change in tax rates

  37,000   (64,000)

Permanent differences

  (5,000)  150,000 

Adjustment to prior years provision

  (5,000)  2,147,000 

Change in unrecognized deductible temporary

  434,000   (1,816,000)
         

Total income taxes

 $-  $- 
         

Current income tax

 $-  $- 

Deferred tax recovery

 $-  $- 
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
  

 

December 31,

2022

  

December 31,

2021

 
         

Non-capital losses

 $5,445,227  $5,010,903 
         
  $5,445,227  $5,010,903 

Unrecognized deferred tax assets

  (5,445,227)  (5,010,903)

Net deferred tax assets

 $-  $- 
Summary of Operating Loss Carryforwards [Table Text Block]
  

2022

  

Expiry Date

Range

  

2021

  

Expiry Date

Range

 

Temporary Differences

                

Non-capital losses available for future periods

 $25,155,000   2026to2041  $23,473,000   2026to2041 

Canada

 $18,334,000   2023to2037  $18,334,000   2023to2037 

USA

 $6,821,000  

No expiry date

  $5,139,000  

No expiry date

 
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Note 13 - Related Parties (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Related Party Transactions [Table Text Block]
  

 

Year ended

December 31,

 
  

2022

  

2021

 
         

Selling general and administrative

 $215,331  $124,972 

Share-based compensation to directors and officers

  47,062   151,261 
  $262,393  $276,233 
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Note 2 - Going Concern (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Net Income (Loss) Attributable to Parent, Total $ (1,649,589) $ (1,986,665)
Retained Earnings (Accumulated Deficit), Total (47,795,434) $ (46,145,845)
Working Capital (Deficit) $ 415,417  
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Note 3 - Summary of Significant Accounting Policies (Details Textual) - shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 5,415,000 5,315,000
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 17,400,000 17,400,000
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Note 3 - Summary of Significant Accounting Policies - Summary of Subsidiary (Details)
Dec. 31, 2022
Dec. 31, 2021
ComplyTrust Inc. [Member]    
ComplyTrust Inc. 100.00% 100.00%
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Prepaid expenses $ 28,028 $ 28,141
Tax Receivable – Canadian GST 2,210 9,691
Prepaid Expense and Other Assets, Current $ 30,238 $ 37,832
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Accounts payable $ 224,716 $ 61,836
Accrued fees and expenses 51,869 34,362
Accounts Payable and Accrued Liabilities, Current, Total $ 276,585 $ 96,198
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Note 6 - Common Stock (Details Textual)
$ / shares in Units, $ / shares in Thousands
12 Months Ended
Jun. 14, 2021
USD ($)
shares
Jun. 14, 2021
CAD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Common Stock, No Par Value (in dollars per share) | $ / shares     $ 0 $ 0
Common Stock, Shares Authorized (in shares)     500,000,000 500,000,000
Common Stock, Shares, Outstanding, Ending Balance (in shares)     91,422,569 91,422,569
Preferred Stock, Shares Authorized (in shares)     250,000,000 250,000,000
Preferred Stock, Shares Issued (in shares)     0 0
Common Stock, Shares Held in Escrow (in shares)     1,875,000  
Payments of Stock Issuance Costs | $     $ (0) $ 36,370
Gains (Losses) on Commitment to Issue Shares | $     $ 414,128 $ 0
Warrants Issued in Connection with Private Placement [Member]        
Equity Offering, Number of Warrants Per Unit (in shares)   1    
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)   1    
Class of Warrant or Right, Exercise Price of Warrants or Rights (in CAD per share) | $ / shares   $ 1.00    
Warrants and Rights Outstanding, Term (Month)   24 months    
Class of Warrant of Right, Stock Price Trigger (in CAD per share) | $ / shares   $ 2.50    
Class of Warrant or Right, Threshold Consecutive Trading Days 10 10    
Payments of Stock Issuance Costs $ 36,370 $ 45,500    
Private Placement [Member]        
Equity Offering, Number of Units Issued (in shares) 4,900,000 4,900,000    
Equity Offering, Price Per Unit Issued (in CAD per share) | $ / shares   $ 0.80    
Proceeds from Issuance or Sale of Equity, Total $ 3,098,616 $ 3,920,000    
Equity Offering, Number of Common Shares Per Unit (in shares)   1    
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Note 7 - Stock Options (Details Textual)
1 Months Ended 9 Months Ended 12 Months Ended
Dec. 21, 2020
CAD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2022
CAD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
CAD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2021
CAD ($)
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2022
CAD ($)
$ / shares
shares
Dec. 30, 2022
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
CAD ($)
$ / shares
shares
Dec. 31, 2020
CAD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)               100,000 100,000   1,465,000 1,465,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares)     3,861,000           3,861,000        
Share-Based Payment Arrangement, Expense | $               $ 396,520     $ 713,684    
Share-Based Payment Arrangement, Option [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)               3 years 3 years   3 years 3 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate               0.00% 0.00%   0.00% 0.00%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares     $ 0.80   $ 0.86       $ 0.80     $ 0.86  
Rolling Stock Option Plan [Member]                          
Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved         10.00%         10.00%   10.00%  
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of January 31, 2025 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)               100,000 100,000        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares)     100,000           100,000        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares     $ 0.80           $ 0.80        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $                 $ 54,600        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate               119.10% 119.10%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)               3 years 3 years        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions               1.24% 1.24%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate               0.00% 0.00%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares     $ 0.78           $ 0.78        
Share-Based Payment Arrangement, Expense               $ 28,162 $ 36,511        
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of January 29, 2024 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       500,000 500,000                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares)         500,000             500,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares         $ 1.20             $ 1.20  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $         $ 424,300                
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate       125.00% 125.00%                
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)       3 years 3 years                
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions       0.14% 0.14%                
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate       0.00% 0.00%                
Share-Based Payment Arrangement, Expense   $ 89,648 $ 115,811 $ 230,215 $ 285,557                
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of June10, 2024 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                     375,000 375,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares)         375,000             375,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares         $ 0.80             $ 0.80  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $                       $ 211,700  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate                     120.80% 120.80%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)                     3 years 3 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions                     0.25% 0.25%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate                     0.00% 0.00%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares         $ 0.80             $ 0.80  
Rolling Stock Option Plan [Member] | Share-Based Payment Arrangement, Option [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)                         3 years
Share-Based Payment Arrangement, Expense           $ 83,342 $ 101,058 64,460 83,351        
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of October 14, 2024 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                     590,000 590,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares)         590,000             590,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares         $ 0.60             $ 0.60  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $                       $ 219,100  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate                     119.89% 119.89%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)                     3 years 3 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions                     0.63% 0.63%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate                     0.00% 0.00%  
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares         $ 0.54             $ 0.54  
Share-Based Payment Arrangement, Expense               99,315 128,164   $ 33,964 $ 42,819  
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of July 21, 2023 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                         3,600,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares)                         3,600,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares                         $ 0.35
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $                         $ 909,900
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate                         125.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions                         0.27%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate                         0.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares                         $ 0.35
Share-Based Payment Arrangement, Expense               100,848 129,990   324,132 406,133  
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of December 21, 2023 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) 250,000                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares) 250,000                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares $ 0.45                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $ $ 75,800                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate 125.00%                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year) 3 years                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions 0.02%                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate                         0.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares $ 0.425                        
Share-Based Payment Arrangement, Expense               $ 14,087 $ 18,207   $ 42,031 $ 52,835  
Rolling Stock Option Plan [Member] | Vesting Every Six Months [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage                   20.00%      
Rolling Stock Option Plan [Member] | Vesting Every Six Months [Member] | Employee Stock Option, Expiration Date of January 31, 2025 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage               20.00% 20.00%        
Rolling Stock Option Plan [Member] | Vesting Every Six Months [Member] | Employee Stock Option, Expiration Date of January 29, 2024 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage       20.00% 20.00%                
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares         $ 1.18             $ 1.18  
Rolling Stock Option Plan [Member] | Vesting Every Six Months [Member] | Share-Based Payment Arrangement, Option [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage                     20.00% 20.00%  
Rolling Stock Option Plan [Member] | Vesting Every Six Months [Member] | Employee Stock Option, Expiration Date of October 14, 2024 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage                     20.00% 20.00%  
Rolling Stock Option Plan [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Employee Stock Option, Expiration Date of July 21, 2023 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage                         20.00%
Rolling Stock Option Plan [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Employee Stock Option, Expiration Date of December 21, 2023 [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage 20.00%                        
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Note 7 - Stock Options - Changes in Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Options outstanding (in shares) 5,315,000 3,850,000  
Options outstanding, weighted average exercise price (in dollars per share) $ 0.49 $ 0.36  
Options outstanding, aggregate intrinsic value $ 0 $ 3,910,950 $ 3,363,000
Granted, options (in shares) 100,000 1,465,000  
Granted, weighted average exercise price (in dollars per share) $ 0.80 $ 0.86  
Granted, aggregate intrinsic value (in dollars per share) $ 0 $ 0  
Options outstanding (in shares) 5,415,000 5,315,000 3,850,000
Options outstanding, weighted average exercise price (in dollars per share) $ 0.50 $ 0.49 $ 0.36
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Note 7 - Stock Options - Details of Options Outstanding (Details)
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Dec. 31, 2021
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Exercise price (in CAD per share) | $ / shares $ 0.50   $ 0.49 $ 0.36
$Number of options outstanding (in shares) 5,415,000 5,415,000 5,315,000 3,850,000
Exercisable (in shares) 3,861,000 3,861,000    
Range One [Member]        
Exercise price (in CAD per share) | $ / shares   $ 0.350    
$Number of options outstanding (in shares) 3,600,000 3,600,000    
Expiry date Jul. 21, 2023      
Exercisable (in shares) 2,880,000 2,880,000    
Remaining contractual life (Year) 6 months 18 days      
Range Two [Member]        
Exercise price (in CAD per share) | $ / shares   $ 0.450    
$Number of options outstanding (in shares) 250,000 250,000    
Expiry date Dec. 21, 2023      
Exercisable (in shares) 200,000 200,000    
Remaining contractual life (Year) 11 months 19 days      
Range Three [Member]        
Exercise price (in CAD per share) | $ / shares   $ 1.200    
$Number of options outstanding (in shares) 500,000 500,000    
Expiry date Jan. 29, 2024      
Exercisable (in shares) 300,000 300,000    
Remaining contractual life (Year) 1 year 29 days      
Range Four [Member]        
Exercise price (in CAD per share) | $ / shares   $ 0.800    
$Number of options outstanding (in shares) 375,000 375,000    
Expiry date Jun. 10, 2024      
Exercisable (in shares) 225,000 225,000    
Remaining contractual life (Year) 1 year 5 months 8 days      
Range Five [Member]        
Exercise price (in CAD per share) | $ / shares   $ 0.600    
$Number of options outstanding (in shares) 590,000 590,000    
Expiry date Oct. 14, 2024      
Exercisable (in shares) 236,000 236,000    
Remaining contractual life (Year) 1 year 9 months 14 days      
Range Six [Member]        
Exercise price (in CAD per share) | $ / shares   $ 0.800    
$Number of options outstanding (in shares) 100,000 100,000    
Expiry date Jan. 31, 2025      
Exercisable (in shares) 20,000 20,000    
Remaining contractual life (Year) 2 years 1 month 2 days      
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details) - Share-Based Payment Arrangement, Option [Member]
12 Months Ended
Dec. 31, 2022
$ / shares
$ / shares
Dec. 31, 2021
$ / shares
$ / shares
Risk-free interest rate 1.24% 0.37%
Exercise price (CAD) (in CAD per share) $ 0.80 $ 0.86
Expected life of options (in years) (Year) 3 years 3 years
Expected annualized volatility 119.10% 121.87%
Fair value of options granted (CAD) (in dollars per share) $ 0.55 $ 0.58
Expected dividend rate 0.00% 0.00%
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Note 8 - Warrants - Schedule of Warrants (Details)
12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Warrants outstanding (in shares) 12,500,000  
Warrants outstanding, weighted average exercise price (in dollars per share) | $ / shares $ 0.001  
Warrants outstanding, Aggregate Intrinsic Value | $ $ 0  
Granted, warrants (in shares) 4,900,000  
Granted, weighted average exercise price (in dollars per share) | $ / shares $ 1.00  
Granted, Aggregate Intrinsic Value | $ $ 0  
Warrants outstanding (in shares) 17,400,000  
Warrants outstanding, weighted average exercise price (in dollars per share) | $ / shares $ 0.28  
Warrants outstanding, Aggregate Intrinsic Value | $ $ 0  
Number of warrants outstanding (in shares)   17,400,000
Number of warrants exercisable (in shares)   4,900,000
Warrants Expiring on April 19, 2023 [Member]    
Warrants outstanding (in shares) 4,900,000  
Exercise price (in CAD per share) | $ / shares   $ 1.00
Number of warrants outstanding (in shares)   4,900,000
Number of warrants exercisable (in shares)   4,900,000
Remaining contractual life (Year) 3 months 18 days  
Warrants Expiring on June 4, 2025 [Member]    
Warrants outstanding (in shares) 12,500,000  
Number of warrants outstanding (in shares)   12,500,000
Remaining contractual life (Year) 2 years 5 months 4 days  
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Filing and regulatory fees $ 40,158 $ 38,396
Marketing 76,459 41,374
Professional fees 104,801 133,134
Rent 38,922 39,134
Office and administration 139,127 178,653
Selling, General and Administrative Expense, Total $ 399,467 $ 430,691
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Note 10 - Research and Development - Research and Development (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Project management $ 11,990 $ 144,000
Software development 820,996 585,953
Business development 133,588 60,533
Payroll 171,309 27,783
Research and Development Expense, Total $ 1,137,883 $ 818,269
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Note 11 - Financial Instruments and Risks (Details Textual) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Cash and Cash Equivalents, at Carrying Value, Total $ 687,602 $ 2,208,451
Liabilities, Current, Total $ 302,423 $ 122,623
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Loss before taxes for the year $ (1,649,589) $ (1,986,665)
Expected income tax (recovery) (461,000) (417,000)
Effect of change in tax rates 37,000 (64,000)
Permanent differences (5,000) 150,000
Adjustment to prior years provision (5,000) 2,147,000
Change in unrecognized deductible temporary 434,000 (1,816,000)
Total income taxes 0 0
Current income tax 0 0
Deferred tax recovery $ 0 $ 0
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Note 12 - Income Taxes - Net Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Non-capital losses $ 5,445,227 $ 5,010,903
Deferred Tax Assets, Gross, Total 5,445,227 5,010,903
Unrecognized deferred tax assets (5,445,227) (5,010,903)
Net deferred tax assets $ 0 $ 0
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Note 12 - Income Taxes - Components of Temporary Difference (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Operatinting loss $ 25,155,000 $ 23,473,000
Foreign Tax Authority [Member] | Canada Revenue Agency [Member]    
Operatinting loss 18,334,000 18,334,000
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]    
Operatinting loss $ 6,821,000 $ 5,139,000
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Note 13 - Related Parties (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Related Party Transaction, Expenses from Transactions with Related Party $ 262,393 $ 276,233
Share-based Compensation [Member]    
Related Party Transaction, Expenses from Transactions with Related Party 47,062 151,261
Research and Development Expense [Member]    
Related Party Transaction, Expenses from Transactions with Related Party 0 0
Reimbursement [Member]    
Related Party Transaction, Amounts of Transaction $ 215,331 $ 124,972
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Note 13 - Related Parties - Related Party Expenses (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Selling general and administrative $ 262,393 $ 276,233
Selling, General and Administrative Expenses [Member]    
Selling general and administrative 215,331 124,972
Share-based Compensation [Member]    
Selling general and administrative $ 47,062 $ 151,261
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Note 14 - Operating Leases (Details Textual)
12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2022
CAD ($)
Dec. 31, 2021
USD ($)
Operating Lease, Expense $ 38,922   $ 39,134
Vancouver, CA Operating Lease [Member]      
Operating Leases, Monthly Rent Expense   $ 3,950  
Operating Lease, Expense $ 36,894   $ 36,340
XML 66 ovtz20221231_10k_htm.xml IDEA: XBRL DOCUMENT 0001107280 2022-01-01 2022-12-31 0001107280 2022-06-30 0001107280 2023-03-28 0001107280 2022-12-31 0001107280 2021-12-31 0001107280 2021-01-01 2021-12-31 0001107280 us-gaap:CommonStockMember 2020-12-31 0001107280 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2020-12-31 0001107280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001107280 us-gaap:RetainedEarningsMember 2020-12-31 0001107280 2020-12-31 0001107280 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001107280 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2021-01-01 2021-12-31 0001107280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001107280 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001107280 us-gaap:CommonStockMember 2021-12-31 0001107280 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2021-12-31 0001107280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001107280 us-gaap:RetainedEarningsMember 2021-12-31 0001107280 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001107280 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2022-01-01 2022-12-31 0001107280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001107280 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001107280 us-gaap:CommonStockMember 2022-12-31 0001107280 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2022-12-31 0001107280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001107280 us-gaap:RetainedEarningsMember 2022-12-31 0001107280 ovtz:ComplytrustIncMember 2022-12-31 0001107280 ovtz:ComplytrustIncMember 2021-12-31 0001107280 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001107280 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001107280 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001107280 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001107280 us-gaap:PrivatePlacementMember 2021-06-14 2021-06-14 0001107280 us-gaap:PrivatePlacementMember 2021-06-14 0001107280 ovtz:WarrantsIssuedInConnectionWithPrivatePlacementMember 2021-06-14 0001107280 ovtz:WarrantsIssuedInConnectionWithPrivatePlacementMember 2021-06-14 2021-06-14 0001107280 ovtz:RollingStockOptionPlanMember 2022-12-30 0001107280 ovtz:RollingStockOptionPlanMember 2021-12-31 0001107280 ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2022-01-01 2022-12-30 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary312025Member ovtz:RollingStockOptionPlanMember 2022-01-01 2022-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary312025Member ovtz:RollingStockOptionPlanMember 2022-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary312025Member ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2022-01-01 2022-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Member ovtz:RollingStockOptionPlanMember 2021-12-01 2021-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Member ovtz:RollingStockOptionPlanMember 2021-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Member ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2021-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Member ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2021-12-01 2021-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJanuary292024Member ovtz:RollingStockOptionPlanMember 2022-12-01 2022-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJune102024Member ovtz:RollingStockOptionPlanMember 2021-01-01 2021-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJune102024Member ovtz:RollingStockOptionPlanMember 2021-12-31 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2021-01-01 2021-12-31 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2021-01-01 2021-09-30 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2022-01-01 2022-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfOctober142024Member ovtz:RollingStockOptionPlanMember 2021-01-01 2021-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfOctober142024Member ovtz:RollingStockOptionPlanMember 2021-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfOctober142024Member ovtz:RollingStockOptionPlanMember ovtz:VestingEverySixMonthsMember 2021-01-01 2021-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfOctober142024Member ovtz:RollingStockOptionPlanMember 2022-01-01 2022-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember 2020-01-01 2020-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember 2020-12-31 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2020-01-01 2020-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-01-01 2020-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember 2021-01-01 2021-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfJuly212023Member ovtz:RollingStockOptionPlanMember 2022-01-01 2022-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember 2020-12-21 2020-12-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember 2020-12-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember 2020-01-01 2020-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-12-21 2020-12-21 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember 2021-01-01 2021-12-31 0001107280 ovtz:EmployeeStockOptionExpirationDateOfDecember212023Member ovtz:RollingStockOptionPlanMember 2022-01-01 2022-12-31 0001107280 ovtz:RangeOneMember 2022-12-31 0001107280 ovtz:RangeOneMember 2022-01-01 2022-12-31 0001107280 ovtz:RangeTwoMember 2022-12-31 0001107280 ovtz:RangeTwoMember 2022-01-01 2022-12-31 0001107280 ovtz:RangeThreeMember 2022-12-31 0001107280 ovtz:RangeThreeMember 2022-01-01 2022-12-31 0001107280 ovtz:RangeFourMember 2022-12-31 0001107280 ovtz:RangeFourMember 2022-01-01 2022-12-31 0001107280 ovtz:RangeFiveMember 2022-12-31 0001107280 ovtz:RangeFiveMember 2022-01-01 2022-12-31 0001107280 ovtz:RangeSixMember 2022-12-31 0001107280 ovtz:RangeSixMember 2022-01-01 2022-12-31 0001107280 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001107280 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001107280 us-gaap:EmployeeStockOptionMember 2022-12-31 0001107280 us-gaap:EmployeeStockOptionMember 2021-12-31 0001107280 ovtz:WarrantsExpiringOnApril192023Member 2022-12-31 0001107280 ovtz:WarrantsExpiringOnApril192023Member 2022-01-01 2022-12-31 0001107280 ovtz:WarrantsExpiringOnJune42025Member 2022-12-31 0001107280 ovtz:WarrantsExpiringOnJune42025Member 2022-01-01 2022-12-31 0001107280 us-gaap:ForeignCountryMember us-gaap:CanadaRevenueAgencyMember 2022-12-31 0001107280 us-gaap:ForeignCountryMember us-gaap:CanadaRevenueAgencyMember 2021-12-31 0001107280 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember 2022-12-31 0001107280 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember 2021-12-31 0001107280 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001107280 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001107280 ovtz:SharebasedCompensationMember 2022-01-01 2022-12-31 0001107280 ovtz:SharebasedCompensationMember 2021-01-01 2021-12-31 0001107280 ovtz:ReimbursementMember 2022-01-01 2022-12-31 0001107280 ovtz:ReimbursementMember 2021-01-01 2021-12-31 0001107280 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001107280 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001107280 ovtz:VancouverCAOperatingLeaseMember 2022-01-01 2022-12-31 0001107280 ovtz:VancouverCAOperatingLeaseMember 2021-01-01 2021-12-31 iso4217:USD shares thunderdome:item iso4217:USD shares pure iso4217:CAD shares iso4217:CAD utr:M utr:Y 0001107280 OCULUS VISIONTECH INC. false --12-31 FY 2022 0 0 250000000 250000000 0 0 0 0 500000000 500000000 91422569 91422569 91422569 91422569 -0.02 0 500000000 0.80 3920000 1 1 1 1.00 2.50 10 45500 0.10 0.80 54600 1.1910 0.0124 0 0.78 36511 1.20 424300 1.2500 0.0014 0 1.18 285557 115811 0.80 211700 1.2080 0.0025 0 0.80 101058 83351 0.60 219100 1.1989 0.0063 0 0.54 42819 128164 0.35 909900 1.25 0.0027 0 0.35 406133 129990 0.45 75800 1.25 0.0002 0 0.425 52835 18207 2023-07-21 2023-12-21 2024-01-29 2024-06-10 2024-10-14 2025-01-31 1.00 0 10-K true 2022-12-31 false 000-29651 WY 06-1576391 #507, 837 West Hastings Street Vancouver BC V6C 3N6 604 685-1017 No No Yes Yes Non-accelerated Filer true false true false 37800000 91422469 Davidson & Company LLP Vancouver, BC. Canada 731 687602 2208451 30238 37832 717840 2246283 276585 96198 25838 26425 302423 122623 46850710 46850710 1394997 998477 0 414128 -34856 6190 -47795434 -46145845 415417 2123660 717840 2246283 135000 24021 1137883 818269 399467 430691 396520 713684 -2068870 -1986665 5153 0 414128 0 -1649589 -1986665 41046 -6190 -1608543 -1992855 -0.02 91422569 89968723 86522569 43788464 284793 414128 0 -44159180 328205 4900000 3098616 0 0 0 0 3098616 36370 -0 -0 -0 -0 36370 0 713684 0 0 0 713684 -0 -0 -0 -6190 -0 -6190 0 0 0 0 -1986665 -1986665 91422569 46850710 998477 414128 6190 -46145845 2123660 0 396520 0 0 0 396520 0 0 -414128 0 0 -414128 -0 -0 -0 41046 -0 41046 0 0 0 0 -1649589 -1649589 91422569 46850710 1394997 0 -34856 -47795434 415417 -1649589 -1986665 396520 713684 414128 -0 -2441 32230 180387 63869 -108833 -1484369 -1350175 0 3098616 -0 36370 0 3062246 -5153 -0 5153 0 -41633 6190 -1520849 1718261 2208451 490190 687602 2208451 0 0 0 0 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">1.</em> </b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>BASIS OF PRESENTATION AND BUSINESS</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The accompanying consolidated financial statements include the accounts of Oculus Visiontech Inc. (“Oculus”) and its wholly-owned subsidiary, ComplyTrust Inc. (“CTI”), (together “the Company”). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company is a designer of digital watermarking services and solutions. At <em style="font: inherit;"> December 31, 2022 </em>and for the <em style="font: inherit;">two</em>-year period then ended, substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.</p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">2.</em> </b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>GOING CONCERN </b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">These consolidated financial statements are prepared on a going concern basis which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses from inception and does <em style="font: inherit;">not</em> currently have the financial resources to sustain operations in the long-term. As shown in the financial statements, the Company has incurred a loss of $1,649,589 for the year ended <em style="font: inherit;"> December 31, 2022 </em>and, in addition the Company incurred losses of $1,986,665 for the year ended <em style="font: inherit;"> December 31, 2021. </em>As of <em style="font: inherit;"> December 31, 2022, </em>the Company had an accumulated deficit of $47,795,434 and working capital of $415,417. As a result of the Company’s current financial position and challenging access to capital, there can be <em style="font: inherit;">no</em> assurance that the Company will be able raise additional funds in the future, in which case the Company will be unable to meet its financial obligations. These material uncertainties raise substantial doubt upon the Company’s ability to continue as a going concern. The financial statements do <em style="font: inherit;">not</em> include adjustments to amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue operations. The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">There are many external factors that can adversely affect general workforces, economies and financial markets globally. Examples include, but are <em style="font: inherit;">not</em> limited to, the COVID-<em style="font: inherit;">19</em> global pandemic and political conflict in other regions. It is <em style="font: inherit;">not</em> possible for the Company to predict the duration or magnitude of adverse results of such external factors and their effect on the Company’s business or ability to raise funds.</p> -1649589 -1986665 -47795434 415417 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 9pt;"> </td><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">3.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Basis of consolidation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On <em style="font: inherit;"> March 28, 2023, </em>the Board approved the consolidated financial statements dated <em style="font: inherit;"> December 31, 2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than <em style="font: inherit;">50%</em> of the voting rights or currently exercisable potential voting rights of a Company’s capital stock. All significant intercompany transactions and balances have been eliminated.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The controlled entities are listed in the following table:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23.5%; border-top: 1px solid black;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Name of Subsidiary</p> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23.5%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Country of</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Incorporation</p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ownership</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interest at</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">December 31,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ownership</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interest at</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">December 31,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Principal Activity</p> </td></tr> <tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">ComplyTrust Inc.</p> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">US/Delaware</em></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">Software Development</em></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Significant judgments, estimates and assumptions</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are <em style="font: inherit;">not</em> limited to the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><span style="text-decoration: underline; ">Significant judgments</span></p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the determination of functional currencies; and</p> </td></tr> <tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">share-based compensation and warrants issued in connection with private placements, using the fair value method. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based compensation. This estimate also requires determining the most appropriate inputs to the valuation model. The main factor affecting the estimates of the fair value of stock options is the stock price, expected volatility used and the expected duration of the instrument. The Company currently estimates the expected volatility of its common shares based on historical stock price information. The Company recognizes the commitment to issue shares, based on the trading price at the date of the commitment on a percentage basis on the likelihood of the completion of the event.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Cash and cash equivalents</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Cash equivalents include highly liquid investments with original maturities of <em style="font: inherit;">twelve</em> months or less, and which are subject to an insignificant risk of change in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Impairment of long-lived assets and long-lived assets to be disposed of</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount and the fair value less costs to sell.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Research and development </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Expenditure on research activities is recognized on the consolidated statements of operations and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at <em style="font: inherit;"> December 31, 2022, </em>it was <em style="font: inherit;">not</em> yet able to demonstrate with sufficient certainty that it is probable that any economic benefits will flow to the Company. Accordingly, all research and development costs incurred to date have been expensed. </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"/> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Intangible asset</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The useful lives of intangible assets are assessed as either finite or indefinite.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually and whenever there is an indication that the intangible asset <em style="font: inherit;"> may </em>be impaired. The amortization period and method for an intangible asset with a finite useful life are reviewed at least at each financial year-end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in profit or loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets <em style="font: inherit;"> may </em>be impaired.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Income taxes</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than <em style="font: inherit;">not</em> that some portion or the entire deferred tax asset will <em style="font: inherit;">not</em> be recognized.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Net loss per share</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that <em style="font: inherit;"> may </em>require the issuance of common shares in the future were converted, unless the impact is anti-dilutive. For the year ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021,</em> this calculation proved to be anti-dilutive, and therefore the Company’s 5,415,000 (<em style="font: inherit;">2021:</em> 5,315,000) stock options and 17,400,000 (<em style="font: inherit;">2021:</em> 17,400,000) warrants were excluded from the calculation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Right of use asset</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company recognizes a right of use asset and a lease liability at the lease commencement date. The right of use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove or to restore the underlying asset or the site on which it is located, less any lease incentives received.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The right of use assets are subsequently amortized from the commencement date to the earlier of the end of the useful life of the right of use asset or the end of the lease term using the straight line method.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Lease liability</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The lease liability is initially measured at the present value of the lease payments that are <em style="font: inherit;">not</em> paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Lease payments included in the measurement of the lease liability comprise the following payments during the lease term: fixed payments (including in-substance fixed payments), and the exercise price under a purchase option that the Company is reasonably certain to exercise.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising mainly if the Company changes its assessment of whether it will exercise a purchase, renewal or termination option, or if there is a revised in substance fixed lease payment.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right of use asset, or is recorded in profit or loss if the carrying amount of the right of use asset has been reduced to zero.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Stock-based compensation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section <em style="font: inherit;">718</em> “Compensation - Stock Compensation”, which establishes accounting for equity-based compensation awards to be accounted for using the fair value method. Equity-settled share-based payment arrangements are initially measured at fair value at the date of grant and recorded within shareholders’ equity. Arrangements considered to be cash-settled are initially recorded at fair value and classified as accrued liabilities, and subsequently re-measured at fair value at each reporting date. The Company’s stock option plan is an equity-settled arrangement.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Functional currency</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus is the Canadian (“CAD” or “C”) dollar and the functional currency of CTI is the U.S. dollar.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">In accordance with ASC <em style="font: inherit;">830,</em> Foreign Currency Matters, for companies that have a functional currency other than the US dollar, the Company translates the assets and liabilities into U.S. dollars using the rate of exchange prevailing at the balance sheet date and the statements of operations and comprehensive loss and cash flows are translated at an average rate during the reporting period. Adjustments resulting from the translation from CAD into U.S. dollars are recorded in shareholders' equity as part of accumulated other comprehensive (income) loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are <em style="font: inherit;">not</em> re-translated at period end are measured at historical cost (translated using the exchange rates at the transaction date), except for non-monetary items measured at fair value, which are translated using the exchange rates as at the date when fair value was determined. Gains and losses are recorded in the statement of operations and comprehensive loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b/></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Recently adopted accounting pronouncements</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company has reviewed new and revised accounting pronouncements that have been issued but are <em style="font: inherit;">not</em> yet effective. The Company does <em style="font: inherit;">not</em> expect any material impact from future accounting pronouncements.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Basis of consolidation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On <em style="font: inherit;"> March 28, 2023, </em>the Board approved the consolidated financial statements dated <em style="font: inherit;"> December 31, 2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than <em style="font: inherit;">50%</em> of the voting rights or currently exercisable potential voting rights of a Company’s capital stock. All significant intercompany transactions and balances have been eliminated.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The controlled entities are listed in the following table:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23.5%; border-top: 1px solid black;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Name of Subsidiary</p> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23.5%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Country of</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Incorporation</p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ownership</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interest at</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">December 31,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ownership</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interest at</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">December 31,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Principal Activity</p> </td></tr> <tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">ComplyTrust Inc.</p> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">US/Delaware</em></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">Software Development</em></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23.5%; border-top: 1px solid black;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Name of Subsidiary</p> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23.5%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Country of</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Incorporation</p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ownership</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interest at</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">December 31,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ownership</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interest at</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">December 31,</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 23%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Principal Activity</p> </td></tr> <tr style="vertical-align: bottom;"><td style="text-align: center;"> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">ComplyTrust Inc.</p> </td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">US/Delaware</em></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">100</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td><td style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;">Software Development</em></p> </td></tr> </tbody></table> 1 1 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Significant judgments, estimates and assumptions</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are <em style="font: inherit;">not</em> limited to the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><span style="text-decoration: underline; ">Significant judgments</span></p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the determination of functional currencies; and</p> </td></tr> <tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">share-based compensation and warrants issued in connection with private placements, using the fair value method. The Company uses the Black-Scholes option pricing model to determine the fair value of share-based compensation. This estimate also requires determining the most appropriate inputs to the valuation model. The main factor affecting the estimates of the fair value of stock options is the stock price, expected volatility used and the expected duration of the instrument. The Company currently estimates the expected volatility of its common shares based on historical stock price information. The Company recognizes the commitment to issue shares, based on the trading price at the date of the commitment on a percentage basis on the likelihood of the completion of the event.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Cash and cash equivalents</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Cash equivalents include highly liquid investments with original maturities of <em style="font: inherit;">twelve</em> months or less, and which are subject to an insignificant risk of change in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather than for investment or other purposes.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Impairment of long-lived assets and long-lived assets to be disposed of</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount and the fair value less costs to sell.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Research and development </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Expenditure on research activities is recognized on the consolidated statements of operations and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at <em style="font: inherit;"> December 31, 2022, </em>it was <em style="font: inherit;">not</em> yet able to demonstrate with sufficient certainty that it is probable that any economic benefits will flow to the Company. Accordingly, all research and development costs incurred to date have been expensed. </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Intangible asset</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The useful lives of intangible assets are assessed as either finite or indefinite.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually and whenever there is an indication that the intangible asset <em style="font: inherit;"> may </em>be impaired. The amortization period and method for an intangible asset with a finite useful life are reviewed at least at each financial year-end. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in profit or loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets <em style="font: inherit;"> may </em>be impaired.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Income taxes</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than <em style="font: inherit;">not</em> that some portion or the entire deferred tax asset will <em style="font: inherit;">not</em> be recognized.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Net loss per share</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that <em style="font: inherit;"> may </em>require the issuance of common shares in the future were converted, unless the impact is anti-dilutive. For the year ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021,</em> this calculation proved to be anti-dilutive, and therefore the Company’s 5,415,000 (<em style="font: inherit;">2021:</em> 5,315,000) stock options and 17,400,000 (<em style="font: inherit;">2021:</em> 17,400,000) warrants were excluded from the calculation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> 5415000 5315000 17400000 17400000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Right of use asset</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company recognizes a right of use asset and a lease liability at the lease commencement date. The right of use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove or to restore the underlying asset or the site on which it is located, less any lease incentives received.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The right of use assets are subsequently amortized from the commencement date to the earlier of the end of the useful life of the right of use asset or the end of the lease term using the straight line method.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Lease liability</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The lease liability is initially measured at the present value of the lease payments that are <em style="font: inherit;">not</em> paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the discount rate.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Lease payments included in the measurement of the lease liability comprise the following payments during the lease term: fixed payments (including in-substance fixed payments), and the exercise price under a purchase option that the Company is reasonably certain to exercise.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising mainly if the Company changes its assessment of whether it will exercise a purchase, renewal or termination option, or if there is a revised in substance fixed lease payment.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right of use asset, or is recorded in profit or loss if the carrying amount of the right of use asset has been reduced to zero.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Stock-based compensation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section <em style="font: inherit;">718</em> “Compensation - Stock Compensation”, which establishes accounting for equity-based compensation awards to be accounted for using the fair value method. Equity-settled share-based payment arrangements are initially measured at fair value at the date of grant and recorded within shareholders’ equity. Arrangements considered to be cash-settled are initially recorded at fair value and classified as accrued liabilities, and subsequently re-measured at fair value at each reporting date. The Company’s stock option plan is an equity-settled arrangement.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Functional currency</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus is the Canadian (“CAD” or “C”) dollar and the functional currency of CTI is the U.S. dollar.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">In accordance with ASC <em style="font: inherit;">830,</em> Foreign Currency Matters, for companies that have a functional currency other than the US dollar, the Company translates the assets and liabilities into U.S. dollars using the rate of exchange prevailing at the balance sheet date and the statements of operations and comprehensive loss and cash flows are translated at an average rate during the reporting period. Adjustments resulting from the translation from CAD into U.S. dollars are recorded in shareholders' equity as part of accumulated other comprehensive (income) loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are <em style="font: inherit;">not</em> re-translated at period end are measured at historical cost (translated using the exchange rates at the transaction date), except for non-monetary items measured at fair value, which are translated using the exchange rates as at the date when fair value was determined. Gains and losses are recorded in the statement of operations and comprehensive loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Recently adopted accounting pronouncements</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company has reviewed new and revised accounting pronouncements that have been issued but are <em style="font: inherit;">not</em> yet effective. The Company does <em style="font: inherit;">not</em> expect any material impact from future accounting pronouncements.</p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">4.</em></b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>PREPAID EXPENSES AND OTHER CURRENT ASSETS</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Prepaid expenses and other current assets consist of the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2022</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid expenses</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">28,028</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">28,141</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Tax Receivable – Canadian GST</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,210</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">9,691</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">30,238</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">37,832</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2022</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid expenses</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">28,028</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">28,141</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Tax Receivable – Canadian GST</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,210</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">9,691</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">30,238</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">37,832</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> 28028 28141 2210 9691 30238 37832 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">5.</em></b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ACCOUNTS PAYABLE AND ACCRUED EXPENSES</b></p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Accounts payable and accrued expenses consist of the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2022</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts payable</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">224,716</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">61,836</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accrued fees and expenses</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">51,869</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">34,362</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">276,585</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">96,198</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2022</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts payable</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">224,716</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">61,836</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Accrued fees and expenses</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">51,869</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">34,362</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">276,585</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">96,198</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> 224716 61836 51869 34362 276585 96198 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 9pt;"> </td><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">6.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>COMMON STOCK</b> </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company has no par value common stock with 500,000,000 authorized shares and 91,422,569 outstanding on <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company has authorized the issuance of 250,000,000 non-voting preferred shares without par value, none issued.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">As of <em style="font: inherit;"> December 31, 2022, </em>there were 1,875,000 common shares held in escrow.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">On <em style="font: inherit;"> June 14, 2021, </em>the Company closed a non-brokered private placement financing of 4,900,000 units of the Company at a price of <span style="-sec-ix-hidden:c95837616">CDN$0.80</span> per unit for gross proceeds of <span style="-sec-ix-hidden:c95837617">$3,920,000CDN</span> ($3,098,616). Each unit consisted of <span style="-sec-ix-hidden:c95837619">one</span> common share of the Company and <span style="-sec-ix-hidden:c95837620">one</span> common share purchase warrant, with each warrant entitling the holder to acquire <span style="-sec-ix-hidden:c95837621">one</span> additional common share of the Company at an exercise price of <span style="-sec-ix-hidden:c95837622">$1.00CDN</span> for a period of 24 months from the date of closing. The expiry date of the warrants <em style="font: inherit;"> may </em>be accelerated at the Company’s discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than <span style="-sec-ix-hidden:c95837624">$2.50CDN</span> for a minimum of <span style="-sec-ix-hidden:c95837625">ten</span> consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant. In connection to the private placement, the Company paid <span style="-sec-ix-hidden:c95837626">$45,500CDN</span> ($36,370) as share issuance costs.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">During the year ended <em style="font: inherit;"> December 31, 2022, </em>the Company wrote-off the commitment to issue shares of $414,128 due to the uncertainty in the Company meeting the required performance conditions.</p> 0 500000000 91422569 250000000 0 1875000 4900000 3098616 P24M 36370 414128 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 9pt;"> </td><td style="width: 45pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">7.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>STOCK OPTIONS</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">During the year ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021,</em> the Company adopted a Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares <em style="font: inherit;"> may </em>be reserved for granting of stock options. All of the options granted vest 20% every <em style="font: inherit;">six</em> months.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">However, all options will be considered vested if <em style="font: inherit;">one</em> of the following criteria are met by the Company:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">i.</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Meeting sales forecasts:</p> </td></tr> </tbody></table> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 72pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">-</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The greater of either the <em style="font: inherit;">20%</em> vesting every <em style="font: inherit;">six</em> months or based on a pro rata percentage of revenue earned by the Company’s subsidiary.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">ii.</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the listing of the Company on any national securities exchange.</p> </td></tr> <tr><td style="width: 54pt;"> </td><td style="width: 18pt;"> </td><td style="width: auto;"> </td></tr> <tr style="vertical-align: top;"><td style="width: 54pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">iii.</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">a Change of Control Event.</p> </td></tr> </tbody></table> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">During the year ended <em style="font: inherit;"> December 31, 2022, </em>the Company:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">i) granted 100,000 stock options to a consultant, exercisable into 100,000 shares at an exercise price of <span style="-sec-ix-hidden:c95837641">$0.80CAD</span> and an expiry date of <em style="font: inherit;"> January 31, 2025. </em>The options have a fair value of <span style="-sec-ix-hidden:c95837642">$54,600CAD,</span> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <span style="-sec-ix-hidden:c95837643">119.10%;</span> (ii) Term of 3 years; (iii) Discount rate of <span style="-sec-ix-hidden:c95837645">1.24%;</span> (iv) Dividend rate of <span style="-sec-ix-hidden:c95837646">Nil;</span> and (v) market stock price of <span style="-sec-ix-hidden:c95837647">$0.78CAD.</span> The options vest 20% every <em style="font: inherit;">6</em> months starting <em style="font: inherit;"> August 1, 2022. </em>During the year ended <em style="font: inherit;"> December 31, 2022, </em>the Company recorded <span style="-sec-ix-hidden:c95837650">$36,511CAD</span> ($28,162) of share-based compensation relating to the vesting period.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">During the year ended <em style="font: inherit;"> December 31, 2021, </em>the Company:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">i) granted 500,000 stock options to consultants, exercisable into 500,000 shares at an exercise price of <span style="-sec-ix-hidden:c95837654">$1.20CAD</span> and an expiry date of <em style="font: inherit;"> January 29, 2024. </em>The options have a fair value of <span style="-sec-ix-hidden:c95837655">$424,300CAD,</span> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <span style="-sec-ix-hidden:c95837656">125.00%;</span> (ii) Term of 3 years; (iii) Discount rate of <span style="-sec-ix-hidden:c95837658">0.14%;</span> (iv) Dividend rate of <span style="-sec-ix-hidden:c95837659">Nil;</span> and (v) market stock price of <span style="-sec-ix-hidden:c95837660">$1.18CAD.</span> The options vest 20% every <em style="font: inherit;">6</em> months starting <em style="font: inherit;"> July 29, 2021. </em>During the year ended <em style="font: inherit;"> December 31, 2021, </em>the Company recorded <span style="-sec-ix-hidden:c95837663">$285,557CAD</span> ($230,215) of share-based compensation relating to the vesting period. During the year ended <em style="font: inherit;"> December 31, 2022, </em>the Company recorded <span style="-sec-ix-hidden:c95837665">$115,811CAD</span> ($89,648) of share-based compensation relating to the vesting period.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">ii) granted 375,000 stock options to consultants, exercisable into 375,000 shares at an exercise price of <span style="-sec-ix-hidden:c95837669">$0.80CAD</span> and an expiry date of <em style="font: inherit;"> June 10, 2024. </em>The options have a fair value of <span style="-sec-ix-hidden:c95837670">$211,700CAD,</span> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <span style="-sec-ix-hidden:c95837671">120.80%;</span> (ii) Term of 3 years; (iii) Discount rate of <span style="-sec-ix-hidden:c95837673">0.25%;</span> (iv) Dividend rate of <span style="-sec-ix-hidden:c95837674">Nil;</span> and (v) market stock price of <span style="-sec-ix-hidden:c95837675">$0.80CAD.</span> The options vest 20% every <em style="font: inherit;">6</em> months starting <em style="font: inherit;"> December 10, 2021. </em>During the period ended <em style="font: inherit;"> September 30, 2021, </em>the Company recorded <span style="-sec-ix-hidden:c95837678">$101,058CAD</span> ($83,342) of share -based compensation relating to the vesting period. During the year ended <em style="font: inherit;"> December 31, 2022, </em>the Company recorded <span style="-sec-ix-hidden:c95837680">$83,351CAD</span> ($64,460) of share-based compensation relating to the vesting period.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">iii) granted 590,000 stock options to consultants, exercisable into 590,000 shares at an exercise price of <span style="-sec-ix-hidden:c95837684">$0.60CAD</span> and an expiry date of <em style="font: inherit;"> October 14, 2024. </em>The options have a fair value of <span style="-sec-ix-hidden:c95837685">$219,100CAD,</span> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <span style="-sec-ix-hidden:c95837686">119.89%;</span> (ii) Term of 3 years; (iii) Discount rate of <span style="-sec-ix-hidden:c95837688">0.63%;</span> (iv) Dividend rate of <span style="-sec-ix-hidden:c95837689">Nil;</span> and (v) market stock price of <span style="-sec-ix-hidden:c95837690">$0.54CAD.</span> The options vest 20% every <em style="font: inherit;">6</em> months starting <em style="font: inherit;"> April 14, 2021. </em>During the year ended <em style="font: inherit;"> December 31, 2021, </em>the Company recorded <span style="-sec-ix-hidden:c95837693">$42,819CAD</span> ($33,964) of share -based compensation relating to the vesting period. During the year ended <em style="font: inherit;"> December 31, 2022, </em>the Company recorded <span style="-sec-ix-hidden:c95837695">$128,164AD</span> ($99,315) of share-based compensation relating to the vesting period. </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 31pt;"><b>OCULUS VISIONTECH INC. AND SUBSIDIARY </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 31pt;"><b>NOTES TO </b> <b>CONSOLIDATED FINANCIAL STATEMENTS </b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 31pt;"><b><em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021</em></b> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 31pt;"><b>(Stated in US Dollars) </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">During the year ended <em style="font: inherit;"> December 31, 2020, </em>the Company:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">i) granted 3,600,000 stock options to consultants, directors and officers exercisable into 3,600,000 shares at an exercise price of <span style="-sec-ix-hidden:c95837701">$0.35CAD</span> and an expiry date of <em style="font: inherit;"> July 21, 2023. </em>The options have a fair value of <span style="-sec-ix-hidden:c95837702">$909,900CAD,</span> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <span style="-sec-ix-hidden:c95837703">125%;</span> (ii) Term of 3 years; (iii) Discount rate of <span style="-sec-ix-hidden:c95837705">0.27%;</span> (iv) Dividend rate of <span style="-sec-ix-hidden:c95837706">Nil;</span> and (v) market stock price of <span style="-sec-ix-hidden:c95837707">$0.35CAD.</span> The options vest 20% every <em style="font: inherit;">6</em> months starting <em style="font: inherit;"> January 21, 2021. </em>During the year ended <em style="font: inherit;"> December 31, 2021, </em>the Company recorded <span style="-sec-ix-hidden:c95837710">$406,133CAD</span> ($324,132) of stock-based compensation relating to the vesting period. During the year ended <em style="font: inherit;"> December 31, 2022, </em>the Company recorded <span style="-sec-ix-hidden:c95837712">$129,990CAD</span> ($100,848) of share-based compensation relating to the vesting period.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">ii) granted 250,000 stock options to consultants, directors and officers exercisable into 250,000 shares at an exercise price of <span style="-sec-ix-hidden:c95837716">$0.45CAD</span> and an expiry date of <em style="font: inherit;"> December 21, 2023. </em>The options have a fair value of <span style="-sec-ix-hidden:c95837717">$75,800CAD,</span> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <span style="-sec-ix-hidden:c95837718">125%;</span> (ii) Term of 3 years; (iii) Discount rate of <span style="-sec-ix-hidden:c95837720">0.02%;</span> (iv) Dividend rate of <span style="-sec-ix-hidden:c95837721">Nil;</span> and (v) market stock price of <span style="-sec-ix-hidden:c95837722">$0.425CAD.</span> The options vest 20% every <em style="font: inherit;">6</em> months starting <em style="font: inherit;"> June 21, 2021. </em>During the year ended <em style="font: inherit;"> December 31, 2021, </em>the Company recorded <span style="-sec-ix-hidden:c95837725">$52,835CAD</span> ($42,031) of stock-based compensation relating to the vesting period. During the year ended <em style="font: inherit;"> December 31, 2022, </em>the Company recorded <span style="-sec-ix-hidden:c95837727">$18,207CAD</span> ($14,087) of share-based compensation relating to the vesting period.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">The changes in options are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Number of</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>options</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Weighted </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>average exercise </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>price</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>(CAD)</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Aggregate </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Intrinsic Value</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2020</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"><b> </b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>3,850,000</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.36</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>3,363,000</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">1,465,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">0.86</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2021</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"><b> </b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>5,315,000</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"><b> </b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.49</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"><b> </b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>3,910,950</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">100,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">0.80</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2022</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b> </b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>5,415,000</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>0.50</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>-</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for the options that were in-the-money at <em style="font: inherit;"> December 31, 2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Details of options outstanding as at <em style="font: inherit;"> December 31, 2022 </em>are as follows: </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td colspan="2" style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:9pt;"><b><b><em style="font: inherit;">Exercise price (CAD)</em></b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>Number of </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>options</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>outstanding</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 18%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><em style="font: inherit;">Expiry date</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Number of options</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>exercisable</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>Remaining </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>contractual life (years)</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom;"><td style="width: 1%;"> </td><td style="width: 17%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.350</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,600,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838619">July 21, 2023</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,880,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.55</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.450</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">250,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838624">December 21, 2023</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">200,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.97</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.200</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">500,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838629">January 29, 2024</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">300,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.08</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.800</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">375,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838634">June 10, 2024</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">225,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.44</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.600</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">590,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838639">October 14, 2024</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">236,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.79</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.800</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">100,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838644">January 31, 2025</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">20,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2.09</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="width: 1%;"> </td><td style="width: 17%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 17%;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">5,415,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 18%;"><em style="font: inherit;"> </em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,861,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 18%;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 31pt;"><b>OCULUS VISIONTECH INC. AND SUBSIDIARY </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 31pt;"><b>NOTES TO </b> <b>CONSOLIDATED FINANCIAL STATEMENTS </b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 31pt;"><b><em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021</em></b> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 31pt;"><b>(Stated in US Dollars) </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">The following weighted average assumptions were used for the Black-Scholes valuation of stock options granted:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 20%; width: 80%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b><b>December 31, 2022</b></b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b><b>December 31, 2021</b></b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 62%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Risk-free interest rate</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.24</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.37</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercise price (CAD)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.80</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.86</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected life of options (in years)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3.00</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3.00</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected annualized volatility</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">119.10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">121.87</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fair value of options granted (CAD)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.55</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.58</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected dividend rate</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> 0.10 0.20 100000 100000 P3Y 0.20 28162 500000 500000 P3Y 0.20 230215 89648 375000 375000 P3Y 0.20 83342 64460 590000 590000 P3Y 0.20 33964 99315 3600000 3600000 P3Y 0.20 324132 100848 250000 250000 P3Y 0.20 42031 14087 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Number of</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>options</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Weighted </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>average exercise </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>price</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>(CAD)</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Aggregate </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Intrinsic Value</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2020</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"><b> </b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>3,850,000</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.36</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>3,363,000</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">1,465,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">0.86</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2021</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"><b> </b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>5,315,000</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"><b> </b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.49</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"><b> </b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>3,910,950</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">100,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">0.80</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Options outstanding, December 31, 2022</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b> </b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>5,415,000</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>0.50</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td><td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>-</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> 3850000 0.36 3363000 1465000 0.86 0 5315000 0.49 3910950 100000 0.80 0 5415000 0.50 0 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px; margin-left: 18pt;"><tbody><tr style="vertical-align: bottom;"><td colspan="2" style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:9pt;"><b><b><em style="font: inherit;">Exercise price (CAD)</em></b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>Number of </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>options</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>outstanding</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 18%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><em style="font: inherit;">Expiry date</em></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Number of options</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>exercisable</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>Remaining </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>contractual life (years)</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom;"><td style="width: 1%;"> </td><td style="width: 17%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.350</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3,600,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838619">July 21, 2023</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">2,880,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.55</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.450</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">250,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838624">December 21, 2023</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">200,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.97</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.200</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">500,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838629">January 29, 2024</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">300,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.08</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.800</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">375,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838634">June 10, 2024</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">225,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.44</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.600</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">590,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838639">October 14, 2024</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">236,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.79</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 17%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.800</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">100,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 18%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><span style="-sec-ix-hidden:c95838644">January 31, 2025</span></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">20,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2.09</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="width: 1%;"> </td><td style="width: 17%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 1%;"> </td><td style="width: 18%;"> </td><td style="width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 17%;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">5,415,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 18%;"><em style="font: inherit;"> </em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 18%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,861,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td><td style="text-align: right; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 18%;"><em style="font: inherit;"> </em></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td></tr> </tbody></table> 0.350 3600000 2880000 P0Y6M18D 0.450 250000 200000 P0Y11M19D 1.200 500000 300000 P1Y29D 0.800 375000 225000 P1Y5M8D 0.600 590000 236000 P1Y9M14D 0.800 100000 20000 P2Y1M2D 5415000 3861000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 20%; width: 80%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b><b>December 31, 2022</b></b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b><b>December 31, 2021</b></b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 62%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Risk-free interest rate</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.24</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.37</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Exercise price (CAD)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.80</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.86</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected life of options (in years)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3.00</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">3.00</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected annualized volatility</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">119.10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">121.87</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Fair value of options granted (CAD)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.55</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.58</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected dividend rate</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 16%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> 0.0124 0.0037 0.80 0.86 P3Y P3Y 1.1910 1.2187 0.55 0.58 0 0 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">8.</em> </b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>WARRANTS</b>  </p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The changes in warrants are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px; margin-left: 18pt;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Number of </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>warrants</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Weighted </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>average exercise </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>price</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>(CAD)</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Aggregate </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Intrinsic Value</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Warrants outstanding, December 31, 2020</b></p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">12,500,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>$</b></td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.001</b></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>$</b></td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>-</b></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">4,900,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">1.00</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Warrants outstanding, December 31, 2022 and 2021</b></p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b> </b></td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>17,400,000</b></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>0.28</b></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>-</b></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Details of warrants outstanding as at <em style="font: inherit;"> December 31, 2022 </em>are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px; margin-left: 18pt;"> <tbody> <tr style="vertical-align: bottom;"> <td colspan="2" style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:9pt;"><b><b>Exercise price</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 14%; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>Number of </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>warrants</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>outstanding</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b>Expiry date</b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>Number of warrants</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>exercisable</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>Remaining </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>contractual life (years)</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 14%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.00</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 14%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="-sec-ix-hidden:c95837825">(CAD)</span></p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,900,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 15%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">April 19, 2023</em></p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,900,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.30</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.001</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 14%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="font-size:8pt;">(1)</span> (USA)</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">12,500,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">June 4, 2025</em></p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2.43</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 14%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td> <td style="text-align: right; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 14%;"><em style="font: inherit;"> </em></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">17,400,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"><em style="font: inherit;"> </em></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,900,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td> <td style="text-align: right; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"><em style="font: inherit;"> </em></td> <td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 36pt;"> </td> <td style="width: 18pt;"> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 8pt; font-variant: normal; margin: 0pt;">(<em style="font: inherit;">1</em>)</p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><em style="font: inherit;">No</em> share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being <em style="font: inherit;">1</em>) targeted revenue sales projections met, or <em style="font: inherit;">2</em>) listing on a major US exchange, or <em style="font: inherit;">3</em>) change of control.</p> </td> </tr> </tbody> </table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px; margin-left: 18pt;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Number of </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>warrants</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Weighted </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>average exercise </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>price</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>(CAD)</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Aggregate </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>Intrinsic Value</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 52%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Warrants outstanding, December 31, 2020</b></p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">12,500,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>$</b></td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>0.001</b></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>$</b></td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;"><b>-</b></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Granted</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">4,900,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">1.00</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">-</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Warrants outstanding, December 31, 2022 and 2021</b></p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"><b> </b></td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>17,400,000</b></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>0.28</b></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td> <td style="width: 13%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;"><b>-</b></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; width: 95%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px; margin-left: 18pt;"> <tbody> <tr style="vertical-align: bottom;"> <td colspan="2" style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:9pt;"><b><b>Exercise price</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 14%; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>Number of </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>warrants</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>outstanding</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b>Expiry date</b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>Number of warrants</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>exercisable</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>Remaining </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:9pt;"><b><b>contractual life (years)</b></b></p> </td> <td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 14%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">$</td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">1.00</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 14%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="-sec-ix-hidden:c95837825">(CAD)</span></p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,900,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; width: 15%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">April 19, 2023</em></p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">4,900,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">0.30</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.001</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 14%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="font-size:8pt;">(1)</span> (USA)</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">12,500,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><em style="font: inherit;">June 4, 2025</em></p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">-</em></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2.43</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 14%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 15%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td> <td style="text-align: right; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 14%;"><em style="font: inherit;"> </em></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">17,400,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"><em style="font: inherit;"> </em></td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,900,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> </td> <td style="text-align: right; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 15%;"><em style="font: inherit;"> </em></td> <td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td> </tr> </tbody> </table> 12500000 0.001 0 4900000 1.00 0 17400000 0.28 0 4900000 4900000 P0Y3M18D 12500000 P2Y5M4D 17400000 4900000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">9.</em> </b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>SELLING, GENERAL AND ADMINISTRATIVE</b>  </p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The breakdown of selling, general and administrative for the year ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021</em> is as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2022</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Filing and regulatory fees</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">40,158</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">38,396</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Marketing</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">76,459</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">41,374</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Professional fees</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">104,801</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">133,134</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Rent</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">38,922</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">39,134</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Office and administration</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">139,127</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">178,653</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">399,467</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">430,691</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2022</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Filing and regulatory fees</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">40,158</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">38,396</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Marketing</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">76,459</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">41,374</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Professional fees</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">104,801</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">133,134</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Rent</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">38,922</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">39,134</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Office and administration</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">139,127</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">178,653</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">399,467</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">430,691</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> 40158 38396 76459 41374 104801 133134 38922 39134 139127 178653 399467 430691 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">10.</em> </b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>RESEARCH AND DEVELOPMENT</b>  </p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The breakdown of research and development for the year ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021</em> is as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2022</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Project management</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">11,990</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">144,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Software development</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">820,996</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">585,953</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Business development</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">133,588</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">60,533</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Payroll</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">171,309</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">27,783</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,137,883</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">818,269</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"> <tbody> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2022</p> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> </td> <td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</p> </td> <td style="font-family: Times New Roman; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Project management</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">11,990</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">144,000</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Software development</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">820,996</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">585,953</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Business development</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">133,588</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">60,533</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Payroll</p> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">171,309</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">27,783</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,137,883</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">818,269</td> <td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </tbody> </table> 11990 144000 820996 585953 133588 60533 171309 27783 1137883 818269 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 9pt;"> </td><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">11.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>FINANCIAL INSTRUMENTS AND RISKS</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Financial instruments measured at fair value are classified into <em style="font: inherit;">one</em> of <em style="font: inherit;">three</em> levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The <em style="font: inherit;">three</em> levels of the fair value hierarchy are described below.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Level <em style="font: inherit;">1</em> - quoted prices (unadjusted) in active markets for identical assets or liabilities;</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Level <em style="font: inherit;">2</em> – inputs other than quoted prices included in Level <em style="font: inherit;">1</em> that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices); and</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Level <em style="font: inherit;">3</em> - inputs for the asset or liability that are <em style="font: inherit;">not</em> based on observable market data (unobservable inputs).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Fair value of financial instruments</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company has various financial instruments including cash, receivables, accounts payable and accrued liabilities and a loan payable. The carrying values of receivables, accounts payable and accrued liabilities, and loan payable approximate their fair values due to the short-term nature of these financial instruments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Cash is carried at a level <em style="font: inherit;">1</em> fair value measurement.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company’s risk exposures and the impact on the Company’s financial instruments are summarized below:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b><i>Credit risk </i></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company is exposed to credit risk only with respect to uncertainties as to timing and amount of collectability of receivables. The Company believes its credit risk is low because a portion of receivables are comprised of goods and services tax (GST) and other government refunds, which is recoverable from the governing body in Canada. Management does <em style="font: inherit;">not</em> believe the receivables are impaired. The Company doesn’t believe there is significant credit risk associated with cash as these amounts are held with major Canadian banks.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><i>Liquidity risk </i></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Liquidity risk is the risk that the Company will <em style="font: inherit;">not</em> be able to meet its financial obligations as they fall due. The Company’s approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities when due. As at <em style="font: inherit;"> December 31, 2021, </em>the Company had a cash balance of $687,602 (<em style="font: inherit;">2021</em> – $2,208,451) to settle current liabilities of $302,423 (<em style="font: inherit;">2021</em> – $122,623). All of the Company’s financial liabilities have contractual maturities of <em style="font: inherit;">30</em> days or due on demand and are subject to normal trade terms.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><i>Interest rate risk </i></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Interest rate risk is the risk that the future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The risk that the Company will realize such a loss is limited as it does <em style="font: inherit;">not</em> have any significant interest-bearing financial instruments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><i>Foreign currency risk </i></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">As at <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021,</em> the Company is exposed to foreign currency risk as certain monetary financial instruments are denominated in Canadian currency. The Company’s sensitivity analysis suggests that reasonably expected changes in the rates of exchange in Norway, and the United States would change foreign exchange gain or loss by an insignificant amount.</p> 687602 2208451 302423 122623 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 9pt;"> </td><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">12.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>INCOME TAXES</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">A reconciliation of income taxes at statutory rates with the reported taxes is as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2022</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2021</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Loss before taxes for the year</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(1,649,589</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(1,986,665</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected income tax (recovery)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(461,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(417,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Effect of change in tax rates</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">37,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(64,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Permanent differences</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(5,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">150,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Adjustment to prior years provision</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(5,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">2,147,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in unrecognized deductible temporary</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">434,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(1,816,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total income taxes</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Current income tax</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax recovery</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">The significant components of the Company’s deferred tax assets that have <em style="font: inherit;">not</em> been included on the consolidated statement of financial position are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2022</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2021</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-capital losses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">5,445,227</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">5,010,903</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">5,445,227</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">5,010,903</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Unrecognized deferred tax assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(5,445,227</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(5,010,903</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Net deferred tax assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The significant components of the Company’s temporary differences, unused tax credits and unused tax losses that have <em style="font: inherit;">not</em> been included on the consolidated statement of financial position are as follows: </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 40%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Expiry Date</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Range</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2021</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Expiry Date</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Range</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 40%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Temporary Differences</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 12%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 5%;"><b> </b></td><td colspan="2" style="font-family: Times New Roman; font-size: 10pt; width: 3%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 12%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 5%;"><b> </b></td><td colspan="2" style="font-family: Times New Roman; font-size: 10pt; width: 3%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 40%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-capital losses available for future periods</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">25,155,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; text-align: right;"><em style="font: inherit;"> 2026</em></td><td style="width: 3%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">to</em></td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">2041</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">23,473,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; text-align: right;"><em style="font: inherit;"> 2026</em></td><td style="width: 3%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">to</em></td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">2041</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 40%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Canada</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">18,334,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; text-align: right;"><em style="font: inherit;"> 2023</em></td><td style="width: 3%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">to</em></td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">2037</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">18,334,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; text-align: right;"><em style="font: inherit;"> 2023</em></td><td style="width: 3%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">to</em></td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">2037</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 40%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>USA</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">6,821,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">No expiry date</em></em></em></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">5,139,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">No expiry date</em></em></em></p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2022</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2021</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Loss before taxes for the year</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(1,649,589</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(1,986,665</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Expected income tax (recovery)</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(461,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(417,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Effect of change in tax rates</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">37,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(64,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Permanent differences</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(5,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">150,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Adjustment to prior years provision</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">(5,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">2,147,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Change in unrecognized deductible temporary</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">434,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(1,816,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Total income taxes</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Current income tax</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Deferred tax recovery</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> -1649589 -1986665 -461000 -417000 37000 -64000 -5000 150000 -5000 2147000 434000 -1816000 0 0 0 0 0 0 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2022</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2021</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-capital losses</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">5,445,227</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">5,010,903</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">5,445,227</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">5,010,903</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Unrecognized deferred tax assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(5,445,227</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">(5,010,903</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Net deferred tax assets</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">-</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td></tr> </tbody></table> 5445227 5010903 5445227 5010903 5445227 5010903 0 0 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 40%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Expiry Date</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Range</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2021</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 3px double black; width: 8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Expiry Date</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Range</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 40%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Temporary Differences</b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 12%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 5%;"><b> </b></td><td colspan="2" style="font-family: Times New Roman; font-size: 10pt; width: 3%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 12%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 5%;"><b> </b></td><td colspan="2" style="font-family: Times New Roman; font-size: 10pt; width: 3%;"><b> </b></td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 40%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Non-capital losses available for future periods</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">25,155,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; text-align: right;"><em style="font: inherit;"> 2026</em></td><td style="width: 3%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">to</em></td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">2041</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">23,473,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; text-align: right;"><em style="font: inherit;"> 2026</em></td><td style="width: 3%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">to</em></td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">2041</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 40%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Canada</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">18,334,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; text-align: right;"><em style="font: inherit;"> 2023</em></td><td style="width: 3%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">to</em></td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">2037</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: right;">18,334,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; text-align: right;"><em style="font: inherit;"> 2023</em></td><td style="width: 3%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; text-align: center;"><em style="font: inherit;">to</em></td><td style="width: 5%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">2037</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 40%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>USA</b></p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">6,821,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">No expiry date</em></em></em></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td><td style="width: 12%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">5,139,000</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); width: 1%;"> </td><td colspan="3" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); width: 8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><em style="font: inherit;"><em style="font: inherit;"><em style="font: inherit;">No expiry date</em></em></em></p> </td><td style="font-family: Times New Roman; font-size: 10pt; width: 1%;"> </td></tr> </tbody></table> 25155000 23473000 18334000 18334000 6821000 5139000 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 9pt;"> </td><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">13.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>RELATED PARTIES</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">Related parties include the Board of Directors, officers, close family members and enterprises that are controlled by these individuals as well as certain persons performing similar functions.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company defines its key management as the Board of Directors, Chief Executive Officer, President, and Chief Financial Officer. Remuneration of directors and key management personnel of the Company was as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Year ended </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31,</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Selling general and administrative</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>215,331</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">124,972</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Share-based compensation to directors and officers</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b> </b></td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>47,062</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">151,261</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>$</b></td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>262,393</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">276,233</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company for the years ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021</em> reimbursed a related party $215,331 and $124,972 , respectively, for selling, general and administrative expenses paid on behalf of the Company. The Company also recorded share-based compensation of $47,062 (<em style="font: inherit;">2021</em> - $151,261) for options vested to related parties during the years ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021.</em> The Company incurred no expenses from a related party for research and development for the years ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021.</em></p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-top: 1px solid black;"> </td><td colspan="6" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-top: 1px solid black;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Year ended </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31,</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p> </td><td style="font-family: Times New Roman; font-size: 10pt;"> </td></tr> <tr style="vertical-align: bottom;"><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 70%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Selling general and administrative</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>$</b></td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><b>215,331</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">124,972</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">Share-based compensation to directors and officers</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b> </b></td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>47,062</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">151,261</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>$</b></td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>262,393</b></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td><td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">276,233</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> </td></tr> </tbody></table> 215331 124972 47062 151261 262393 276233 215331 124972 47062 151261 0 <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 31pt; text-align: center;"><b/></p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 9pt;"> </td><td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">14.</em> </b></p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>OPERATING LEASES</b>  </p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company has <em style="font: inherit;">one</em> operating leases with unrelated <em style="font: inherit;">third</em> parties for office space at the Vancouver, Canada.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The lease at the Vancouver, Canada location is on a month-to-month basis with monthly rental payments of $3,950 (CND). For the years ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021</em> rent expense was $36,894 and $36,340, respectively.</p> 3950 36894 36340 <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">15.</em> </b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>SEGMENTED INFORMATION</b>  </p> </td> </tr> </tbody> </table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">The Company currently operates in a single reportable operating segment. All of the Company’s assets and expenditures are located in the United States. Since the Company does <em style="font: inherit;">not</em> have any revenue producing activities, there is <em style="font: inherit;">no</em> segment information by revenues.</p> EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

N^E1!1Z70!;K3 V>7"U#N+$5 MG$Q698%35-K2LH!?P4I8\!78<79)KEI% *TZOJ%A!S1A%A:C%I?V3VV; MRKER6:YZ(O3$LWG*59B0 [-"7+E*I/V(016V2Z%S[QE\[_E-X"I]/@*AG(5VG),OH_D MS;RP=BD$T Q#4$M^76)'!*HKM"0C=ID/]4AEF3_NN,WS%<1;UA1/8[LA"";9 M-=,;"50;T??]ZKH6=*W]2\M/,UZ5WHN?[]7WO#TA3EG@VIG:O\1HLK-X4ERO M;6+E#LC/01)G!SR>)>Q9IBO5OUJMVDS=S1^TA_7:#25,A,J_6;H'O>;=/QY-I4/(6OQAR '^">SLN>]!1DT8F/(2["37N%0D4[\>O[6U1#MLF>66@81E06>\\ VUQQ-E]H! M82@3ZTRYW-34KH1H)3=LL9'FW"MGM!UQ->A8H]^SWQVQ]\NUMBP7UEVHT?N: M1N$S6?F*).L(I@U@$L+4.P@@/9!]&AU\;<)93XW+&"6@4*!1PL//N@]/O7Z_ M+*;[IG$J9%^H,\]$@]U)_+DM!@."7#_=06< MZ0C)LF3Q@8 0=0@$#-3:HEL)Z?;C4Y==0P32\<3-K*\;QDTMUO9?#X)!?]OC M\;_ 3M4#?ZLRR:+\[M*HU='=_'TLN3>DXUI?C,RQ]:;50<6IC["/%#(_-H), M=H-/A'SSSW\OTD$7X1D,0$^'L:AM>$GM,+V)_E84^ ]2:M3='5D_.1J (@[-*.P:C$#I^&MAHW NX&T?B^";;.\ M^U.M0YE;[H%S\M9ID1'7U>.R35QVG_?L:8VWW-N$I ":])4=4"E0V/E0IZN# M*#P9@#HPT]3$-G3R^M?;2M)+YVFY^7NQ#/'2M&-2YE/%A(#W81HI@A7ZX)2! M*E;A%2!.@Z#&FI[<,1H+!!GR9RTE+VW73F]))_L[(> (G;W67SM MJ;G@;OG)VT$>$%"W4 <0QZ1/F'2Y6S\U'LT[B:(I7 &HI8L<]XW%>]B,=C3X MOA <$RM?UX)V3)6-E3K$.GOH72_6BN$;A_./8)NW M?<#>[Q3$&;^UI:[))+4BZF5ZZ,UDR=_O&T^VW6^4E#ON&2N%4H8 &@EIA"=0 MRUEAP)>]AQN)9&?FO\MQ(Y^:@B1F9F9FVZ_EM<0UE.GR6^587.\.CO=I2YU7 M81GGYKP]N@7.(H\.V21*XDR =&88NRNM_I/&6;9"W/IFOAAV::PM3_-]/6DT MOKC4(20B6"=0KT3_>$>T4P_XI-5)\7@77Q#7?!;,DP-SH@#QD&(K)C'%2V+H MYU@H B_C'Z-5&[Y=6'RYEF3"BCC&F_1!^B>^,GBMZ_ MYR,\&5^_187$7*&: MI$##&/G@28<"#VRNKIZ>L_G]DE:=2@//B/S[O1N8(&]'AV]#;TN8(2B!.+;" MX#.O6X@K?>Q4HM'Z?N#!)+46=VP0=V1T(* 6?94:L=U8O63"N84D]1LJARF' MD,]6J)^2NGY.+_Z'X,_'8/H!J%IZ8N4?BXM=5]@.U-3PMO_ U!RD9TA=DYZ[WA>?O<.RM-(_PMR&2X]793 M$%\CX(BR)RQHS^?HT\_;,LU2<]=IWB,#AGUF?TI4;KV\[4+&>LEDVC;>:#>^ M'FW-LEU18)]N]3*I!0:*>*:C:U#[-]AE!%N$=WS: $@.6Y?"9K:-68\:9AEX M=FLW&&]=Q0=VZ]3Y&W?%=.VW7GP[9 __\'[>, M_=\.U"G>Q>U2\@F>QW8IZ2:K<"80 J[$P Y.^(]YZ; A3X/6,3HWFBEI=E5U M7#3"-ZXXZ\OY;#=WAK-1GJ3TN=7:Q:5_7;I0()AN=+] Z]+()W'*WWG"LU4: MS/G-3C[G5 8;M[BM%=W*8&$ 3_SE7GLH8K9L^/FR40TEZD%U$EFP<(&F\6U8B MES48G,M^*D5SIW6''6*9'\V;FG7S_GUG^LG*[W^C@_16J-P+6%0'7)ROX[F< M#^:?P%UC$7FJHP_I"9BUG]\W+QA.!2--1WL1Y.1O;@GC*/NZ5-66QO#FU#7Q MNO-O2Q/=<;N!3UQ5/HV^ZR>+_YRUU0F1(KF!.PC*V 1;TIANW:J2S+NE%N%> MFBM=W/2VDVB&I&KF> 3?XV>ES=7W>]; L:CZL38(S;S32P8CNIQIQJ]APL6G ML#F6+9X&H?ZA[2WQ@QNW!\^_-3W>['>\J<''[>V]&-?AQUYZ;&6^N#T+[0Q< M9U;T)^29-C:/U1V6E_";6N*+LV5;C+,P(;Z'_U1U;&9R(@OBF:-G6?I:"Z\K M(R?<;+_1&_16HG_\NO63M>;JCEF['O'E; M7+O"MZ0KZC#-P[Y.,33'\OSHF[,K[F=&.3E?^/ZO&SH=$RGVSU'U/R&DLOUG MSY3#9^JE<1< )[6%)R2%2C_RL1U0;(+;H.YMMEY"&'9U,P=MC_5[<*^J CGY M X5">?;YRSI+'8SYNG6E[[XX[0*XFM\#J=\!$4@(MMG89XH<3SD:_VH4TN">/P.Y )%V98?@<"HHSS8@O1BA<2G+?KD*)AZZL?$UH^N1[/ M_(_IMU*I<^/W:M @31QA?H9IJ?-CL#O$J-OOD0$^B#YY>M9VI;0$9P4D06)X M(AA6 N/)>$&*\_ \?YH]_A+Y+V6B\^C-^A"=-H'Z]VI->=AT)\H5IK^/-L:W M(DCW61OM$#EH6!$0WAI.V1,MA/W0WP;3RYA?6X1:X]S-%8T.GQL2Y83&=X3M MZ\]@T&9H/QZQHE<^1L.BO^77F;3O@"8C^3)5B,^"Q<-4<18LN78%O 34HA)G M.6QH'B7_[\W=GEZ<40NE1=UZB'[NC?1B333DOR(W+[M\D]DNG@R5&?YT%AAA M42P)K?=QD.T"* K#S,5XD$:KCX[RC/:G+PXL95X9KRKL"/5%*BHIVG^%(;V, MYVZ*_?OF,&%5@^N/\]O.Y5T-8TY9,01O?C5:UA6[8,.RKLX**[O UV:[!YAD M-J@XU?Q&3+ZQ6]M2>YU\)UO+WZVH45O6DNW"80'%+#2GDD6(_[,N"LB/4:>A M['=8J[.L2O?F%G9GU0T[-RCBT)7:=NV;M V$^%%L57IQANM/B&_EQQW0(WB= MR; MNZ;<:RMY;J T>\-\EKZ2PJ9R4H%\[S= _F7 ,I+A"6;*YS*W19B73O<%,:?$ M[6J'WPZK#,[4<%6.3TEDN"G78,LX&]!4J0?8EWO*MC]1T)1$NO .R)_X!"X1 M#4'A=+[_!%Z58@F.GT:A(1+##9E/$)YGBJY6RE W[#ACW^:A-J?,1O$KK0+V M5B,-\]S8""I*OIHDLH#3'R69O,6W.S9Q=7+S,YWMCGY,8[RQ M\]8[_G:J5<5 ZU!H?OW"BK@WUR-Z B6$N\G,!V,5.NA@_N%?TR<^C!IBI,:+ M!6$?;"0W)%R9CNR5:9^$=1G/^S@6C 6O]A$T1P3XE9TO15;@08!T5B,C=^R1 M$P//4XN& '&LH8O#>9'&K+GMS&;_"KK?\Y5PP(VD5[SD_)">7(^H0CF1!QC?Z]:%T(UDU>2E MKEYN@'V1E0\M=OYXZ[2R\ 8M M3; G0O- ?P5/A[42?7P IS.[W \&2J^-;.K KP.U3"V4+%:Z9VEP\(3.YOI! MJ^#&P;ALK6[U9.S!"UFGNN;?UUJ=$!G,TQ8DZ&*>!"LKCF=:!3F(0KOCDW'& M9(,Z/!B+N3:6-WD^./O%CP?.0Q8ORH^-];6X/@]UK+XO^Q@WAY\I;AFMX8:X M\4P' GD:[P#X%79U'(-KX4-SR5T/#(/L6U82\%FZZN_Q?UMP8D_?E"?;SF14 M0JU_[*U[X '\_4, .]2)837Q0Q"WF"J@N/,5HVI^RA,N![EZ=E M/\:/MB''D]T6C^P;X5FHWNTPS;/> =F1'Q?:!=_!J'F0OLXN@+;T:.N<:TNVZ!1([?<4/ MQ7(F/.(?8]$3PQ)QUXE6)5@T51I+8S(W6FE3V5Z_]#]H9U=EY?I1,+4.!@9# MM(@R^?.W'GQXWHMOO82_"5>,'B?KL[P*&,CU Q-4!ET,2[=J5LK]^KW6H?)7 M?-O \]ZDWRGZ7V.?73>]LC!7_9P*K['8G#8$8%!K<$(87 QK,K/6S**WFX6$ MAU$R^0Y@7$W!6:4?7<6>6O(GZ="SFC\FSYH34E&-J+;^B?6.YWXP+;9AYL.O M9F&99=I5H153YYA8(D:II^>,(TU1"9V2\T_&F:!9"<-.Q8LJ^WY4_^WBXZ3W MY#V@[#"FX,XV:L\N:8;'O_E>15*N++<,#BZICU+4.5"HW!4HM$J>.AM_ MX>>W;JFP@7[IH:V?'0Y"E9 POO4CI2^/8KU+H2&V6$E_CU\-I_ MNOFE]N43Z9%W0CF-65M$Z*X1#$956#7IY>$*(J#6GU;%/Q1%AL?#)3#U?4Z= MRTQ[VPLM0/.L(M02O=_]HJO[E#O08!O9M#Y[F[:46=/&>7KTVZT--="?;2N^ MN!&+/#G[(*YX<@<4Z,4S'8D^B,;+!$-]]SZI0*!O8DKLE?J%:JI>_::=&5WO MDS:PDQVP#AY(*DU2#N;RQ4]SH>.N2_<;DTG7]3B7GT,2YY+!(" ^,JG.13J] MBBKM^DIC$']O9DE?BZ:I_^2$03OD,_^HP 2=(L.P78SB3_&%3 =Q[,=VI:U6 M"(2G/K+^IU]ZJC^DV+C&;,IO33(HTXA]:_K[%?)9[;C M>)Y,O;0CAFRUJK$$E?=C?"%K5F>W5X2S7[U:TZ=G7SZ?/S<9U)0R+T2^QGN] M_]%#2(<><&*AE?Z$5FG<0DG&Z!::V38I<'=U<5;[4-'V#0OE8&X., M5':3UW3S;UIO+%N&+$5AP1GC[]OTV,WJ*D98GLNV_DMQ"=*,4 MX'N]:7!3/-=2)Z]KM276N<\??8CY^X=J[:7T&I\K$VEG*8?0>):-0R)?OG;D MZ% H70*8((7-@ \ OLY(@4O58J7EO%TR>Y#<K7/B>,!_N/0NF<2?QAN' M^A7O/M^;0H-I"';K--2M*OK+#J@NGTH 3P&71V>9U<1"#ZQ_45-S&FUTL.L< MBY_M./.A5]LW^OG=Z^&7'T CB[21H".+7 /^Q"B^+JL+G.HE]H1*5AGP >#, M1-Z9X/6Z2"XRRO4P[-MBB9UO8YKVOUFZ%8SRHI>X3-)*.5E5-C+\/.NZ: M@OX).]&@3X05.LNE$[4/[D\GN)<4HQF+)(&;;,^$G1P@KM:;(J^D71\([3.( M1*8X/[ZZN^'U;3?'\!^UH*L77_^;T+D^H,YL7^H.2()G"E3,H @/ M[:M*TW BL_8^L]97(X/\#-EAZ'"Y8IJ=1$=BLF+5G<=W@]('4;F#C\R6'2:G M'28V9KX1RJ,'_A/GF;"]BIE)..4[005(3R!MJ,.E8G^C9'])<9&CQ\OJF_$V M%TJ2U-RDWE(;.I][7Q+DUU<\A1&^!A*X")8)H-!]-.AVD (<.B' F/,&7(9(8+2JPA12X@]9T7-FVCE>7I M(3C;M8,^HZM*8?F7/&W0MVM-GJP,&7Q6WU"]MC^YI\>A_V'^B@2;Z7FOM]69 MLP,2ZZ?F:LS. )UYQYY[DCUO_>[!2'97(DIV0+XIIV7OMP^U)/&'NX^WI\P5 MO,C317"N HKL^YP"P%M B/O[2GCP ;XDX,)YS-9(0[4C*G[\0&^ABX%9ET\$ M!T\H+=$[P_Z-HJJAQW:K1*+2*GP]C,N50WM1+:]_P@=CU#]-8$=1(UV6!P<(R(0]4"GYB4 MB12F?#[C)0_RAG>%TC!2B=,(VRXW]^?$T5PWN;U)$C5AZ=[Z]JH(F;*PVRXW M$XBO RDSJ68.*\MX%J0=(OQG!R1GQ23$N']Z0;)C]BLNFY6\BGB# (_71YX) M4L]#HNW4&S!F\..REA9U>WY:_GX4FL^R)P G2I,I07!E#W_RT>\\>!$5_'B% M=$79029X8X$MDAC:2=!=@=;($_:DG2:[F:KX'199M1.\)VL@G/5PEFD;NXF1 M=T/RS@,8N8]H%2<6N3GJ[:^]V*,?8^D>;D@SFUKDM_VH,QN'#'3GTZR]'/BB MJ0+2^<.FK/C.YJ0B.MP3XC$ZIWRP%G^!&X*-E-F>?3D+SOAQ"O@RV/PF7+X'IX1^SI..8+99Q=FAW,3>7R, M1* JU=&,OE$,R\46KP;X!P86D5QP=F*7O?1TO8]:[B\VA4R@^&+$&6)*2S%% MD.2CU.-FHZRZIM58%AE4QI2CA32ZROSZ<$%]+7\0F]V[.CCN6C3_XX?HP1JM M@_M34(K QZZ6890,"<(U 9P\!88W)0C,>97087_S,.=-GD5=#4K6CBG>&E[8 M&R _39LJRAV[;F(O/$*Z&TB(&ES];P _DS]M#!'BRP/W5_E*W/ 8/G0)+T.D MKYZ._9H M"EO<\O\;C9[US4J](0J31:9'J0 M2M)PP98I)0 %ZN">ZF._PEEC0EC?Z%0,*S\ MN"3EX.3'9.!C.YYU&9(,81$W<^47/N/WXSRFQ=GKJ493(M?J@90J -%^EX;. MKJ.]^#1277$S0*TF7?CK,X^)H&Q-7MEMF>A?-M,+E?QN@94G!0E.1RQ;HQ5U M$-MKST[H($KC#$>@&F%,Y>[#0<%AXA6*J[/^/JZQ&:H^YVU>MZG^8W-;/_[> MHSW7!,)T'2;6RYC21K@. M;/:97/65-\EJY&3^IDU8PKIN9\R[#K\]O7!#Q\N(>PO?:H:[,TND50BD00ZG M4MK*O$<6:F#9%+_5Z(!+XB/=VRAN@XC/9#,C@0\TZR]G(CA:<6:B"4BJY^#[: M)#YP+JUMC6D>^P_RJT;2 9VB%XH%=W)H?_+']3H:=T#OPQ.AX* H1AE,S7\' M)!E&3X*!A]7\58=6C6S8=]83#0ON3KNF>]_4EO18.7?.[FXYZ<9[$3R3"&CZ M"GRJV')+?$;+0F+]JC=BA+B)3C6GYDF.XBP?UHZ+XQM:6KW1AJG"'Z=:9;/$ M2F1?\3*85[Z8TFF^?+%B%G$&WV9>A;G(%LI3'UXGR>BE;F)6HL0=1U?VYMUZ M1J-[]=\12I]P0Z@&OF7.,9\FSAVKD8V+#AT6+)PP?0; O..=9E\F:/"T'63\ M\T2RJ&2#1E0R^3CP<.R_OLYR=6)8A654L4JW]GW4-.KC9/\1D)_B/K\>B_6] M^%8#\JF_G6;!)/L"GOX@[, 2@NW$>) _$Q1-OS)6'WG8I,T]]>U2_J(SPM!E MRV0T:+M<_48>=DYO'^Q64DXWB)O \05R(ME$SET /ZMSD3;=?Y4='K^Y&K T M30]_+M1H7//U5TZ2N97I'M77N[)7*[HI=U )T\: #FOL,UEXM IGI/Z$ =[M M1T,L&6?'#GHYO)MLO]%L*7.NG',CO;U;=WOEVTQG@26L]JSPW\N$_W/< ;(^ M_Z?W=+JO/E4%,9)CGQM<)3%7>7\[\P[W@RWI<)KYJ5:Y\O\+5^2"WB:#]O4) MW?Y[);+K_^0)0K>O_L_;AKL:G_[?KKG__\?_TV/7SL3_ E!+ P04 " "O M6'Q6-V!8(1,A "[)0 !P &\P,BYJ<&?==V507$NX[1X&=W<&@@0+)'AP M"Q @2$)P"T$'=W<27 ($"(2@P8*[NP8)/A#<@@8R@PXZEW/K29WSWI7W_KRZ MK[O6KJ[=O5=]JW?U]ZU&S:/6 &(5165% 0" 6_N.X!:!QXI>$.M $!-#> " M #[?HX/0+L?X=Z#]AZ DJNEI:.;C9,[@%H$Y $L# Q,#'0L3 Q,;"PL;%P2 M/%P<'%P*(F)\$FH*6AIJ"FHJ.@C[ SH&-@8J:F9>9C8.3NY'W+1,CP4><_&S MBIZ;G^C]NJ"Z !!L0!KN#0

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end

%80 M<,B,9:!X6<$ .+=$*.-WP^FTK[3 [OJ)_7-5.]8RI1H&DO]@,[/H.Q<.F4%. ME]R,Y?H+-/5$EB^37%?_9-WD>@[)EMK(H@&C@H*)^DHW31\Z +]W ! T@."Y M@+ !A%6AM;*JK"$U-$V47!-ELY'-+JK>5&BLA@GKXL0H?,H09]*OT@#Q _*! MC$0F"R!W= ,:PX$L2BE &$UD3NX (X4VDR'+3(3EY M>YJX!D59:C=K!%S7 H(# H:0G9'0?T\"+PCVP ?/A_O;%2ZWT5U11116&WR2H-(C^*/,]+W%57^Y[$L'<>=A.W5(:M MRO"H2OR"\?L4UBQRM30+J9AY)#]OH)B"^D7^D $5=$;)&%8@ED"NYFC8OX1] M-1U]H9TEE[JD&?0='!8:U J<]-T;/_8^[?/LEM-K>]-[N8,U1=PQQK\( MP]ZN@\](W%(9M2JCHRJ'N->T8=EA"T?"@!*4MR9.L%',;KO1>')ZU,NCK_Y? M+U^);*M+<=NE^.5>QCN;++X(_%TK=_,B/_RXZZ3;F:;V)+NA:LZ$)AQR1'IG MYTBAZM.A#HPLJP$[E0;'=;5Y9CDX(,HBD1B#JLX0!9)D&4FG\*3&M*J1VK(\WZ%\, M=\5E0@0,6/8SC672LRXM%,.4+#)YQU9?H>33UG@1RX3Y1:O"-O L%"V$9+1T M5AG0-"^^9%W6H>;@^D<<<.F =QU:1QR\TL$S1(O,#*TAD23LBDV::Q7'DJO=5/G)\#N3@%P/G:,[R(B$&(T(ERD(=#($2=),H'M8RP7) M3I7-PWB(3CZ>=FVI0FL .RK#](LP^$@8%Z-;ELM$H)L\AG@;P%8Y5XGC3>)] MW(@XA.@">>X9P@[&!Q(:_+N[VY".5]71,WBM(WCUZCVA>TYR0BW/E?!:\I6^12(#:MKQ^J1F?_ MXG3;GN?NZ+5OYN)6)\ [HMFUQY@"GYD>1:!(9U,\;]5JU09=F]=_9[VOVJ.B MFWF&*7JK6\)GJ?HG9C!5D,Y%H)+B1;]23"2;FR=_PJ1J(,PP42T><&V@]J=, M/?OE1 >HFL;P+U!+ P04 " "O6'Q6J__=DL$" ! " &0 'AL+W=O MTD[7\_VU!*TB3JI/8%_./NN^_SF3OB-1?WL@!0Z*$J MF1PXA5*+"]>5:0$5D6=\ 4SOS+FHB-)3D;MR(8!DUJDJ7>QYH5L1RIPDMFL3 MD<1\J4K*8"*07%85$8]#*/EZX/C.T\(MS0ME%MPD7I !OY7$EV8^[IU'>'<2 MPY9R>)AR002&ULK59;;],P%/XK5D!H2&6YAVVDD=9F$T@,IHV-!\2# MFYRVT1P[V.YE_Q[;R4);TFB5^I+X]GWGG,\^/HY7C#^).8!$ZY)0,;3F4E87 MMBVR.918G+(*J)J9,EYBJ;I\9HN* \X-J"2VYSB17>*"6DELQFYY$K.%) 6% M6X[$HBPQ?QX!8:NAY5HO W?%;"[U@)W$%9[!/5HAX! )C4#5K\EC($03:3<^--P M6JU)#=QLO[!?F]A5+!,L8,S(SR*7\Z%U9J$FT06BA;",G*!JP\* M:__&ZT6$#X'E[ %X#\%X+\!N _UI T "HTP=BM$A MQ1(G,61JME XF7QC$I ;H _H>P4]A=#]TP*N<"7=$<\FT"6[G: M^NN]^#OR>AE3R$Z1[PZ0YW@>>KA/TT1U0V7>B>GD/U3/L."NA MLWTZTR-9W-(I:G6*CI9KT?_!1&?GP4ZN]=H[] AUF?0#9R?7[(T*4 *?F4HJ MD$HH*NO+M1UMB_6EJ5$[XR-5Q.N:^X^F?@'<8#XKJ$ $IHK2.?VH?.)U5:T[ MDE6FSDR85%7+-.?J(0)<+U#S4Z9J3=/1!MJG3?(74$L#!!0 ( *]8?%8K MR%7(*@, $H2 - >&POJ9-(BN=(%-7:JYV%5:D:S"DB% M" >]7AP6E$LR'LEE<568*IBII30I.6]-@;M]S5+2CS^2P+F;J(REY.[D_:^E M,I?O G<_^G!TU+L[O=RWG]3 *0F]3L]?X/2LA_NU&.8ZWG5=+S^VCASQ&*-= M>&@V2L>$"48>OBR=9_-Q"85-4<:C7,FN-A%Q!AN=%BRXIR(E$RKX5'-@Y;3@ M8NW, S#,E% Z,+8IK)P^6*H'!_?=#/JE\5-PJ70=VT5P?Z?-\CU@,P.!7(A6 MX( XPWA44F.8EE=V4B^NC4^@H!G?KDNK<*[INC\X)QVAOMD@4Z4SIMLP?;(Q MC4>"Y2!'\_D"[D:5(8#&J,(.,D[G2M):PX;1#*S;&1/B!AZFG_F.[U6^5=<> M5%6V0RNH&3HW;@+^M[TYW]MN7^"L"\ M]W'OM"S%^K/@_^0=_G5BIO3YU]HKO^M["OVBHPN#E]C M<^(>NLCX+8A\$^4>'J3(L#D;MP[@G>.WM0;PFI.2'_!2);J@P73)A>&RF2UX MEC'YY!2V[@V=VA?E'?]V?<9RNA3FM@53THV_LXPOBZ1==0T;T:SJQM\@O7[< MOF/96%QF;,6R23/5\VD]#.S 1FTN(.PC5_7E1S".P_P(8%@<3 '&<2PLSO^4 MSQ#-QV&8MJ$7&:*<(\.T 0.+ Y'^;*_Q:N,=\GP?8#5]KD.P3/%.Q#+%]QH0_[X!(TG\U<;B .K M M8[$-\?!WK*SXDBJ"JF#7N"<21), 1ZT=^C<8SL3@P??WVPIR2*DL2/ .97 M$$48 D\CCF *0 .&1%%]#NZ=1^'FG J[7X_&CU!+ P04 " "O6'Q6EXJ[ M', 3 @ "P %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6 M!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV M)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA-/E_G;@2=&A(E@6FD7)TZ(= MI7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( M *]8?%80$.-":00 (,B / >&PO=V]R:V)O;VLN>&ULQ9I;;]LV%(#_ M"J&G#-AF2Z*="^H"6;QF 8K$J(/VL6 DVB9"D09)Y])?OT,*WJA:.NB+Z:=$ M%$5].I+.=TCKPZLVST]:/Y.W1BH[RS;.;:]&(UMM>,/LGWK+%>Q9:=,P!YMF M/;);PUEM-YR[1HZ*\7@Z:IA0V< MA!5/0@KW/LO"_Y)GI!%*-.('KV?9."-VHU__T4;\T,HQN:R,EG*6Y>V.K]PX M41TT+SWD(WNRH<6QIR\,0&;9= P#KH2Q+O0(XS-@?.'0N=W:.?U)2,?-G#E^ M:_1N*]3:#P-7,8HN(\1A_[<-XI7YE3#JU4I4?*ZK7<.5:^-HN/2 RF[$UF9$ ML8;/LGT7M0/<*(;F2L .=AR$T%2 M!)*>#'+I=!5!3A#(RXPE\'$"S E@7E>5WOEW9<'>&3 $ MS.L8$_7,D443,*> >:.;!EX2GW*>8SC,,?F1)1/@SOWSZ*D@9X<>,1TFE_S( M=@ET%T#WC1D#KT<'#!-*?F2C!+!+'S8N)229W\DM5]PP>?CH84K)C^R4-EV/ M@?,+9&EFJDW@F_,7+O6VB3$QJ>1)K.*U\DDH*',$Q/%.66?"@9V;CFDE3^&5 MW(OE3E6ZX>21O?$.'2:6/(59\C+<:QF*B 6#*487$)-*GL(JN=>*KPQA/[CY M,V>V0UA@0BE2""6?A-=Z[?M"$/OG+04FE.+(0HGJA;WZ?"P74#U6W?M=H-.7 M%&H9*G6^%S$FYI@BA6.&BITN)F:<(H5QAHJ=+B9FG"*%<0[J"7+VZ%'M;S$F M9IPBA7'BPJ*7$)--D4(V0Q5&]WYCUBF26&>@PNAB8NXIDKCG9W7WW?02$U"9 M1$ ]#F])8TQ,0&6*&X/BA;02LU"9PD(].N]YTS$+ ME2DL=(@)T=TPM>8Q)F:A,H6%^C#;<,:+Y9B%: H+]6%^XV*]B=@SCA/,Z;%+,0//@@*FC1NNWB\ M7%FU_:')EV6_#EVSW#7K&'0RF8;^YXSJ9?9SYFAQ[N)?)K:KU7897]OEYR$> M\R^#PU?;[](FQER-%DV_CGE>A=/^?CJ%ZT'&E\G5Z.UC7O5O'U*%TD$*05H^ MR"#(R@BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJ MK01Z&^IM!'H;ZFT$>AOJ;01ZVV"SA$!O0[V-0&]#O8U ;T.]C4!O0[V-0&]# MO8U ;T.]C4!O1[V=0&]'O9U ;T>]G4!O1[V=0&\?;'83Z.VHMQ/H[:BW$^CM MJ+<3Z.VHMQ/H[:BW$^A=H]XU@=XUZEW_I]XIG_UW7VSI;#)^VUGRO6U5UGZ2+$.P#XSY;$F5 M]JFQ5,>1N7&5#O'1+9C5V4HOB(G!8,0R4P>J0S\T-9+I^(GF>EV&WO,VOO:% MJ2>)H](GON[ M,:N__CG:W--*%_4QG[5_H*>?4$L! A0#% @ KUA\5@=!36*! L0 M ! ( ! &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4 M" "O6'Q6[NS;/N\ K @ $0 @ &O 9&]C4')O<',O M8V]R92YX;6Q02P$"% ,4 " "O6'Q6F5R<(Q & "<)P $P M @ '- 0 >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( *]8?%9U MIY:/!0< #,M 8 " @0X( !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% @ MKUA\5O16B;^: @ I@@ !@ ("!Y!, 'AL+W=OP#7L6@% "/' & @(%.&P >&PO=V]R M:W-H965T&UL4$L! A0#% @ KUA\5MB,3Y*0!0 :A4 M !@ ("![" 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ KUA\5FYTSQ$H#P &BH !@ ("! MQBT 'AL+W=O&UL4$L! A0#% @ KUA\5LN=P+*T @ VP4 !D M ("!'4 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ KUA\5B*<=5 L P _@8 !D ("!FDT 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ KUA\ M5I83/>U_! 2 H !D ("!+E< 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ KUA\5A9H))N6 @ >P4 M !D ("![V, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ KUA\5O76VKJP @ V@4 !D M ("!$WH 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ KUA\5N#2X:LA! E@H !D ("!;8( 'AL+W=O M&PO=V]R:W-H965TF) M !X;"]W;W)K&UL4$L! A0#% @ KUA\5I?I MA#&0 @ @04 !D ("!Q8P 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ KUA\5G,$U/FJ @ 708 !D M ("!?I8 'AL+W=O&PO M=V]R:W-H965T< !X;"]W;W)K&UL4$L! A0#% @ KUA\5B*L)"M+ @ L04 !D ("! MMYX 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ KUA\5H%@0KSE%@ ^)&PO=V]R:W-H965TJ:R 0< #4] 9 " @<+$ !X M;"]W;W)K&UL4$L! A0#% @ KUA\5E7-OU0? M P UP@ !D ("!^LL 'AL+W=OVH$ "0%P &0 M@(%0SP >&PO=V]R:W-H965T&UL4$L! A0#% @ KUA\5KT2QDJK @ 7@< !D M ("!_M8 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ KUA\5KU!%81+ @ '08 !D ("!S=\ M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MKUA\5JO_W9+! @ 0 @ !D ("!;.@ 'AL+W=O&PO=V]R:W-H965T : " 2'W !X;"]? M 3 " 2+Y !;0V]N=&5N=%]4>7!E&UL4$L%!@ 0 [ #L %! !;[ $! end XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 108 199 1 false 37 0 false 9 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Basis of Presentation and Business Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-1-basis-of-presentation-and-business Note 1 - Basis of Presentation and Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Going Concern Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern Note 2 - Going Concern Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Summary of Significant Accounting Policies Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies- Note 3 - Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets Note 4 - Prepaid Expenses and Other Current Assets Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses Note 5 - Accounts Payable and Accrued Expenses Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Common Stock Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock Note 6 - Common Stock Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Stock Options Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options Note 7 - Stock Options Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Warrants Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants Note 8 - Warrants Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Selling, General and Administrative Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative Note 9 - Selling, General and Administrative Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Research and Development Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development Note 10 - Research and Development Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Financial Instruments and Risks Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks- Note 11 - Financial Instruments and Risks Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Income Taxes Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes Note 12 - Income Taxes Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Related Parties Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties Note 13 - Related Parties Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Operating Leases Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases Note 14 - Operating Leases Notes 20 false false R21.htm 020 - Disclosure - Note 15 - Segmented Information Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-15-segmented-information Note 15 - Segmented Information Notes 21 false false R22.htm 021 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies- 22 false false R23.htm 022 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Tables) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-tables Note 3 - Summary of Significant Accounting Policies (Tables) Tables http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies- 23 false false R24.htm 023 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables Note 4 - Prepaid Expenses and Other Current Assets (Tables) Tables http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets 24 false false R25.htm 024 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses (Tables) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables Note 5 - Accounts Payable and Accrued Expenses (Tables) Tables http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses 25 false false R26.htm 025 - Disclosure - Note 7 - Stock Options (Tables) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables Note 7 - Stock Options (Tables) Tables http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options 26 false false R27.htm 026 - Disclosure - Note 8 - Warrants (Tables) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-tables Note 8 - Warrants (Tables) Tables http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants 27 false false R28.htm 027 - Disclosure - Note 9 - Selling, General and Administrative (Tables) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-tables Note 9 - Selling, General and Administrative (Tables) Tables http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative 28 false false R29.htm 028 - Disclosure - Note 10 - Research and Development (Tables) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-tables Note 10 - Research and Development (Tables) Tables http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development 29 false false R30.htm 029 - Disclosure - Note 12 - Income Taxes (Tables) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-tables Note 12 - Income Taxes (Tables) Tables http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes 30 false false R31.htm 030 - Disclosure - Note 13 - Related Parties (Tables) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-tables Note 13 - Related Parties (Tables) Tables http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties 31 false false R32.htm 031 - Disclosure - Note 2 - Going Concern (Details Textual) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern-details-textual Note 2 - Going Concern (Details Textual) Details http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern 32 false false R33.htm 032 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual Note 3 - Summary of Significant Accounting Policies (Details Textual) Details http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-tables 33 false false R34.htm 033 - Disclosure - Note 3 - Summary of Significant Accounting Policies - Summary of Subsidiary (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details Note 3 - Summary of Significant Accounting Policies - Summary of Subsidiary (Details) Details 34 false false R35.htm 034 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Details 35 false false R36.htm 035 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Details 36 false false R37.htm 036 - Disclosure - Note 6 - Common Stock (Details Textual) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual Note 6 - Common Stock (Details Textual) Details http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock 37 false false R38.htm 037 - Disclosure - Note 7 - Stock Options (Details Textual) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual Note 7 - Stock Options (Details Textual) Details http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables 38 false false R39.htm 038 - Disclosure - Note 7 - Stock Options - Changes in Options (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details Note 7 - Stock Options - Changes in Options (Details) Details 39 false false R40.htm 039 - Disclosure - Note 7 - Stock Options - Details of Options Outstanding (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details Note 7 - Stock Options - Details of Options Outstanding (Details) Details 40 false false R41.htm 040 - Disclosure - Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details) Details 41 false false R42.htm 041 - Disclosure - Note 8 - Warrants - Schedule of Warrants (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details Note 8 - Warrants - Schedule of Warrants (Details) Details 42 false false R43.htm 042 - Disclosure - Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) Details 43 false false R44.htm 043 - Disclosure - Note 10 - Research and Development - Research and Development (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details Note 10 - Research and Development - Research and Development (Details) Details 44 false false R45.htm 044 - Disclosure - Note 11 - Financial Instruments and Risks (Details Textual) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-details-textual Note 11 - Financial Instruments and Risks (Details Textual) Details http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks- 45 false false R46.htm 045 - Disclosure - Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) Details 46 false false R47.htm 046 - Disclosure - Note 12 - Income Taxes - Net Deferred Tax Assets (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details Note 12 - Income Taxes - Net Deferred Tax Assets (Details) Details 47 false false R48.htm 047 - Disclosure - Note 12 - Income Taxes - Components of Temporary Difference (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details Note 12 - Income Taxes - Components of Temporary Difference (Details) Details 48 false false R49.htm 048 - Disclosure - Note 13 - Related Parties (Details Textual) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual Note 13 - Related Parties (Details Textual) Details http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-tables 49 false false R50.htm 049 - Disclosure - Note 13 - Related Parties - Related Party Expenses (Details) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details Note 13 - Related Parties - Related Party Expenses (Details) Details 50 false false R51.htm 050 - Disclosure - Note 14 - Operating Leases (Details Textual) Sheet http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual Note 14 - Operating Leases (Details Textual) Details http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases 51 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 10 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. ovtz20221231_10k.htm 94, 6767, 6768, 6769, 6773 [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. ovtz20221231_10k.htm 4092 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 84 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, dei:EntityRegistrantName, ovtz:ClassOfWarrantOfRightStockPriceTrigger, ovtz:ClassOfWarrantOrRightThresholdConsecutiveTradingDays, ovtz:EquityOfferingNumberOfCommonSharesPerUnit, ovtz:EquityOfferingNumberOfWarrantsPerUnit, ovtz:EquityOfferingPricePerUnitIssued, ovtz:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue, ovtz:SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved, us-gaap:AllocatedShareBasedCompensationExpense, us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1, us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight, us-gaap:CommonStockNoParValue, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:EarningsPerShareBasic, us-gaap:PaymentsOfStockIssuanceCosts, us-gaap:PreferredStockNoParValue, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:ProceedsFromIssuanceOrSaleOfEquity, us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice - ovtz20221231_10k.htm 8, 10, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94 ovtz20221231_10k.htm ex_491983.htm ex_491984.htm ex_491985.htm ex_491986.htm ovtz-20221231.xsd ovtz-20221231_cal.xml ovtz-20221231_def.xml ovtz-20221231_lab.xml ovtz-20221231_pre.xml o01.jpg o02.jpg o03.jpg ovtz20221231_10kimg001.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ovtz20221231_10k.htm": { "axisCustom": 0, "axisStandard": 14, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 430, "http://xbrl.sec.gov/dei/2022": 33 }, "contextCount": 108, "dts": { "calculationLink": { "local": [ "ovtz-20221231_cal.xml" ] }, "definitionLink": { "local": [ "ovtz-20221231_def.xml" ] }, "inline": { "local": [ "ovtz20221231_10k.htm" ] }, "labelLink": { "local": [ "ovtz-20221231_lab.xml" ] }, "presentationLink": { "local": [ "ovtz-20221231_pre.xml" ] }, "schema": { "local": [ "ovtz-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 312, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 70, "http://www.oculusvisiontech.com/20221231": 12, "http://xbrl.sec.gov/dei/2022": 6, "total": 88 }, "keyCustom": 33, "keyStandard": 166, "memberCustom": 22, "memberStandard": 14, "nsprefix": "ovtz", "nsuri": "http://www.oculusvisiontech.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets", "menuCat": "Notes", "order": "10", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "shortName": "Note 4 - Prepaid Expenses and Other Current Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses", "menuCat": "Notes", "order": "11", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses", "shortName": "Note 5 - Accounts Payable and Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Note 6 - Common Stock", "menuCat": "Notes", "order": "12", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "shortName": "Note 6 - Common Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Note 7 - Stock Options", "menuCat": "Notes", "order": "13", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "shortName": "Note 7 - Stock Options", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:ClassOfWarrantOrRightTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Note 8 - Warrants", "menuCat": "Notes", "order": "14", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants", "shortName": "Note 8 - Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:ClassOfWarrantOrRightTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Note 9 - Selling, General and Administrative", "menuCat": "Notes", "order": "15", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative", "shortName": "Note 9 - Selling, General and Administrative", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Note 10 - Research and Development", "menuCat": "Notes", "order": "16", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development", "shortName": "Note 10 - Research and Development", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Note 11 - Financial Instruments and Risks", "menuCat": "Notes", "order": "17", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-", "shortName": "Note 11 - Financial Instruments and Risks", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Note 12 - Income Taxes", "menuCat": "Notes", "order": "18", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes", "shortName": "Note 12 - Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Note 13 - Related Parties", "menuCat": "Notes", "order": "19", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "shortName": "Note 13 - Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Note 14 - Operating Leases", "menuCat": "Notes", "order": "20", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases", "shortName": "Note 14 - Operating Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Note 15 - Segmented Information", "menuCat": "Notes", "order": "21", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-15-segmented-information", "shortName": "Note 15 - Segmented Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "22", "role": "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-tables", "shortName": "Note 3 - Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "shortName": "Note 4 - Prepaid Expenses and Other Current Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "shortName": "Note 5 - Accounts Payable and Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Note 7 - Stock Options (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables", "shortName": "Note 7 - Stock Options (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ovtz:ClassOfWarrantOrRightTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:ScheduleOfWarrantsOrRightTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Note 8 - Warrants (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-tables", "shortName": "Note 8 - Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ovtz:ClassOfWarrantOrRightTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:ScheduleOfWarrantsOrRightTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Note 9 - Selling, General and Administrative (Tables)", "menuCat": "Tables", "order": "28", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-tables", "shortName": "Note 9 - Selling, General and Administrative (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Note 10 - Research and Development (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-tables", "shortName": "Note 10 - Research and Development (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ovtz:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)", "menuCat": "Statements", "order": "3", "role": "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals", "shortName": "Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Note 12 - Income Taxes (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-tables", "shortName": "Note 12 - Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Note 13 - Related Parties (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-tables", "shortName": "Note 13 - Related Parties (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Note 2 - Going Concern (Details Textual)", "menuCat": "Details", "order": "32", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern-details-textual", "shortName": "Note 2 - Going Concern (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "lang": null, "name": "ovtz:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Note 3 - Summary of Significant Accounting Policies (Details Textual)", "menuCat": "Details", "order": "33", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "shortName": "Note 3 - Summary of Significant Accounting Policies (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis-EmployeeStockOptionMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock", "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31_OwnershipAxis-ComplytrustIncMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Note 3 - Summary of Significant Accounting Policies - Summary of Subsidiary (Details)", "menuCat": "Details", "order": "34", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details", "shortName": "Note 3 - Summary of Significant Accounting Policies - Summary of Subsidiary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock", "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31_OwnershipAxis-ComplytrustIncMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)", "menuCat": "Details", "order": "35", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "shortName": "Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details)", "menuCat": "Details", "order": "36", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "shortName": "Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ovtz:CommonStockSharesHeldInEscrow", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Note 6 - Common Stock (Details Textual)", "menuCat": "Details", "order": "37", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual", "shortName": "Note 6 - Common Stock (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ovtz:CommonStockSharesHeldInEscrow", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Note 7 - Stock Options (Details Textual)", "menuCat": "Details", "order": "38", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "shortName": "Note 7 - Stock Options (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-30_PlanNameAxis-RollingStockOptionPlanMember", "decimals": "1", "lang": null, "name": "ovtz:SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Note 7 - Stock Options - Changes in Options (Details)", "menuCat": "Details", "order": "39", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details", "shortName": "Note 7 - Stock Options - Changes in Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ovtz:ConsultingExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Consolidated Statements of Operations and Comprehensive Loss", "menuCat": "Statements", "order": "4", "role": "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "shortName": "Consolidated Statements of Operations and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ovtz:ConsultingExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "USDPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Note 7 - Stock Options - Details of Options Outstanding (Details)", "menuCat": "Details", "order": "40", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "shortName": "Note 7 - Stock Options - Details of Options Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis-RangeOneMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "CADPerShare", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details)", "menuCat": "Details", "order": "41", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "shortName": "Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31_AwardTypeAxis-EmployeeStockOptionMember", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfWarrantsOrRightTableTextBlock", "ovtz:ClassOfWarrantOrRightTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Note 8 - Warrants - Schedule of Warrants (Details)", "menuCat": "Details", "order": "42", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details", "shortName": "Note 8 - Warrants - Schedule of Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfWarrantsOrRightTableTextBlock", "ovtz:ClassOfWarrantOrRightTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ovtz:FilingAndRegulatoryFee", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details)", "menuCat": "Details", "order": "43", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "shortName": "Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ovtz:FilingAndRegulatoryFee", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ovtz:ResearchAndDevelopmentExpenseProjectManagement", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Note 10 - Research and Development - Research and Development (Details)", "menuCat": "Details", "order": "44", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details", "shortName": "Note 10 - Research and Development - Research and Development (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfResearchAndDevelopmentExpensesTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ovtz:ResearchAndDevelopmentExpenseProjectManagement", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Note 11 - Financial Instruments and Risks (Details Textual)", "menuCat": "Details", "order": "45", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-details-textual", "shortName": "Note 11 - Financial Instruments and Risks (Details Textual)", "subGroupType": "details", "uniqueAnchor": null }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Note 12 - Income Taxes - Reconciliation of Income Taxes (Details)", "menuCat": "Details", "order": "46", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "shortName": "Note 12 - Income Taxes - Reconciliation of Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Note 12 - Income Taxes - Net Deferred Tax Assets (Details)", "menuCat": "Details", "order": "47", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details", "shortName": "Note 12 - Income Taxes - Net Deferred Tax Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Note 12 - Income Taxes - Components of Temporary Difference (Details)", "menuCat": "Details", "order": "48", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details", "shortName": "Note 12 - Income Taxes - Components of Temporary Difference (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - Note 13 - Related Parties (Details Textual)", "menuCat": "Details", "order": "49", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual", "shortName": "Note 13 - Related Parties (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31_IncomeStatementLocationAxis-ResearchAndDevelopmentExpenseMember", "decimals": "-3", "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2020-12-31_StatementEquityComponentsAxis-CommonStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Consolidated Statements of Stockholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "i_2020-12-31_StatementEquityComponentsAxis-CommonStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Share", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - Note 13 - Related Parties - Related Party Expenses (Details)", "menuCat": "Details", "order": "50", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details", "shortName": "Note 13 - Related Parties - Related Party Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31_IncomeStatementLocationAxis-SellingGeneralAndAdministrativeExpensesMember", "decimals": "INF", "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "ovtz:ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "ovtz:SellingGeneralAndAdministrativeDisclosureTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - Note 14 - Operating Leases (Details Textual)", "menuCat": "Details", "order": "51", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual", "shortName": "Note 14 - Operating Leases (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31_LeaseContractualTermAxis-VancouverCAOperatingLeaseMember", "decimals": "INF", "lang": null, "name": "ovtz:OperatingLeasesMonthlyRentExpense", "reportCount": 1, "unique": true, "unitRef": "CAD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - Note 1 - Basis of Presentation and Business", "menuCat": "Notes", "order": "7", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-1-basis-of-presentation-and-business", "shortName": "Note 1 - Basis of Presentation and Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Note 2 - Going Concern", "menuCat": "Notes", "order": "8", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern", "shortName": "Note 2 - Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Note 3 - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "9", "role": "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-", "shortName": "Note 3 - Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ovtz20221231_10k.htm", "contextRef": "d_2022-01-01_2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 37, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r312", "r313", "r314" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r312", "r313", "r314" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r312", "r313", "r314" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r312", "r313", "r314" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information", "http://www.oculusvisiontech.com/20221231/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-15-segmented-information", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r312", "r313", "r314" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information", "http://www.oculusvisiontech.com/20221231/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-15-segmented-information", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "ovtz_AdjustmentsToAdditionalPaidInCapitalStockIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "ovtz_AdjustmentsToAdditionalPaidInCapitalStockIssuanceCosts", "negatedLabel": "Share issuance costs \u2013 cash" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuanceCosts", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "monetaryItemType" }, "ovtz_ClassOfWarrantOfRightStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained for the conversion of warrant or right to be accelerated", "label": "ovtz_ClassOfWarrantOfRightStockPriceTrigger", "terseLabel": "Class of Warrant of Right, Stock Price Trigger (in CAD per share)" } } }, "localname": "ClassOfWarrantOfRightStockPriceTrigger", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "perShareItemType" }, "ovtz_ClassOfWarrantOrRightExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights exercisable.", "label": "ovtz_ClassOfWarrantOrRightExercisable", "verboseLabel": "Number of warrants exercisable (in shares)" } } }, "localname": "ClassOfWarrantOrRightExercisable", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "sharesItemType" }, "ovtz_ClassOfWarrantOrRightGrantedAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of warrants.", "label": "Granted, Aggregate Intrinsic Value" } } }, "localname": "ClassOfWarrantOrRightGrantedAggregateIntrinsicValue", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "monetaryItemType" }, "ovtz_ClassOfWarrantOrRightGrantsInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or right granted.", "label": "Granted, warrants (in shares)" } } }, "localname": "ClassOfWarrantOrRightGrantsInPeriod", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "sharesItemType" }, "ovtz_ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share of class of warrant or right granted.", "label": "Granted, weighted average exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "perShareItemType" }, "ovtz_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of warrants.", "label": "ovtz_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue", "periodEndLabel": "Warrants outstanding, Aggregate Intrinsic Value", "periodStartLabel": "Warrants outstanding, Aggregate Intrinsic Value" } } }, "localname": "ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "monetaryItemType" }, "ovtz_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price of class of warrant or right outstanding.", "label": "ovtz_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Warrants outstanding, weighted average exercise price (in dollars per share)", "periodStartLabel": "Warrants outstanding, weighted average exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "perShareItemType" }, "ovtz_ClassOfWarrantOrRightRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining contractual term of class of warrant or right.", "label": "ovtz_ClassOfWarrantOrRightRemainingContractualTerm", "verboseLabel": "Remaining contractual life (Year)" } } }, "localname": "ClassOfWarrantOrRightRemainingContractualTerm", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "durationItemType" }, "ovtz_ClassOfWarrantOrRightTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for warrant or right.", "label": "Class of Warrant or Right [Text Block]" } } }, "localname": "ClassOfWarrantOrRightTextBlock", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants" ], "xbrltype": "textBlockItemType" }, "ovtz_ClassOfWarrantOrRightThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of warrant or right must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "ovtz_ClassOfWarrantOrRightThresholdConsecutiveTradingDays", "terseLabel": "Class of Warrant or Right, Threshold Consecutive Trading Days" } } }, "localname": "ClassOfWarrantOrRightThresholdConsecutiveTradingDays", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "integerItemType" }, "ovtz_CommitmentToIssueSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents commitment to issue shares.", "label": "Commitment to Issue Shares [Member]" } } }, "localname": "CommitmentToIssueSharesMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "domainItemType" }, "ovtz_CommonStockSharesHeldInEscrow": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of common stock held in escrow.", "label": "ovtz_CommonStockSharesHeldInEscrow", "terseLabel": "Common Stock, Shares Held in Escrow (in shares)" } } }, "localname": "CommonStockSharesHeldInEscrow", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "ovtz_ComplytrustIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents ComplyTrust Inc.", "label": "ComplyTrust Inc. [Member]" } } }, "localname": "ComplytrustIncMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details" ], "xbrltype": "domainItemType" }, "ovtz_ConsultingExpense": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred for consultation.", "label": "Consulting" } } }, "localname": "ConsultingExpense", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "xbrltype": "monetaryItemType" }, "ovtz_EmployeeStockOptionExpirationDateOfDecember212023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents stock option with an expiration date of December 21, 2023.", "label": "Employee Stock Option, Expiration Date of December 21, 2023 [Member]" } } }, "localname": "EmployeeStockOptionExpirationDateOfDecember212023Member", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EmployeeStockOptionExpirationDateOfJanuary292024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents stock option with an expiration date of January 29, 2024.", "label": "Employee Stock Option, Expiration Date of January 29, 2024 [Member]" } } }, "localname": "EmployeeStockOptionExpirationDateOfJanuary292024Member", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EmployeeStockOptionExpirationDateOfJanuary312025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents stock option with an expiration date of January 31, 2025.", "label": "Employee Stock Option, Expiration Date of January 31, 2025 [Member]" } } }, "localname": "EmployeeStockOptionExpirationDateOfJanuary312025Member", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EmployeeStockOptionExpirationDateOfJuly212023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents stock option with an expiration date of July 21, 2023.", "label": "Employee Stock Option, Expiration Date of July 21, 2023 [Member]" } } }, "localname": "EmployeeStockOptionExpirationDateOfJuly212023Member", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EmployeeStockOptionExpirationDateOfJune102024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents stock option with an expiration date of June 10, 2024.", "label": "Employee Stock Option, Expiration Date of June10, 2024 [Member]" } } }, "localname": "EmployeeStockOptionExpirationDateOfJune102024Member", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EmployeeStockOptionExpirationDateOfOctober142024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents Employee Stock Option, Expiration Date of October 14, 2024. .", "label": "Employee Stock Option, Expiration Date of October 14, 2024 [Member]" } } }, "localname": "EmployeeStockOptionExpirationDateOfOctober142024Member", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_EquityOfferingNumberOfCommonSharesPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of common shares per unit in the equity offering.", "label": "ovtz_EquityOfferingNumberOfCommonSharesPerUnit", "terseLabel": "Equity Offering, Number of Common Shares Per Unit (in shares)" } } }, "localname": "EquityOfferingNumberOfCommonSharesPerUnit", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "ovtz_EquityOfferingNumberOfUnitsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of units issued during the period in the equity offering.", "label": "ovtz_EquityOfferingNumberOfUnitsIssued", "terseLabel": "Equity Offering, Number of Units Issued (in shares)" } } }, "localname": "EquityOfferingNumberOfUnitsIssued", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "ovtz_EquityOfferingNumberOfWarrantsPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of warrant per unit in the equity offering.", "label": "ovtz_EquityOfferingNumberOfWarrantsPerUnit", "terseLabel": "Equity Offering, Number of Warrants Per Unit (in shares)" } } }, "localname": "EquityOfferingNumberOfWarrantsPerUnit", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "ovtz_EquityOfferingPricePerUnitIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The price per unit issued in the equity offering.", "label": "ovtz_EquityOfferingPricePerUnitIssued", "terseLabel": "Equity Offering, Price Per Unit Issued (in CAD per share)" } } }, "localname": "EquityOfferingPricePerUnitIssued", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "perShareItemType" }, "ovtz_FilingAndRegulatoryFee": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": 2.0, "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenditures for filing and regulatory.", "label": "Filing and regulatory fees" } } }, "localname": "FilingAndRegulatoryFee", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "ovtz_GainsLossesOnCommitmentToIssueShares": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) related to the commitment to issue shares.", "label": "Gain on reduction of commitment to issue shares (Note 6)", "negatedLabel": "Gain on reduction of commitment to issue shares", "terseLabel": "Gains (Losses) on Commitment to Issue Shares" } } }, "localname": "GainsLossesOnCommitmentToIssueShares", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "monetaryItemType" }, "ovtz_IncomeTaxRateReconciliationChangeInUnrecognizedDeductibleTemporary": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "order": 0.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to change in unrecognized deductible temporary.", "label": "Change in unrecognized deductible temporary" } } }, "localname": "IncomeTaxRateReconciliationChangeInUnrecognizedDeductibleTemporary", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "xbrltype": "monetaryItemType" }, "ovtz_IncomeTaxRateReconciliationExpectedIncomeTaxRecovery": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to expected income tax (recovery).", "label": "Expected income tax (recovery)" } } }, "localname": "IncomeTaxRateReconciliationExpectedIncomeTaxRecovery", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "xbrltype": "monetaryItemType" }, "ovtz_NoteToFinancialStatementDetailsTextual": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note To Financial Statement Details Textual" } } }, "localname": "NoteToFinancialStatementDetailsTextual", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_NotesToFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes To Financial Statements [Abstract]" } } }, "localname": "NotesToFinancialStatementsAbstract", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_OperatingLeasesMonthlyRentExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of monthly rent expense incurred under the operating lease.", "label": "ovtz_OperatingLeasesMonthlyRentExpense", "terseLabel": "Operating Leases, Monthly Rent Expense" } } }, "localname": "OperatingLeasesMonthlyRentExpense", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual" ], "xbrltype": "monetaryItemType" }, "ovtz_RangeFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents range five.", "label": "Range Five [Member]" } } }, "localname": "RangeFiveMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "domainItemType" }, "ovtz_RangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents range four.", "label": "Range Four [Member]" } } }, "localname": "RangeFourMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "domainItemType" }, "ovtz_RangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents range one.", "label": "Range One [Member]" } } }, "localname": "RangeOneMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "domainItemType" }, "ovtz_RangeSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the range six.", "label": "Range Six [Member]" } } }, "localname": "RangeSixMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "domainItemType" }, "ovtz_RangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents range three.", "label": "Range Three [Member]" } } }, "localname": "RangeThreeMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "domainItemType" }, "ovtz_RangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents range two.", "label": "Range Two [Member]" } } }, "localname": "RangeTwoMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "domainItemType" }, "ovtz_ReductionOfCommitmentToIssueShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents a reduction of the commitment to issue shares.", "label": "Reduction of commitment to issue shares" } } }, "localname": "ReductionOfCommitmentToIssueShares", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "monetaryItemType" }, "ovtz_ReimbursementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the related party transaction for reimbursement.", "label": "Reimbursement [Member]" } } }, "localname": "ReimbursementMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_ResearchAndDevelopmentExpenseBusinessDevelopment": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details": { "order": 1.0, "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Research and development expense during the period related to business development.", "label": "Business development" } } }, "localname": "ResearchAndDevelopmentExpenseBusinessDevelopment", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details" ], "xbrltype": "monetaryItemType" }, "ovtz_ResearchAndDevelopmentExpensePayroll": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details": { "order": 0.0, "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Research and development expense during the period related to payroll.", "label": "Payroll" } } }, "localname": "ResearchAndDevelopmentExpensePayroll", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details" ], "xbrltype": "monetaryItemType" }, "ovtz_ResearchAndDevelopmentExpenseProjectManagement": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details": { "order": 3.0, "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Research and development expense during the period related to project management.", "label": "Project management" } } }, "localname": "ResearchAndDevelopmentExpenseProjectManagement", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details" ], "xbrltype": "monetaryItemType" }, "ovtz_RollingStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related to the Rolling Stock Option Plan.", "label": "Rolling Stock Option Plan [Member]" } } }, "localname": "RollingStockOptionPlanMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of research and development expenses.", "label": "Schedule of Research and Development Expenses [Table Text Block]" } } }, "localname": "ScheduleOfResearchAndDevelopmentExpensesTableTextBlock", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-tables" ], "xbrltype": "textBlockItemType" }, "ovtz_ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of selling, general and administrative expenses.", "label": "Schedule of Selling, General and Administrative Expenses [Table Text Block]" } } }, "localname": "ScheduleOfSellingGeneralAndAdministrativeExpensesTableTextBlock", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-tables" ], "xbrltype": "textBlockItemType" }, "ovtz_ScheduleOfWarrantsOrRightTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's warrants or rights.", "label": "Schedule of Warrants or Right [Table Text Block]" } } }, "localname": "ScheduleOfWarrantsOrRightTableTextBlock", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-tables" ], "xbrltype": "textBlockItemType" }, "ovtz_SellingGeneralAndAdministrativeDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for selling, general and administrative expenses.", "label": "Selling, General and Administrative Disclosure [Text Block]" } } }, "localname": "SellingGeneralAndAdministrativeDisclosureTextBlock", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative" ], "xbrltype": "textBlockItemType" }, "ovtz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the fair value of options under the share-based compensation.", "label": "ovtz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "monetaryItemType" }, "ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percent of issued and outstanding common shares reserved in a share-based compensation.", "label": "ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved", "terseLabel": "Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved" } } }, "localname": "SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "percentItemType" }, "ovtz_SharebasedCompensationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents share-based compensation.", "label": "Share-based Compensation [Member]" } } }, "localname": "SharebasedCompensationMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details" ], "xbrltype": "domainItemType" }, "ovtz_VancouverCAOperatingLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the operating lease for the Vancouver, Candada location.", "label": "Vancouver, CA Operating Lease [Member]" } } }, "localname": "VancouverCAOperatingLeaseMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_VestingEverySixMonthsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the options vested every 6 months.", "label": "Vesting Every Six Months [Member]" } } }, "localname": "VestingEverySixMonthsMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_WarrantsExpiringOnApril192023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents warrants expiring on April 19, 2023.", "label": "Warrants Expiring on April 19, 2023 [Member]" } } }, "localname": "WarrantsExpiringOnApril192023Member", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "domainItemType" }, "ovtz_WarrantsExpiringOnJune42025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents warrants expiring on June 4, 2025.", "label": "Warrants Expiring on June 4, 2025 [Member]" } } }, "localname": "WarrantsExpiringOnJune42025Member", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "domainItemType" }, "ovtz_WarrantsIssuedInConnectionWithPrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the warrants issued in connection with the private placement.", "label": "Warrants Issued in Connection with Private Placement [Member]" } } }, "localname": "WarrantsIssuedInConnectionWithPrivatePlacementMember", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "ovtz_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of difference between Current Assets and Current Liabilities.", "label": "ovtz_WorkingCapitalDeficit", "terseLabel": "Working Capital (Deficit)" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://www.oculusvisiontech.com/20221231", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern-details-textual" ], "xbrltype": "monetaryItemType" }, "ovtz_statement-statement-note-10-research-and-development-research-and-development-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 10 - Research and Development - Research and Development (Details)" } } }, "localname": "statement-statement-note-10-research-and-development-research-and-development-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-10-research-and-development-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 10 - Research and Development" } } }, "localname": "statement-statement-note-10-research-and-development-tables", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-12-income-taxes-components-of-temporary-difference-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 12 - Income Taxes - Components of Temporary Difference (Details)" } } }, "localname": "statement-statement-note-12-income-taxes-components-of-temporary-difference-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-12-income-taxes-net-deferred-tax-assets-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 12 - Income Taxes - Net Deferred Tax Assets (Details)" } } }, "localname": "statement-statement-note-12-income-taxes-net-deferred-tax-assets-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 12 - Income Taxes - Reconciliation of Income Taxes (Details)" } } }, "localname": "statement-statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-12-income-taxes-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 12 - Income Taxes" } } }, "localname": "statement-statement-note-12-income-taxes-tables", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-13-related-parties-related-party-expenses-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 13 - Related Parties - Related Party Expenses (Details)" } } }, "localname": "statement-statement-note-13-related-parties-related-party-expenses-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-13-related-parties-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 13 - Related Parties" } } }, "localname": "statement-statement-note-13-related-parties-tables", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 3 - Summary of Significant Accounting Policies - Summary of Subsidiary (Details)" } } }, "localname": "statement-statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-3-summary-of-significant-accounting-policies-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 3 - Summary of Significant Accounting Policies" } } }, "localname": "statement-statement-note-3-summary-of-significant-accounting-policies-tables", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)" } } }, "localname": "statement-statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-4-prepaid-expenses-and-other-current-assets-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 4 - Prepaid Expenses and Other Current Assets" } } }, "localname": "statement-statement-note-4-prepaid-expenses-and-other-current-assets-tables", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details)" } } }, "localname": "statement-statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-5-accounts-payable-and-accrued-expenses-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 - Accounts Payable and Accrued Expenses" } } }, "localname": "statement-statement-note-5-accounts-payable-and-accrued-expenses-tables", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-7-stock-options-changes-in-options-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 - Stock Options - Changes in Options (Details)" } } }, "localname": "statement-statement-note-7-stock-options-changes-in-options-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-7-stock-options-details-of-options-outstanding-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 - Stock Options - Details of Options Outstanding (Details)" } } }, "localname": "statement-statement-note-7-stock-options-details-of-options-outstanding-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-7-stock-options-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 - Stock Options" } } }, "localname": "statement-statement-note-7-stock-options-tables", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 - Stock Options - Weighted Average Assumptions Valuation of Stock Options (Details)" } } }, "localname": "statement-statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-8-warrants-schedule-of-warrants-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 8 - Warrants - Schedule of Warrants (Details)" } } }, "localname": "statement-statement-note-8-warrants-schedule-of-warrants-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-8-warrants-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 8 - Warrants" } } }, "localname": "statement-statement-note-8-warrants-tables", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details)" } } }, "localname": "statement-statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-note-9-selling-general-and-administrative-tables": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 - Selling, General and Administrative" } } }, "localname": "statement-statement-note-9-selling-general-and-administrative-tables", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "ovtz_statement-statement-significant-accounting-policies-policies": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies" } } }, "localname": "statement-statement-significant-accounting-policies-policies", "nsuri": "http://www.oculusvisiontech.com/20221231", "xbrltype": "stringItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses (Note 5)", "totalLabel": "Accounts Payable and Accrued Liabilities, Current, Total" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r9", "r310" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "us-gaap_AccountsPayableCurrent", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r12" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details": { "order": 0.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued fees and expenses" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "auth_ref": [ "r320" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r16", "r18", "r70", "r285", "r299", "r300", "r321", "r322", "r323", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r4", "r310" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r233", "r234", "r235", "r327", "r328", "r329", "r363" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r59", "r60", "r198" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r229" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based compensation (Notes 7, 13)", "terseLabel": "Share-Based Payment Arrangement, Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r78", "r85", "r101", "r119", "r152", "r155", "r158", "r166", "r172", "r173", "r175", "r176", "r177", "r178", "r179", "r181", "r182", "r264", "r266", "r272", "r310", "r331", "r332", "r370" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "us-gaap_Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r200", "r201", "r202", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r224", "r225", "r226", "r227", "r228" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "xbrltype": "stringItemType" }, "us-gaap_CanadaRevenueAgencyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government of Canada.", "label": "Canada Revenue Agency [Member]" } } }, "localname": "CanadaRevenueAgencyMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r31", "r100", "r304" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "terseLabel": "Cash and Cash Equivalents, at Carrying Value, Total", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r25", "r31", "r34" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "periodEndLabel": "Cash and cash equivalents at end of year", "periodStartLabel": "Cash and cash equivalents at beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r25", "r74" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r48", "r50" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "terseLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights (in CAD per share)", "verboseLabel": "Exercise price (in CAD per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "terseLabel": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "us-gaap_ClassOfWarrantOrRightOutstanding", "periodEndLabel": "Warrants outstanding (in shares)", "periodStartLabel": "Warrants outstanding (in shares)", "verboseLabel": "Number of warrants outstanding (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r327", "r328", "r363" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Common stock, no par value (in dollars per share)", "terseLabel": "Common Stock, No Par Value (in dollars per share)" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized (in shares)", "terseLabel": "Common Stock, Shares Authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r3", "r46" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding (in shares)", "terseLabel": "Common Stock, Shares, Outstanding, Ending Balance (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r3", "r310" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 91,422,569" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r19", "r104", "r106", "r111", "r293", "r296" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "us-gaap_ComprehensiveIncomeNetOfTax", "totalLabel": "Total comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": { "auth_ref": [ "r71", "r72" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.", "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]" } } }, "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r69", "r306" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r68", "r250", "r258", "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current income tax" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r29", "r68", "r251", "r257", "r258", "r325" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred tax recovery" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r246" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "us-gaap_DeferredTaxAssetsGross", "totalLabel": "Deferred Tax Assets, Gross, Total" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r361" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "us-gaap_DeferredTaxAssetsNet", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r67", "r362" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Non-capital losses" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r247" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "us-gaap_DeferredTaxAssetsValuationAllowance", "negatedLabel": "Unrecognized deferred tax assets" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r199", "r230", "r231", "r232", "r237", "r309" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_DisclosureTextBlockAbstract", "terseLabel": "Notes to Financial Statements" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20221231/role/statement-note-15-segmented-information", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative" ], "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "xbrltype": "domainItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r9", "r174", "r175", "r176", "r180", "r181", "r182", "r289", "r326" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable and accrued expenses - related parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r112", "r127", "r128", "r129", "r130", "r131", "r135", "r136", "r138", "r139", "r140", "r142", "r270", "r271", "r294", "r297", "r307" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss per share \u2013 basic and diluted (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r36", "r37" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r366" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of foreign currency translation on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r46", "r97", "r108", "r109", "r110", "r122", "r123", "r124", "r126", "r132", "r134", "r143", "r167", "r197", "r233", "r234", "r235", "r253", "r254", "r269", "r276", "r277", "r278", "r279", "r280", "r281", "r285", "r299", "r300", "r301" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r22" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": 3.0, "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Office and administration" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r42", "r43" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r44", "r45" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r20", "r77", "r81", "r90", "r152", "r154", "r157", "r160", "r295", "r308" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Loss before taxes for the year" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r170", "r171" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority, Name [Domain]" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r120", "r243", "r244", "r249", "r255", "r259", "r261", "r262", "r263" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r121", "r133", "r134", "r151", "r241", "r256", "r260", "r298" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "us-gaap_IncomeTaxExpenseBenefit", "totalLabel": "Total income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r107", "r239", "r240", "r244", "r245", "r248", "r252" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r238", "r242" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Effect of change in tax rates" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpense": { "auth_ref": [ "r360" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Permanent differences" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": { "auth_ref": [ "r360" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).", "label": "Adjustment to prior years provision" } } }, "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r26", "r33" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Cash paid during the year for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r80", "r88", "r318" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Tax Receivable \u2013 Canadian GST" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r28" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase in accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r28" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "(Decrease) increase in accounts payable and accrued expenses due to related parties" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r28" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "negatedLabel": "(Increase) decrease in prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r83" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r113", "r115", "r116" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid during the year for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InternalRevenueServiceIRSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.", "label": "Internal Revenue Service (IRS) [Member]" } } }, "localname": "InternalRevenueServiceIRSMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseContractualTermAxis": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Information by contractual term of lease arrangement.", "label": "Lease Contractual Term [Axis]" } } }, "localname": "LeaseContractualTermAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseContractualTermDomain": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Contractual term of lease arrangement.", "label": "Lease Contractual Term [Domain]" } } }, "localname": "LeaseContractualTermDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r8", "r79", "r87", "r310", "r324", "r330", "r365" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "us-gaap_LiabilitiesAndStockholdersEquity", "totalLabel": "Total Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r13", "r99", "r119", "r166", "r172", "r173", "r175", "r176", "r177", "r178", "r179", "r181", "r182", "r265", "r266", "r267", "r272", "r310", "r331", "r370", "r371" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "us-gaap_LiabilitiesCurrent", "terseLabel": "Liabilities, Current, Total", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "stringItemType" }, "us-gaap_MarketingExpense": { "auth_ref": [ "r22" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": 1.0, "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.", "label": "Marketing" } } }, "localname": "MarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "ComplyTrust Inc." } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details" ], "xbrltype": "percentItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r114" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r114" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "totalLabel": "Net cash provided by investing activity" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activity:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r25", "r27", "r30" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r21", "r30", "r82", "r89", "r98", "r103", "r105", "r110", "r119", "r125", "r127", "r128", "r129", "r130", "r133", "r134", "r137", "r152", "r154", "r157", "r160", "r166", "r172", "r173", "r175", "r176", "r177", "r178", "r179", "r181", "r182", "r271", "r272", "r308", "r331" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "us-gaap_NetIncomeLoss", "terseLabel": "Net Income (Loss) Attributable to Parent, Total", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r152", "r154", "r157", "r160", "r308" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "us-gaap_OperatingIncomeLoss", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r367" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": 4.0, "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Rent", "terseLabel": "Operating Lease, Expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r65" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operatinting loss" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r73" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-1-basis-of-presentation-and-business" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Other Assets Disclosure [Text Block]" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r15", "r17", "r273", "r274", "r275" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "order": 0.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Currency translation differences", "negatedLabel": "Currency translation differences" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsForProceedsFromOtherInterestEarningAssets": { "auth_ref": [ "r84" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net cash outflow or inflow for the increase (decrease) in other interest earning assets not separately disclosed.", "label": "us-gaap_PaymentsForProceedsFromOtherInterestEarningAssets", "negatedLabel": "Interest received" } } }, "localname": "PaymentsForProceedsFromOtherInterestEarningAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r24" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "us-gaap_PaymentsOfStockIssuanceCosts", "negatedLabel": "Share issuance costs", "terseLabel": "Payments of Stock Issuance Costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_PolicyTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_PolicyTextBlockAbstract", "terseLabel": "Accounting Policies" } } }, "localname": "PolicyTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockNoParValue": { "auth_ref": [ "r2", "r333" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, no par value (in dollars per share)" } } }, "localname": "PreferredStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized (in shares)", "terseLabel": "Preferred Stock, Shares Authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r2", "r183" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued (in shares)", "terseLabel": "Preferred Stock, Shares Issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r2", "r310" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock - no par value; authorized 250,000,000 shares, none issued" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r319" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "terseLabel": "Prepaid expenses and other current assets (Note 4)", "totalLabel": "Prepaid Expense and Other Assets, Current" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r102", "r168", "r169", "r305" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details": { "order": 0.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r23" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r23" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "us-gaap_ProceedsFromIssuanceOrSaleOfEquity", "terseLabel": "Proceeds from Issuance or Sale of Equity, Total" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r91", "r92" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": 0.0, "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r76", "r288" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "us-gaap_RelatedPartyTransactionAmountsOfTransaction", "terseLabel": "Related Party Transaction, Amounts of Transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r96", "r288", "r289", "r369" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Selling general and administrative", "terseLabel": "Related Party Transaction, Expenses from Transactions with Related Party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r286", "r287", "r289", "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r61", "r94", "r372" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 }, "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development (Note 10)", "totalLabel": "Research and Development Expense, Total" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost": { "auth_ref": [ "r93" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details": { "order": 2.0, "parentTag": "us-gaap_ResearchAndDevelopmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed.", "label": "Software development" } } }, "localname": "ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.", "label": "Research, Development, and Computer Software Disclosure [Text Block]" } } }, "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r5", "r47", "r86", "r302", "r303", "r310" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "terseLabel": "Retained Earnings (Accumulated Deficit), Total" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern-details-textual" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r97", "r122", "r123", "r124", "r126", "r132", "r134", "r167", "r233", "r234", "r235", "r253", "r254", "r269", "r299", "r301" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "Schedule of Related Party Transactions [Table Text Block]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r51", "r52", "r53" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r148", "r149", "r150", "r152", "r153", "r156", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-15-segmented-information" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r22" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 }, "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative (Note 9, 13)", "totalLabel": "Selling, General and Administrative Expense, Total" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r28" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Add back non-cash share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.", "label": "Expiry date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Restrictions on equity-based instruments during the vesting period, such as the inability to transfer unvested awards, are not taken into account in estimating the fair value of the award. However, restrictions that remain in effect after an award is vested, such as the inability to transfer or hedge vested options or a prohibition on the sale of outstanding vested shares (or other type of equity) for a period of time, affect the estimate of an award's fair value.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Exercise price (CAD) (in CAD per share)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Expected dividend rate", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.", "label": "Expected annualized volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Exercisable (in shares)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Granted, aggregate intrinsic value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Granted, options (in shares)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Fair value of options granted (CAD) (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r58" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Options outstanding, aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "$Number of options outstanding (in shares)", "periodEndLabel": "Options outstanding (in shares)", "periodStartLabel": "Options outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Exercise price (in CAD per share)", "periodEndLabel": "Options outstanding, weighted average exercise price (in dollars per share)", "periodStartLabel": "Options outstanding, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r200", "r201", "r202", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r224", "r225", "r226", "r227", "r228" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "terseLabel": "Granted, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-Based Payment Arrangement, Tranche One [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r203", "r222", "r223", "r224", "r225", "r228", "r236", "r237" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected life of options (in years) (Year)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Remaining contractual life (Year)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "us-gaap_SharesIssued", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r35", "r117" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r14", "r46", "r97", "r108", "r109", "r110", "r122", "r123", "r124", "r126", "r132", "r134", "r143", "r167", "r197", "r233", "r234", "r235", "r253", "r254", "r269", "r276", "r277", "r278", "r279", "r280", "r281", "r285", "r299", "r300", "r301" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity", "http://www.oculusvisiontech.com/20221231/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-15-segmented-information", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r122", "r123", "r124", "r143", "r292" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets-parentheticals", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity", "http://www.oculusvisiontech.com/20221231/role/statement-note-1-basis-of-presentation-and-business", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-research-and-development-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-", "http://www.oculusvisiontech.com/20221231/role/statement-note-11-financial-instruments-and-risks-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-components-of-temporary-difference-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-net-deferred-tax-assets-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-reconciliation-of-income-taxes-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-related-party-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases", "http://www.oculusvisiontech.com/20221231/role/statement-note-14-operating-leases-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-15-segmented-information", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern", "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-summary-of-subsidiary-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-changes-in-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-of-options-outstanding-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-weighted-average-assumptions-valuation-of-stock-options-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-schedule-of-warrants-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-selling-general-and-administrative-expenses-details", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-tables", "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r2", "r3", "r46", "r47" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Sale of common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r2", "r3", "r46", "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Sale of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r3", "r6", "r7", "r41", "r310", "r324", "r330", "r365" ], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "us-gaap_StockholdersEquity", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets", "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-stockholders-equity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r49", "r118", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r197", "r268" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock", "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Substantial Doubt about Going Concern [Text Block]" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-2-going-concern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Summary of Operating Loss Carryforwards [Table Text Block]" } } }, "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-cash-flows" ], "xbrltype": "stringItemType" }, "us-gaap_TableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "us-gaap_TableTextBlock", "terseLabel": "Notes Tables" } } }, "localname": "TableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-10-research-and-development-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-12-income-taxes-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-13-related-parties-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-4-prepaid-expenses-and-other-current-assets-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-5-accounts-payable-and-accrued-expenses-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-8-warrants-tables", "http://www.oculusvisiontech.com/20221231/role/statement-note-9-selling-general-and-administrative-tables" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r38", "r39", "r40", "r144", "r145", "r146", "r147" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-significant-accounting-policies-policies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options", "http://www.oculusvisiontech.com/20221231/role/statement-note-7-stock-options-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-", "http://www.oculusvisiontech.com/20221231/role/statement-note-3-summary-of-significant-accounting-policies-details-textual" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "calculation": { "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Commitment to issue shares" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-balance-sheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "us-gaap_WarrantsAndRightsOutstandingTerm", "terseLabel": "Warrants and Rights Outstanding, Term (Month)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-note-6-common-stock-details-textual" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r135", "r140" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of common shares outstanding \u2013 basic and diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.oculusvisiontech.com/20221231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r311": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r312": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r313": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r314": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r315": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r316": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r317": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r35": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4M", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "730", "Topic": "985", "URI": "https://asc.fasb.org/subtopic&trid=2197926", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 74 0001437749-23-008107-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-008107-xbrl.zip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